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When the birth of Louise Joy Brown was announced in 1978 as the world’s first 
baby born from in vitro fertilization (IVF) or the world’s first “test-tube baby,” 
many took notice. There was fear that we were crossing a line into unmarked 
territory and exposing the human embryo like never before. What would hap-
pen to these children formed in cold glass containers in sterile labs? Would they 
be less human? Would they be monstrous? Would they die and feel it? This 
was  science and medicine dealing with the most vulnerable stage of human 
 becoming – should we really be messing about so? Many women, especially those 
of us in or near large modern cities and now used to routine medical attention 
to our reproductivity, saw this as further incursion. Not necessarily unwelcome, 
but was it necessary? Those critical of medical intervention into a normal part 
of human being continued to be critical and could see how genetic engineering 
would figure. However, more women who lived in poverty and social neglect 
with far less attention paid by modern medicine to their reproductivity didn’t 
notice. Some religious authorities welcomed IVF as another step in promoting 
the reproduction of souls, while others sniffed the air and claimed the move too 
close to playing God. And a combination of all from the above worried over the 
status of the newly exposed human embryo.
The news heralded something very new, very important and a big change in 
how we handle reproduction. This book argues the opposite. Although the ex-
ternalization of conception for the first time is significant and unique, the ques-
tions raised by the appearance of the first test-tube baby are not new, and neither 
are the motivations trailing behind. This was less a line suddenly crossed than 
a burst of success after many years of developments from various sectors – from 
animal husbandry to endocrinology. There are also systems at play combining 




to name a few key ones. And throughout there are two important and increas-
ingly overlooked constants: women’s bodies or bodies that can conceive, gestate, 
birth and nurse are at the core, and socio-economic interests are always close to 
hand. How to make sense of it all?
Half of this text is devoted to developing an appreciation of the systems that 
scaffold what is typically understood as reproductive technology (when we add 
“technology” to the term we normally mean “new” reproductive technologies 
post-1978, Louise’s birth year). The first four chapters examine ideas about re-
production as they change through the ages; the social, political and financial im-
pacts of the modern medical age of reproduction; and our constant and shifting 
socio-economic controls of reproduction as well as sexuality. The second half of 
this book examines the nature of shifts in reproductive and genetic science and 
medicine beginning in the last quarter of the 20th century and examines them 
in terms of ongoing legislative challenges, the principles of reproductive justice 
and recent developments in the current systems of reproductivity and replication 
worldwide.
The first chapter examines key shifts in how we understand reproduction 
from veneration of the feminine reproductive to supposed genderless genetic 
recombination. It considers the major developments in reproductive thought, 
especially in terms of gender from the prehistoric times to today. There is an 
obvious decline in the valuation of the feminine reproductive over the ages, and 
a fast-rising sun starting mid-20th century and continuing into the 21st century 
in genetic replication. The current state of medicalization of reproduction and 
birth is explored in the second chapter as a logical development from centuries 
of denigration of feminine reproductivity and the recognition of value in the 
medical care of pregnancy and birth worldwide. The modern social control of 
reproductivity in terms of rights and social justice is the focus of Chapter 3, 
which covers various ways in which we as a society control the means of repro-
duction (access to conception and abortion) and how we recognize and limit 
family formation (kinship). This is explored further in the fourth chapter in 
terms of sexuality. Once we were able to distinguish between sexual desire and 
reproduction, significant sociopolitical developments in reproductive rights were 
achieved, allowing for both control over family size especially by women and the 
recognition of non-heterosexual communities and their rights which eventually 
included the right to reproduce. The commercial interest in the management of 
sexuality and reproduction is included.
Chapter 5 introduces the slate of the so-called new reproductive technologies 
and their constant companion, genetic engineering. Particular attention is played 
to the key characters involved in their development and how they link to a vari-
ety of fields including a well-established industry in dairy and meat, and growing 
speculation in genetic applications. Chapter 6 explores the difficult terrain of 
legislative response to new reproductive technology (NRT) applications in hu-
mans, including bringing under new legislation older reproductive technologies 
and initially hampering reproductive rights for single women and gay men. The 
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challenge with legislating genetic science is also explored. In Chapter 7 we re-
turn to the issue of reproductive rights, but through an intersectional approach: 
reproductive justice. Here the focus is on access issues due to sexual orientation, 
global disparities and intranational racial and socio-economic inequalities. We 
examine feminist responses to NRTs along with responses by dominant religious 
authorities and growing LGBTQ2+ (lesbian, gay, bisexual, transgender, queer, 
two-spirited, plus others questioning their gender) communities giving voice to 
their sexual freedom and reproductive rights. The eighth and final chapter brings 
together many of the themes covered previously in the text by breaking down 
the meaning of each word in the phrase, women and new reproductive technol-
ogy. In the conclusion, this analysis is extended into a selection of developments 
in NRTs and genetic engineering since 2010.
Throughout this volume concepts behind words such as woman, parent, 
right and technology are not seen as stable, nor are they untethered. The text is 
designed to draw attention to the variety of platforms on which reproduction 
occurs: the politics of kinship, gender discrimination and biomedicalized in-
dustries. It is hoped that after reading through this work you become aware of 
how far and deep reproduction and all of its issues spread. Also, we live in a time 
when we are about to take important steps into a world of replication; the more 
informed we are of how genetic engineering intersects with socio-economic 
systems, the better. This is one attempt.
Our ideas of what reproduction is have changed over time. From the prehistoric 
to today, we have wrangled with the question, “where do babies come from?” 
Initially, we didn’t understand the connection between sexual activity and repro-
duction. Then, once we thought we did, we became fascinated by (and restricted 
to) a male–female structure, with varying roles assigned to each gender, with the 
male normally coming out on top. This has extended to all of life in quests to 
explain the vibrant world around us – how does it keep going? How does repro-
duction vary between beings? Why and how do beings change over time? Can we 
control reproduction to our advantage? Should we? The 20th century is an im-
portant time in reproductive theory and practice: it marks not only the discovery 
and coding of an entire human genome (the genetic information unique to each 
human being), but also the achievement of almost 100% effective biochemical 
contraception and conception outside of the body. We have learned enough about 
reproduction and genetic replication to move human reproductive parts from one 
body to another, to freeze and store these parts and to examine and modify them 
genetically before bringing them to term. None of this would have been possible 
without what came beforehand in attempting to understand reproduction. Also, 
this is not a straight arrow of technical development and discovery, but more of a 
spiralling questioning often controlled by dominant interests where unexpected 
ideas from the distant past resurface and continue to play a part today.
The prehistoric veneration of a feminine divine
It is difficult to unearth the meaning of prehistoric imagery and artefact. We 
have little in the way of any recorded voice; only the images and sculpted pieces 
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have been many attempts at making meaning of a growing collection of cave 
drawings and small stone figurines mostly from the Upper (or later) Paleolithic 
period (50000–10000 BCE or Before the Common Era, formerly BC or Before 
Christ). The Paleolithic period, defined by the presence of tools used by early 
humans, began over two and a half million years ago. These images and figurines 
have been considered through an archaeological lens in terms of possible mean-
ings, belief systems and sociality. When searching the Internet for the Paleolithic 
era, a common figurine appears – the so-called Venus of Willendorf, a handheld, 
limestone figure of a rotund female with voluptuous breasts and buttocks, which 
was found in lower Austria, and is dated 30000–25000 BCE. Of course, the 
much later Roman goddess of beauty and love who shares this figurine’s name is 
more commonly rendered in terms of heterosexual desire than venerated for fem-
inine reproductivity, as is believed to be the case for these prehistoric figurines.
The European archaeologist, Marija Gimbutas, gathered, categorized and 
 analysed over 2,000 images and figurines found mostly throughout Eastern 
 Europe, from the Upper Paleolithic period, which is an era associated with the 
appearance of artefacts but before the development of agriculture (which oc-
curred during the Neolithic period 10000–4500 BCE). She places the Venus 
figurine, and many like it, among a constellation of imagery focused on human 
female bodies, particularly their reproductive aspects. There are unabashed rep-
resentations of vulvas, uteri and breasts, surrounded by and incorporating swirls, 
seeds and whirls that are believed to represent the cycle of life. Animals stand in 
for some of the venerated parts and reproductive functions: the hedgehog and the 
bull for the uterus, for example. Male figures also appear during this period but 
much more rarely, and typically as a protector of plants and animals or as consorts 
to the feminine figures. A host of historians and social scientists have mapped 
and attempted explanations of the reproductive female figures and images. Some, 
such as Gimbutas, describe a powerful social role for the feminine reproductive 
that dominates in prehistoric imaging: a venerated goddess.
Again, we do not know exactly how human reproduction was understood 
in prehistoric periods. We can imagine that given what people saw – a wom-
an’s body starting to swell at about the third month of pregnancy followed by 
the birth of a baby six months later, with nothing much obviously happening 
right after heterosexual copulation – the sexual activity was not associated with 
the reproductive outcome. Heterosexual sex was understood as separate from 
 reproduction. There is ample evidence of reproduction being explained apart 
from heterosexual copulation, for example animal spirits or totems being as-
sociated with women’s reproductivity. In about 3000 BCE, the bull, according 
to Gimbutas, was associated with reproducing women (and not with power of 
the thunder god as in later Indo-European mythology) because of the similarity 
between the bull’s head and the female reproductive organs (the array of ovaries, 
fallopian tubes, ligaments and uterus). The hedgehog as prehistoric vessel is a 
representation of the human uterus (5000–4000 BCE).
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The separation of coitus and birth allows for a female-centred philosophy of 
human reproduction where the feminine serves as a symbolic bridge between all 
life and its meaning and purpose. Bulging breasts, swollen bellies and  exaggerated 
vulvas of the prehistoric human figurines are sometimes presented incised with 
concentric circles (read as the cyclical nature of life), while the head, a powerful 
symbol of the modern human being, is almost non-existent. By contemporary 
standards, these naked figures can be read as lewd, even pornographic. But those 
who contextualize the pieces historically and socially ignore the modern sex-
ual triggers of the naked female body and focus attention on the meaning of 
reproduction-as-female. Some, like Gimbutas, argue that the imagery refers to 
how the female reproductive body was venerated for sustaining as well as ex-
plaining the prehistoric world.
Although the relatively very high number of prehistoric female figurines com-
pared to male ones remains uncontested in modern archaeological studies (only 
2–3% of the figurines unearthed are male), there has been a critical response 
to the female goddess theory. Important questions regarding contextualization 
and overgeneralization arise: How can you take so many varied figurines from a 
wide-ranging area, produced at various times, and make generalizations about a 
shared and singular significance among these figurines? The archaeologist, Rich-
ard Lesure, offers a method designed to “diffract” a single-goddess construct. He 
argues for a careful comparison of female figurines between areas – Mesoamerica 
and the Near East, and to not confuse how we make sense of the people producing 
the figurines and the symbols they use with the people themselves and their use of 
the images and figurines. This is sound advice for any historian and archaeologist. 
Indeed, this method does open up the figurines, and the people who made them 
and used them, to a much more detailed, contextualized and self-aware study. But 
such studies do not seem to be forthcoming. Lesure’s caution also has the effect of 
distracting us from questions of why so many made the effort to create so many 
human female figurines, across great distances (the Near East, India, Mesoamerica 
and Europe), over thousands of years, always with feminine reproduction centrally 
featured alongside complex symbolism. And by comparison, there are virtually no 
human male figurines associated with reproduction. Why not?
There may be something of an explanation in Carl Liungman’s – the Swedish 
scholar of symbols – description of the development of the symbol for Venus, 
which indicates both the planet and the Roman goddess (known as A phrodite in 
Ancient Greece). The goddess Venus is represented by the symbol now meaning 
female in modern biological science (a small circle with a cross underneath), and 
meaning emancipated woman in the mid-20th century when the A merican-based 
women’s liberation movement added a closed fist at the top of the cross within 
the circle. Clara Pinto-Correira credits Liungman with identifying an important 
shift in the meaning of Venus:
The planet Venus, [female symbol], was in earlier times associated with a 
common goddess of fertility, war, sex and peace. This was true of nearly all 
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known ancient cultures around the Mediterranean. But from about 2400 
until 250 B.C. this Venus goddess was gradually replaced by masculine 
divinities.
Enter the veneration of the male and masculinity, and what Riane Eisler, a 
cultural historian and evolutionary theorist, calls the “gylanic [gender equita-
ble society]-androcratic [male dominant society] transformation.” Hence the 
20th-century addition of a clenched woman’s fist to the symbol of Venus.
Ancient historic philosophies of generation: epigenesis
This transformation from societies where women’s reproductivity was venerated 
to male-dominant societies occurs near the beginning of the historic age (defined 
by the arrival of writing in about 3200 BCE). In addition to text, early historic 
societies had cities and learning centres where philosophies of good government 
and ideal social life were argued and recorded, along with rationalizations of the 
world around them. Moving from artefacts and symbols to text, we get a better 
handle on what was thought about reproduction, especially from the classical 
Greek “father of philosophy,” Aristotle (384–322 BCE). Although this is not the 
first example of writing on the meaning of reproduction, Aristotle’s Generation of 
Animals is often referred to as one of the earliest theories of reproduction because 
of its detailed rationalization using a proto-scientific approach. It is interesting 
to note that the word “reproduction” was only coined in 1749 by the natu-
ralist Georges-Louis Leclerc, Comte de Buffon (before then “generation” was 
the word commonly used). Aristotle made clear distinctions between gendered 
roles, which include assumed roles in his early scientific explanation of human 
reproduction. Aristotle distinguished between bloodless animals, chiefly insects 
(which were thought to reproduce spontaneously), and all the rest, including 
humans, which relied on distinct female and male contributions. Blood and heat 
purification played significant roles –probably drawn from prehistoric and pagan 
valuations of fire as both life-enhancing (providing heat in cold environments, 
cooking food, sealing and disinfecting wounds) and purifying (new life springs 
from burnt ground, healing elements can be distilled from boiled plant concoc-
tions). Although this classical natural philosophy of human reproduction was 
somewhat empirical, it was limited to what could be seen by the human eye 
unaided by any magnification. At times there are elements in these theories based 
on pure conjecture, such as the role of female “semen.”
By the time of Aristotle’s work on human generation, a connection between 
heterosexual coitus and reproduction had been established: sex and reproduction 
were no longer separated. Autopsy practices of the day focused on genitalia: 
the womb, ovaries, the fallopian tubes (although not yet named so), the vagina, 
testicles and the penis, and the attached blood vessels (undifferentiated veins 
and arteries). Ovaries were understood as female versions of male testes. Sperm 
and eggs were not yet identified; only the fluids thought to carry reproductive 
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components from both sexes were visible and figured in these theories of con-
ception. The obvious absence of menstrual fluid once a woman became pregnant 
was read as the retention of that fluid to nourish the seed planted during the ejac-
ulation of male semen. Both male and female reproductive fluids were thought to 
be generated from blood: male semen was understood as more distilled or perfect 
than female menstrual blood, which was more abundant but far less changed or 
perfected. Heat was the reason given for it. Men, the larger and stronger, and 
thus considered the more developed being, were argued by Aristotle to have a 
much greater ability to generate heat and perfect their blood into semen-as-seed. 
Women’s role was to provide the place and nourishment for the male seed to 
grow. Important to note here is that this seed is not a preformed human being 
but acts on the material provided by the female (menstrual fluid as an inferior 
but necessary blood derivative) by providing a sort of formula or directions for 
embryonic development. This approach is known as epigenesis.
The historian of science, Nancy Tuana, reminds us of Aristotle’s description 
of male ejaculate as “the principle of soul,” which also elevates the male role in 
reproduction to a spiritual level, leaving the female one as mundane (meaning 
literally, of the world) and “just a nurse to the seed.” This view did not exactly 
match other classical theorists, including Hippocrates (c460–370 BCE), who be-
lieved that a foetus resulted from a combination of male and female semen, albeit 
the female version being invisible and weaker than that of the male. The Greek 
physician, surgeon and natural philosopher Galen (130–210 AD), who is often 
cited as one of the founders of modern medicine, initially embraced Hippocrates’ 
notion that female and male semen combined to form the embryo. However, 
without the ability to visualize female semen, Galen eventually adopted Aris-
totle’s theory of generation that reduced the female role to a passive and inferior 
one, explaining how the internalization of female genitalia was a sign of how a 
lack of heat in the female means that the genitalia does not fully unfold or bloom 
outwards as male genitalia. The theory of the superior male role in reproduction 
is perpetuated for over a 1,000 years: Saint Gregory of Nyssa (335–394 AD) ar-
gues that the embryo is implanted in the female by the male; Saint Thomas Aqui-
nas (1225–1274) argues that only God can produce form in matter, so “the active 
seminal power” of man’s seed acts as a medium between God and mankind; and 
the Judaic Midrash Rabbah Genesis (1545) repeats Aristotle’s theory that the male 
sperm acts upon the female matter (menses) to give it form.
Reproductive theory then moves to establish what Tuana calls the “anatomi-
cal tradition” which, alongside natural philosophies of reproduction, helps spread 
the word. The 1575 illustrations of incorrect penis- and testes-shaped female 
genitalia attributed to the work of German surgeon von Georg Bartisch indicate 
female reproductive anatomy as a version of the male. The Belgian physician and 
“father of modern anatomy,” Andreas Vesalius (1514–1564), in his five-volume 
illustration of the human body, De Humani Corpus Fabrica, shows an anatomically 
incorrect image of the ovaries that is used to distinguish between a hot ovary and 
a cool one based on the blood supply and to address Galen’s criticism of Aristotle’s 
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theory of generation as incomplete. Vesalius’ images attempt to prove how the 
“natural deficiency” of the female is reproduced in human reproduction: female 
foetuses are generated from the left ovary thought to be fed by cooler, unpurified 
blood; males are generated from the right ovary thought to be served by a hotter, 
purified blood supply. Actually these early anatomists mixed up the functions of 
ovarian veins (which take blood away from the ovary) and arteries (which bring 
blood to the ovary); but human anatomy in this period is such that the slight 
difference between left and right vein attachment to the ovaries rationalized the 
discriminatory theory of sexual difference. Thanks to inexpensive 16th-century 
printing techniques, images from the Fabrica became widely available and well 
known, and so we arrive at the onset of the Scientific Revolution with women’s 
“natural inferiority” to men well established and based on broadly accepted, dis-
criminatory theories of sexually determined reproductive capacities.
The scientific revolution and preformationism
This gender discrimination, that embryos develop gradually from unorganized 
matter into the perfect human form, with the male seed as the activating agent 
and the female as passive nurturer, persisted over 1,200 years. With advance-
ments starting in the 1600s in anatomy, especially microscopic-aided examina-
tion, and the development of scientific thought and method in general, things 
begin to change in the world of human reproductive theory. William Harvey 
(1578–1657), a renowned British physician and scientist, took up the work of 
Hippocrates and Aristotle on the generation of animals, and at the end of his 
career made an unsubstantiated claim that female eggs played a significant role 
in reproduction: ex ovo omne vivum (every living thing comes from an egg). This 
is not surprising, given that since classical Greece, those interested in explain-
ing reproduction often examined chicken eggs and embryos. However, Harvey 
could not find any sign of eggs in the mammals he examined and concluded 
that reproduction occurred in the uterus following coitus with a combination 
of difficult-to-determine male and female contributions, but he continued to 
assert that nothing substantive came from the female “testes” (ovaries). The med-
ical historian, Mathew Cobb, calls our attention to this period and focuses on 
the 1660s–1670s, shortly after Harvey’s statement about the significance of eggs, 
when evidence appears of human egg function (not yet of the egg itself ) soon 
followed by the visual discovery of sperm.
Typical of the time, gentlemen scientists with little training and education 
provided the means and incentives for scientific exploration. One such gentle-
man who was once a French ambassador, Melchisedec Thévenot, brought two 
medical students from Leiden University to his home in Paris to explore the gen-
eration of animals. The students, Jan Swammerdam and Niels Stenson (known 
as Steno), were struck with the task of disproving Rene Descartes’ theoretical 
approach to generation that followed Aristotle’s, using the emerging scientific 
method based on empirical evidence and replicable experimentation. Although 
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neither student found anything during their stay with Thévenot, they became 
motivated to continue with the work on their own. Because Swammerdam was 
primarily interested in insects, he was the first to state, with empirical evidence, 
that insects were neither bloodless nor did they spontaneously generate but re-
produced with eggs. In 1669, like Harvey, he claimed boldly, “all animals come 
from an egg laid by a female of the same species.” This theory, known as ovism, 
challenged almost 2000 years of thought that animals generated either sponta-
neously or with little female agency. Steno made a similar claim comparing the 
reproductive tracts of egg-laying rays, dogfish that give birth to live young, to 
women and sheep. Because of the similarities between them he concluded that 
eggs must be present in all these animals, whether they are mammals or not. 
Swammerdam looked for eggs in the ovaries of dead women and competed with 
a student colleague, Renier de Graaf, to be the first to prove they exist. Relying 
on dissected rabbit ovaries, de Graaf published in 1672 a new treatise on the gen-
erative organs of women (De Mulierum Organis Generationi Inservientibus Tractatus 
Novus) and argued that the follicles (raised bumps) visible on rabbits’ ovaries were 
eggs (which is why we now refer to ovarian follicles as Graafian follicles). De 
Graaf pointed out in his treatise that Steno had claimed that ovaries contained 
eggs, but he could not see them. Nor could de Graaf, but he was able to prove 
their existence through their function using the new scientific method of empir-
ical experimentation. He proved that the follicles (eggs) moved from the ovary to 
the fallopian tubes (described previously by Gabriele Fallopius, 1523–1562). In 
rabbits he saw small spherical shapes (fertilized eggs) appear in the tubes follow-
ing sexual intercourse and noted that their number never exceeded the number 
of ovarian follicles found in the same animal just before the sexual activity. With-
out the identification of sperm, and unable to find traces of semen in the tubes, 
de Graaf concluded that a male “vapour” fertilized the eggs.
Also typical of the Scientific Revolution is the establishment of societies of 
scientists as a means of professionalizing and disseminating the growing scientific 
experimental work. These societies were found in most western European coun-
tries and became powerful and influential. Among the most influential is the 
British Royal Society of London for Improving Natural Knowledge (commonly 
referred to as the Royal Society), which was established in 1660 and contin-
ues today. The Royal Society reviewed and published the so-called discoveries, 
many of which involved the new scientific instrument, the microscope. In his 
submission of his work to the Royal Society, de Graaf mentioned the work of his 
friend, a draper in Delft, Antonie van Leeuwenhoek (1632–1723), who taught 
himself how to grind lenses, made a particularly powerful microscope and began 
observing with it. Although not a trained scientist, Leeuwenhoek and the Royal 
Society enjoyed a 50-year relationship, and his simple but effective microscope 
design was distributed throughout the Dutch Republic to become a powerful aid 
to the new scientific method enjoyed by many gentlemen. Swammerdam was 
among those who relied on the easy-to-use, single-lens microscope and used it 
to draw the first images of initial cell divisions in a fertilized frog egg. Medical 
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illustration that had long been based on gross anatomy (that visible to the naked 
eye) moved to the microscopic.
The microscope allowed for the exploration of a new tiny terrain that became 
the focus of reproductive theory between the late 17th and mid-19th centuries. 
When Leeuwenhoek came across millions of little “animalcules” swimming in 
his own semen (which he called spermatozoa or sperm animals), a new and en-
ergetic character entered the stage of reproductive theory, ready to address the 
matter of how the male reproductive contribution occurred in concrete and de-
monstrable terms. Initially the function of these animalcules was not understood; 
in fact, Leeuwenhoek argued that other matter in the semen which he saw under 
his microscope (tiny vessels) was more interesting and concluded (with no evi-
dence, and reverting to Aristotle’s theoretical position) that, “it is exclusively the 
male semen that forms the foetus and that all the woman may contribute only 
serves to receive the semen and feed it.” Although credited with the discovery 
of sperm, it was not Leeuwenhoek who recognized their function in reproduc-
tion. Despite the delay in publication of Leeuwenhoek’s discovery of sperm in 
semen, word got out, and others began examining semen through their own 
microscopes and found “little worms” in dog and mice semen. The Dutch phys-
icist, Christaan Huygens (1629–1695), published in 1678 that these findings were 
“extremely important and will provide material for those who seriously study the 
generation of animals,” which it did.
The human egg, which is much larger than a sperm but more difficult to 
access, was not identified until 1827 by Karl Ernst von Baer. It took another 
half century to put forward a theory of reproduction based on the fusion of the 
egg and sperm, which was made by Oscar Hertwig. Meanwhile, over 150 years 
during the 17th and 18th centuries, reproductive theorists continued to speculate 
on the meaning of the microscopic visions in terms of preformed beings, with 
emphasis either on the female egg (ovists) or the male sperm (spermists). Prefor-
mationists marked a significant move away from the earlier epigenecists – from 
Aristotle to Harvey – and believed the entire entity of a being was contained 
in its generative seed; it just required the correct conditions for unfolding or 
development.
As the Scientific Revolution heralded a new way of seeing the world, and 
especially of determining what constituted the truth about the world, this did 
not mean that well-developed religious truths and their explanations for how and 
why we exist suddenly disappeared. For centuries, religious and early scientific 
belief systems worked together. What Pinto-Correia calls “programmed encase-
ment” or the Russian doll metaphor refers to a long-standing human fascination 
with a hierarchy of mysteries, or the box hidden in another box which is hidden 
in another box, and so on. According to Christian belief, the primary creator, 
God, is everywhere and always waiting to be revealed according to His plan. The 
knowledge of God is mysterious and has to be earned. The struggle between early 
theories of reproduction, epigenesis versus preformation, demonstrates a similar 
quest to open reproductive mysteries to human understanding (and eventually 
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control). Both of these sets of concealed mysteries, especially those explaining 
creation, can be linked to the prehistoric spirals signifying (think some) the cir-
cularity of life. However, the more modern explanations, both religious and 
secular, are mechanistic and one way, not circular, and are driven by a desire to 
know the origin and author of all generation with infinities of scale stretching 
in both directions from our key reference point, the human being: downwards 
and inside to the microscopic, and outside and upwards towards the astronomical 
heavens and the beginning of it all.
Modern reproductive science: genetic recombination
As modern science was developing, so were philosophies of knowledge and be-
ing (commonly referred to as the Age of Enlightenment-1685–1815), all along-
side accepted religious beliefs of the time. There are two important streams of 
thought here that relate to the preformation theory of generation, which was 
dominant at the time: Man is a being of reason where reason is God, but man is 
free to make reasonable meaning of the universe (represented by the French phi-
losopher and mathematician, Rene Descartes-1596–1650, who is often quoted 
as saying, “I think, therefore I am”). The second stream sees man as constantly 
striving to understand God’s complex and ungraspable mechanistic universe or 
boxes within boxes (represented by the English mathematician, physicist and 
theologian Isaac Newton, 1643–1727; and the French philosopher and historian 
Voltaire,1694–1778). It is the latter stream of thought that is associated with the 
preformation theory of reproduction that dominates during the Enlightenment 
period.
Perhaps because early seed theories came very close to atheism when they 
argued that some form of male agent acted upon disorganized female matter to 
give rise to human form, preformationists, whether focused on the role of the egg 
or the sperm, believed the entire form was already contained in the germ or seed 
of reproduction. As Pinta-Correia puts it, the battle between the preformation-
ists was focused on “where God had encased all organisms destined to come to 
come to life on earth: the egg [or] the spermatozoan.” Although preformationist 
theory briefly provided a more active role for the female contribution to human 
reproduction than had been seen for millennia, the female reproductive role 
remained restricted by persistent beliefs in the superiority of the male role in pro-
creation, heavily influenced by theological beliefs in masculine origins generally.
By the start of the 20th century, the profession of scientists and physicians 
was well established through expanding systems of public and higher education. 
Reproduction theory was housed in new disciplines including evolutionary and 
cell biology, embryology and gynecology. Cells were first seen in 1665 under the 
microscope and identified by the British scientist, Robert Hooke, who thought 
what he saw were like the monks’ cells in a monastery. With the development of 
more powerful microscopes, cell components and functions were observed and 
gave rise to cell theory, which was formulated and credited to Matthias Schleiden 
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and Theodor Schwann in 1839. This signalled the end of preformationism, as 
well as theories of spontaneous generation. Instead, cell theory claimed that these 
newly discovered entities regenerate through division (Omnis cellula e cellula) and 
are the basis, in terms of both structure and function, of all organisms. This al-
lowed for the “animalcules” and “follicles” first detected by 17th-century eyes to 
be understood in new terms: cellular parts of a complex reproductive functional 
system.
And then came the gene. In The Fundamentals of Genetics by Leslie Vega and 
Bret White we learn that inheritance of attributes had long been observed: herd-
ers and others dealing with domesticated animals watched as traits passed from 
one animal to its progeny, and farmers understood the same happened in plants. 
And these traits could be controlled through breeding practices such as those 
developed in a proto-scientific manner by the British agriculturalist, Robert 
Bakewell, who, in the mid-18th century, separated his male and female livestock 
to control their inter-breeding for desirable traits and against non-desirable ones. 
Meanwhile, in the developing profession of medicine, physicians were observing 
how diseases were passed from one family member to another: Down’s syndrome 
was described in 1866. At the same time, Gregor Mendel, an Augustinian friar 
and scientist who is now acknowledged as the “founder of modern genetics,” 
studied the inherited traits of peas and discovered recessive and dominant in-
herited traits. Charles Darwin published The Origin of Species in 1859, where he 
outlined the theory of how inherited traits change over time or evolve, which 
holds today. All of these developments expanded theories of human reproduction 
by extending our understanding of the function of reproduction. The newly 
identified egg and sperm cells combined to create a new organism, and in doing 
so, they carried forward traits (including those associated with visual appearance 
and disease), and then they recombined to give rise to new traits allowing the 
organism to change over time, or evolve. One species can even develop into 
another called “pangenesis,” from which the word gene is derived. Once again, 
we are drawn into profound questions of who we are, from where we come, and 
who we will become, but now outside of religious terms.
The chromosome or “coloured body” is a thread-like structure within cells 
containing DNA and proteins but was not initially understood in such detail. 
The chromosome was first seen in the early 19th century by several scientists 
and with new dying techniques, was detailed in terms of structure and function 
(mitosis or cell division producing two identical daughter cells) by the German 
anatomist Walther Flemming in 1882. However, Flemming did not know of 
Mendel’s earlier work on the theory and mechanics of inheritance in plants and 
made no links between the chromosome and heredity. In 1868, a weak acid in 
white blood cells was discovered, which we now know as DNA, and in 1889 
the Dutch botanist, Hugo de Vries, argued that “inheritance of specific traits in 
organisms comes in particles… [called] (pan)genes.” In the early 20th century, 
chromosomes were seen to be heredity units and necessary for embryonic devel-
opment. Then genetic discoveries started to tumble forward: A genetic map of a 
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chromosome was first made in 1913, and sex-linked inheritance was discovered. 
Between the 1930s and 1950s, distinctive contributions were identified for the 
cell nucleus (where DNA was discovered) and its surrounding material, called 
cytoplasm (where RNA was identified). At the same time, the “crossing over” 
or interchange of genetic material between two different chromosomes as the 
cause of recombination was demonstrated by American cell geneticists Barbara 
McClintock and Harriet Creighton. As the Second World War came to a close, 
DNA was isolated as the genetic material responsible for cellular transformation, 
and shortly afterwards the main components of DNA, nitrogenous bases or gua-
nine (G), adenine (A), cytosine (C) and thymine (T), were found to be always 
present in equal proportions to each other, and paired: GA and CT. An X-ray 
image of DNA was made in 1952, and a year later the combined work of British 
molecular biologist Francis Crick and X-ray crystallographer Rosalind Franklin, 
with the American molecular biologist James Watson, described the DNA as a 
double helix structure. In 1955, the American cell geneticist, Joe Hin Tjio, de-
termined the number of chromosomes in humans to be 46, as the mechanics of 
cellular division and the distribution of chromosomes from parents to offspring 
was clarified. We have arrived at the theory of reproduction as equal genetic 
contributions from both parents that recombine to produce a genetically distinct 
being. Genesis is genetic.
To be precise, these developments are understood as epigenetic as with Ar-
istotle’s theory of generation. But where Aristotle thought that the undiffer-
entiated essence of being (seed) was passed from the male to the female to be 
nourished and formed into a human being, contemporary epigenesis focuses on 
the differentiation of cells from undifferentiated cells with equal male and female 
genetic contributions. Twentieth-century theories of reproduction continued to 
focus on the mechanics of cellular genetic differentiation and have resulted in the 
engineering of reproduction and genetic replication. In principle, farmers con-
trolling for desired traits in animals and plants over centuries were early genetic 
engineers: penning animals to control their mating controlled the expression 
and recombination of their genes. This took time, however, and was hit-or-miss 
in securing desirable traits and avoiding undesirable ones. As microscopes grew 
more powerful and micro manipulation machines and biochemical instruments 
allowed for scientists to not only identify and move cells but to strip cells down 
to their functional components, a much quicker and more precise manipulation 
of genetic traits evolved.
In terms of reproductive theories and the explosion of scientific research 
throughout the 20th century, reproduction was not reduced to only genetic re-
combination. Again, based on what could be seen, the initial understanding of 
beings as powered machines in the 19th century focused on the complex array 
of nerves found throughout the body and attached to almost everything visible: 
organs (including ovaries and testes) and muscles. The historian of medicine and 
science, Chandak Sengoopta, describes this as the “neural model” of human 
being which included reproduction (and inspired the story of Frankenstein). But 
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in the early 20th century, this model quickly gave way to hormones as not only 
agents and anti-agents in the reproductive process, but also as leading actors in 
emerging theories of human in utero development. After cutting up gonads in 
rabbits and guinea pigs, and re-implanting them away from nerves, scientists 
discovered that something other than nerves activated growth and change. En-
docrine (hormonal) gland organs, including the gonads (ovaries and testes), were 
found to excrete a fluid that was not blood but was released into and carried by 
the blood. In 1905, the British physiologist Ernest Starling named these excre-
tions “hormones” after the Greek word for excitement or arousal; hormones 
were identified as a biochemical agent that can make change, like nerves and 
their innervation power.
Undetermined hormones were valued and used crudely in medical practice 
from the mid-19th century as a sort of rejuvenating tonic with the potency to 
excite or depress sexual development and behaviour. In the late 19th century, es-
pecially in France, gonads were being removed from slaughtered animals, dried, 
ground up and administered as the medical practice of “organotherapy.” This 
so-called treatment was clearly sexed and problematic from the start: male go-
nadal derivatives were used in men in an attempt to reverse impotence and senil-
ity, while female gonadal derivatives were used in women for uterine disorders 
(heavy bleeding) and hysteria (which literally means wandering womb).
A woman’s reproductive capacity was often associated with her mental health 
at this time and was a common rationale for preventing women from participat-
ing in the public world (such as attending university and practising as a doctor 
or lawyer) as it would overtax their brains, and thus hamper their natural repro-
ductive role. Aside from organotherapy, the removal of a woman’s ovaries began 
in 1872 in Germany as a treatment for “menstrual madness,” nymphomania, 
masturbation and hysteria, among other female ailments. Ovariectomies were 
practised liberally by physicians throughout western Europe until after the First 
World War. Besides being a highly questionable medical practice, this generated 
a significant and valuable source of human ovaries and ovarian tissue for research, 
medical practice and the distillation of hormones for pharmaceutical use. It also 
helped provide the rationale for the medicalization of female reproduction as it 
contributed to a new and growing industry in hormones.
The Dutch social scientist Nelly Oudshoorn provides an important and crit-
ical overview of the making of sex hormones. Initially sex hormones were de-
rived from organs in animals used in food production, and in 1923, the German 
Physician Ernst Laqueur signed a contract with a Dutch slaughterhouse to secure 
access to organ products to be processed for medical and scientific use. After 
sex hormones were later sourced in urine (horses’, and then pregnant women’s), 
Laqueur created the world-renowned hormone pharmaceutical company, Orga-
non, a key player in the development of human in vitro fertilization (IVF).
The discrimination in sourcing for sex hormones was perpetuated by medical, 
scientific and pharmaceutical practices in the early 20th century, from whole or-
gan or gland treatments to ones based on biochemicals distilled from the glands. 
16 Reproductive theories: then and now
The need for testing for the presence of specific hormones and the ability to 
distill them out of source material (for example, urine) gave rise to a profession 
of biochemists and to an adjunct industry of hormone assays (or testing), which 
resulted in the pregnancy test made accessible to women on a do-it-yourself basis 
by the inventor and graphic designer Meg Crane in 1967. Crane worked for Or-
ganon at the time. Oudshoorn argues that the struggle for access to and control 
over the distribution of newly discovered sex hormones resulted in a dispropor-
tionate focus on female sex hormones, female fertility and female reproductivity. 
This was partly due to difficulties in sourcing male sex hormones because of 
physiological factors: sex hormone in men’s urine is very weak compared to that 
in pregnant women’s urine. Another part has to do with scientific and medical 
fascinations with the ovary and its role in reproduction established in the 19th 
century, which provided ample reasons and opportunities for collecting female 
sex hormones. Also, during this period, women were increasingly medicalized 
because of their reproductivity and because of perceived links between an ac-
tively reproductive female and her overall well-being, which included meeting 
requirements of social feminine norms. Women were literally more available to 
study, in whole or in their parts, and there was more reason to do so furnished 
both by professional authorities in science and medicine and from pressures stem-
ming from social expectations regarding women’s primary role in society as a 
reproducing being.
The emphasis between 1929 and 1935 on studying various glands and their 
hormonal secretions led to what the physiologist Alan Parkes called “the heroic 
age of reproductive endocrinology.” A much clearer picture of the reproductive 
hormonal dance or “orchestra” involved in maturing and releasing the egg (fol-
licle stimulating hormone or FSH and luteinizing hormone or LH), readying it 
for fertilization and preparing the uterine wall for implantation of the fertilized 
egg (oestrogen and progesterone), emerged at this time. The bisexuality of sex 
hormones was discovered: both men and women produce both types of sex hor-
mones; it is a question of balance as to what sexual trait is expressed. And finally, 
the role of the brain was described, particularly hormonal messaging between 
the ovaries, the pituitary gland and the hypothalamus.
Oudshoorn indicates how, initially, these discoveries led to various medical 
applications of gonadal-based hormones including the treatment of senility and 
hemophilia with oestrogen derived from sheep placentas and ovaries. Also, a 
connection between sex hormones, especially oestrogen, and some cancers was 
suspected. The “most secret quintessence of life,” or the male hormone andro-
gen, was distilled in 1931 with great effort from 25,000 litres of male urine in 
Germany by the chemist Adolf Butenandt and was renamed by Laqueur in 1935 
(with research funding by Organon) as “testosterone.” Its medical application 
induced increased muscle mass and hair growth and was used to treat symptoms 
of ageing in men (called the “male climacteric” or a form of male menopause) 
including senility and declining sexual function, but with disappointing results 
in otherwise normal men. As hormones became associated with behaviour, 
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oestrogen was used in women diagnosed with an array of now questionable men-
tal illnesses, including hysteria. Testosterone was used to “treat” male homosexu-
ality (female homosexuality went largely unrecognized in the early 20th century 
and escaped such attention). In a period where gender was considered distinct, 
even oppositional, in terms of physicality and behaviour, hormones held out the 
promise to normalize perceived abnormalities or imbalances in both, and thus to 
stabilize the social and moral norms of the sexually conservative Victorian age.
Sengoopta explains how the distinction between male and female sex hor-
mones was complex, and sometimes misguided. The German physician, homo-
sexual activist and founder of the Berlin Institute for Sexual Science, Magnus 
Hirschfeld, put forward the “principle of universal sexual intermediacy” as an 
indication that all people contained a balance of male and female factors, phys-
ical and mental, and sometimes that balance failed. His Austrian colleague, the 
physiologist Eugen Steinach, began studying the basis of sexual difference in 
1912. He found the feminization of males possible through castration, and to a 
far lesser degree, the masculinization of women through castration and testicular 
transplant. This led initially to a very financially successful phase of vasectomy 
in older men as an anti-ageing and virilizing treatment (it was thought to trigger 
the pituitary gland and its growth hormone). A similar technique was tried in 
women shortly afterwards using the heating and radiation of the ovaries and was 
considered successful in terms of “rejuvenating” post-menopausal females. These 
techniques relied on the 1920s discovery by Harvey Cushing of the function of 
the tiny pituitary gland lying deep at the base of the brain, “like the nugget in the 
innermost series of Chinese boxes,” as the ignition for all glandular secretions in-
cluding the ovaries and testes, and was considered a fountain of youth. However, 
using sex hormones to control fertility remained out of reach in the first half of 
the 20th century. With oestrogen alone, physicians could not trigger menstrua-
tion in a woman unable to menstruate, but it was discovered that a combination 
of progestin (considered a male sex hormone) and oestrogen would lead to the 
complex build-up of the blood-filled lining of the uterus required to nourish the 
fertilized egg if present, and to be released as menstrual fluid if not.
Meanwhile, what Sengoopta calls “an ever-expanding cast of new characters” 
entered the scene of human reproduction. The adrenal glands (sitting atop each 
kidney and the source of the hormone adrenaline) became known during the 
early part of the 20th century as significant players in human development. A 
sexual component of the gland, “the third gonad,” was described in the 1950s and 
was held responsible for “virilizing” women and was even blamed for the earlier 
Suffragette movement! The pineal gland (found in the brain and now known as 
the source of the hormone melatonin used to regulate sleep) was thought to cause 
premature sexual behaviour in children. In the 1930s, the thymus gland found 
in the upper chest (the source of T cells and most active in pre-adolescents in 
establishing the immune system) was suspected of playing a role in the hormone 
or endocrine system that was then understood to orchestrate growth, including 
sexual maturation and reproduction. And king among these was considered the 
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pituitary gland, which in 1935 Bernhard Zondek called “the motor of all endo-
crine function.” As was becoming a common cycle, initially surgery, in this case 
pituitary transplants, was used to treat growth and development disorders. Once 
growth hormones or gonadotrophins were identified and distilled, they were 
used in treatment, but not yet effectively for infertility, even though this higher 
level of hormone signalling was known to influence the sexual gonads (ovaries 
and testes). Also, despite early endocrinology recognizing that sex hormones 
were not sexually exclusive, women and men both produced and required so-
called female and male sex hormones, sex hormones remain tightly associated 
with gendered traits today.
The mid-20th century brought important developments in understanding the 
complex combination of biochemical and neurobiological aspects of reproduc-
tion. Although the “era of the glands” in the early part of the century focused 
there, it came after a considerable time of early scientific exploration of the neu-
rological system as an electric generator of growth and development. In the early 
part of the 19th century Giovanni Aldini and Alessandro Volta were at odds over 
the role of “animal electricity” as potential reanimation. It was fairly widely 
known that applying electrical current through the system of nerves could stim-
ulate muscular movement in dead animals and cadavers. Could applying this life 
force not bring them back to life? It was these proto-neurological experiments 
and debates about life forces that inspired Mary Shelley’s Frankenstein in 1818. 
And they were not forgotten a century later as hormones entered the scene as life 
stimulators: in the mid-1930s, the biologist Francis Marshall demonstrated how 
electrically stimulating a rabbit’s head encouraged ovulation. By the mid-20th 
century, the link between the brain and the glands was described as a feedback 
circuit looping between the hypothalamus (a small region of the brain respon-
sible for signalling the release of hormones), the pituitary gland and the sexual 
gonadal glands. It was not simply the presence of hormones that was important 
to human reproduction, but when they appeared and where, in what quantity, 
in which combination – all of this in concert with neural messaging. Also, elec-
trical stimulation continues to play a significant part in reproductivity and is a 
key to several IVF-based techniques and some aspects of genetic engineering of 
the embryo.
Perhaps one of the most significant applications stemming from these ad-
vances in hormones, the neural system and reproductivity was the oral contra-
ceptive, the Pill. The Pill was developed in the mid-20th century by American 
endocrine scientists Gregory Pincus and Min Chueh Chang and the gynaecolo-
gist John Rock, and received crucial funding support from the American heiress 
Katherine Dexter McCormick at the urging of her friend, the birth control ad-
vocate Margaret Sanger. Sanger opened the first American birth control clinic in 
1916; the Pill was approved for clinical use in 1957. This progress in controlling 
reproductive hormones represents what sociologists of science such as Celia Rob-
erts characterize as a sociobiological shift. It was not simply new insights into 
the workings of reproductive hormones that led to the Pill’s development, but 
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the constant demand, especially by women, for an effective means of controlling 
their reproduction. Its application resulted in material changes to women’s bodies 
and lives, as well as to the nature of the social body around the world. And it was 
a nascent social movement that connected women’s control of their reproduc-
tivity with social well-being that drove this significant development of scientific 
understanding and medical applications within reproduction.
Biochemists came a long way in identifying and distilling an array of hor-
mones required to generate sperm and mature eggs and to prepare the uterus 
for implantation, but they needed to perfect the synthesis of these hormones in 
order to manipulate them and to provide effective treatment. Besides a highly 
effective oral contraceptive, some key medical applications of hormones in the 
mid-20th century included the treatment of diabetes with the hormone insulin 
and the treatment of dwarfism with human growth hormone. Early on there 
were some attempts at treating male and female infertility with doses of male 
and female hormones, respectively, with measurable success with the latter, but 
the picture was not clear as to what exactly was happening in the reproductive 
neuro-endocrine system. This would require the developments that led to IVF 
in humans in the early 1980s.
Assisted reproduction and genetic replication
Theories of reproduction in the early 20th century depended on an intense tri-
angulation of lab-based technical expertise (such as the emerging profession of 
biochemists), animal husbandry (for ample and steady supplies of organs and 
glands for hormones and sometimes for research subjects) and medical practice 
(particularly gynaecology and obstetrics). The same was true with the engineer-
ing of human reproduction, including genetics, as key areas of development in 
reproductive theory in the later 20th century and early 21st century. The shift 
was signalled by the externalization of human conception from the body known 
as IVF. Key players in this area of reproductive theoretical development included 
pharmacy companies (commercial interest spurring developments in hormone 
manufacture and hormonal screening), medical practice (chiefly in the new 
sub-specialties of assisted reproductive technologies and reproductive medicine), 
lab-based technicians (for gamete preparation and storage), scientists (geneticists 
and developmental biologists keen to access human gametes and cellular embryos 
for experimentation) and veterinarian science (alongside animal husbandry it 
provided support to develop breeding techniques associated with burgeoning 
food industries in meat and dairy).
During the latter half of the 20th century, key developments in reproduc-
tive theory included a refinement in the understanding of the complex system 
of hormones, organs, neural signalling and genetic exchange. These theoretical 
developments gave way to techniques that allowed for control of key aspects 
of the reproductive process at the moment of conception, such as developing a 
medium or nutritional fluid to support gametes and very young embryos outside 
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of the body. Hormonal ovarian stimulation was mastered to produce more than 
a single egg each cycle. The freezing and storage of gametes and embryos was 
achieved. Hormonal enhancements generated higher rates of success with em-
bryo implantation and allowed for embryo donation and surrogate pregnancy. 
Methods for genetic screening and the manipulation of pre implanted embryos 
were also developed.
These technical procedures in the handling of reproductive components and 
processes were honed chiefly in non-human applications first. The ability to 
transfer embryos came from initial attempts with rabbits, especially by the Brit-
ish zoologist and embryologist Walter Heape. The lab work at the turn of the 
20th century exploring embryology, glands and their effects on growth and sex 
attributes was quickly taken up in animal husbandry as a way of controlling for 
desired genetic traits in animals that served the food industry. For example, it was 
more efficient to transfer embryos from a cow with high milk fat content into 
hormonally readied surrogate cows to bring the desired embryos to term than 
wait out the ten-month gestation period in the cow each time she became preg-
nant before being able to start another reproductive cycle. By flushing out the de-
sired embryos at an early stage of pregnancy and implanting them in surrogates, 
you could have several cows pregnant at the same time with the desired genetic 
traits. Techniques of sperm donation, sperm management (including freezing) 
and artificial insemination were well established when cow, sheep and pig em-
bryo flushing and transfer became successful in the 1950s, although only fresh 
embryos at this point were used (transported in live rabbits) as embryo freezing 
was not yet possible. Oocyte or egg freezing was far trickier and, unlike with 
the storing of sperm and embryos, egg freezing entered routine medical practice 
much later in the early 2000s, almost half a century after success in sperm freez-
ing, and 25 years after embryo freezing. By 2010, more had been learned about 
the egg’s membrane or covering and cellular susceptibility to breaking up when 
frozen and thawed. Also, at this time reproductive scientists figured out how to 
maintain the cell’s structural and genetic integrity with particular freezing agents 
and a quick-freezing process.
The reproductive physiologist Martin Johnson provides a useful overview of 
the key developments in IVF techniques that advanced knowledge of reproduc-
tion include the development of culture media in which to keep and nourish eggs 
and newly formed embryos outside of the body (the same in sperm management 
had developed much earlier). Initially, during the late 1960s, chiefly mouse eggs 
and embryos were kept alive and encouraged to continue development in blood 
or serum-based media, sometimes with the addition of fallopian tube cells, or 
placed in parts of the tubes themselves. Experiments with culturing human eggs 
outside of the body started in 1944 and proceeded with experimentations using 
human and fetal calf serum, the patient’s own serum, amniotic fluid and fallo-
pian tubes. They also experimented throughout the 1980s and the early 1990s 
with a variety of cell lines (differentiated cells distilled from various parts of 
bodies and kept alive and replicating) variously combined, and then moved to a 
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“back-to-nature strategy” in the late 1990s and early 2000s. What was learned 
as a result of this considerable experimentation, crucial to the success of IVF as a 
safe medical application, was that the naturally occurring environment for eggs 
and embryos is complex, and it changes as the process of fertilization progresses 
over time and in place, for example, levels of lactate and glucose (nourishment 
for early forming embryos) in the fallopian tubes and uterus change as the ferti-
lized egg and embryo’s needs change. Thanks to increased understanding of cells 
and genetics, we now know that sex cells (eggs and sperm) and early forming 
embryos go through “precisely orchestrated events” of division and genetic ac-
tivation that, without proper support (such as culture media), could have serious 
effects on the outcome of implantation and, more importantly, on the formation 
of the being.
Robert Edwards was the British physiologist credited, along with the British 
gynaecologist Patrick Steptoe, with the first successful human IVF and as a pio-
neer of modern assisted reproduction. Edward’s 1955 PhD thesis focused on ways 
of creating genetic abnormalities in mammalian (mice) eggs in the hope of de-
veloping applications in animal breeding and to further knowledge about genetic 
development. In particular, Edwards’ work built on the knowledge of cell parts 
called centrioles, which were observed in the late 1800s and whose function in 
genetic replication was described in the 1950s.
During the latter part of the 20th century and into the 21st, the significant 
developments in reproductive theory were largely genetic based. This meant a 
turn away from the relatively large-scale realm of gonads – ovaries and testes 
– and their respective sex cells – eggs and sperm – to the genetic helix. The re-
productive organs and their complex hormonal interplay became infrastructure 
and stages in a very promising world where the essence of what makes us human 
was understood as a code. This code not only opened doors to understanding 
the expression of genetic traits but shifted reproductive theory to theories of 
replication. Earlier developments in biochemistry and cellular biology came to 
play in describing the human genome and its function. The genome, unique to 
each being from plant to human, is made up of a molecule which has a spiralling 
ladder-like structure (the double helix) known as DNA (deoxyribonucleic acid) 
that can be unzipped up the middle and zipped up again. Each side of each rung 
of the ladder is made up of one of the four possible bases, known as the building 
blocks of DNA: A, G, C and T (used cleverly to title the film about genetic engi-
neering, Gattaca). Although the Swiss physician and biologist Friedrich Miescher 
isolated DNA in 1869, its molecular structure and function was described in 1953 
by Watson and Crick, with Franklin’s support. DNA clusters around proteins in 
the cell forming chromosomes. Humans have 23 chromosome pairs in each cell 
(46 in total); 22 of these pairs look the same in males and female; one pair, the 
sex chromosome, is different. In males it is an X and Y chromosome pair, and in 
females two X chromosomes are paired. During reproduction it was learned, in 
part thanks to the key Meselson-Stahl experiment (1953–1957), that the DNA 
from each parent’s sex chromosomes (eggs and sperm in animals) unzip, the half 
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ladder (DNA strand or single helix) of each parent meets and zips up to form a 
new DNA or ladder and a distinct genetically coded being. This is why we carry 
some traits of our mother and some of our father. This process of unzipping 
and zipping up with a different side of the ladder is widely regarded as the basis 
of contemporary reproductive biology. DNA with its coding structure is com-
monly characterized as “the blueprint” of life or as argued by the anthropologist 
Sarah Franklin as “life itself,” and what the social scientist, Joan Fujimura calls, 
“vital signs.”
Also important to contemporary reproductive theory is what happens when 
things go wrong along the length of the helix or ladder. DNA working with 
another acid molecule, RNA, instructs cells on how to form. It does this with 
packets of information or genes, which are a series of rungs on the ladder that 
are coded to produce a specific protein. Keep in mind that every human genome 
has about 3 million base pairs (rungs), which are contained in each cell of the 
body (divided between the 23 chromosomes). If you stretched one cell’s DNA 
(ladders) out they would be about two meters long. All of the DNA in one person 
stretched out end to end would be about twice the diameter of the solar system 
(but very, very thin). Surprisingly, given the numbers involved, most of the time 
genetic replication goes right and embryos are properly formed. However, things 
can go wrong: At the individual gene level, cystic fibrosis, and at multiple-gene 
levels, Alzheimer’s disease, due to a combination of gene mutation and environ-
mental factors (some breast cancers), and because of damage to chromosomes or 
chromosomal abnormality (such as a missing chromosome that causes Down’s 
syndrome).
A significant development in reproductive genetics was the discovery of the 
potency of stem cells and the promise in their medical application. Discovered 
in mice in 1981, stem cells were isolated in humans in the US in 1998. Basically, 
animals have two types of cells: somatic and sex or germ line cells. Humans have 
220 types of somatic cells that specialize in producing blood, bones, connective 
tissue, the organs and so on. Sex cells create gametes, sperms and eggs, which are 
distinguished by their ability to combine with each other to create embryos or 
to reproduce entire beings. Stem cells have various degrees of power or potency 
(depending on where they are extracted and at what point in an animal’s devel-
opment) and can divide to form diverse cells types; they are not already special-
ized like somatic cells. Pluripotent stem cells, found in the inner cell mass (ICM) 
of five-day-old embryos, can create any kind of cell, somatic or sex cell, but their 
pluripotency is lost quickly and cannot be found in foetuses, children or adults. 
ICM pluripotent cells can be developed in the lab and are known as embryonic 
stem cells. In 2007, scientists managed to reprogramme human adult somatic 
cells to return to being pluripotent stem cells. Stem cell research and develop-
ment holds out great promise in medical applications, and in 2010 a spinal cord 
injury was treated with stem cells in the hope of rebuilding the injured area at 
the cellular genetic level. In 2012, the treatment showed promise in easing some 
forms of blindness. In 2014, stem cells created insulin-producing cells offering a 
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potential cure for diabetes, and trials began in Japan to treat age-related blind-
ness. By 2019, private clinics began to offer both stem cell therapies for a host of 
illnesses and injuries, and “regenerative medicine” for age-related issues. All such 
offers come carefully packaged with the word “promise.” From a reproductive 
theory point of view, stem cell lines offer researchers a whole new lab material 
with which to explore cellular reproduction and animal development and repair.
IVF provided not only the ability to research human genomes at the earliest 
stage of development, but also the promise of controlling for and correcting 
genetic abnormalities, damage and disease before days-old embryos the size of 
a pin head were implanted. It also made available days-old embryos and their 
very powerful cells. The main implication for reproductive theory here is that 
we are no longer concerned only with how reproduction works even if the focus 
has substantially extended from glands and their neural-hormone triggers to the 
microbiological level, including the relatively new terrain of genes. We now un-
derstand reproduction chiefly as powered by cellular genetic replication.
Conclusions
As humans, we have venerated the female form as the continuation of life, and not 
only human life, longer than we have attempted to explain human reproduction 
as a biological exchange between men and women. But since we started recording 
and writing down these explanations, a significant shift occurred, elevating the 
male contribution to reproduction to near-divine significance. Despite attempts 
from ancient Greece to the European Renaissance to empirically solve the mystery 
of human reproduction, a male-dominant explanation for human procreation per-
sisted for almost 2,000 years. Practices in human anatomy alongside improvements 
in visual technologies, especially the microscope in the 1600s, brought theories 
of human reproduction closer to how we understand it today, first in terms of 
reproductive components: the testes, the ovaries, the sperm and then finally the 
egg. Then relatively quickly and over about 300 years, came the discovery of the 
systems essential to the working of these parts including nutrition and communica-
tion (blood, then cells), activation (nerves, then hormones), and inheritance (genes).
Although we now understand human reproduction to be the equitable ex-
change of genetics from both biological parents, remnants of a theory of a supe-
rior male status in reproduction remain. Throughout the development of early 
and modern theories of reproduction, the main organized religions of the time 
featured a masculine divinity as the font of all creation, often in human form or 
represented by a man as an envoy between the divine and the earthly worlds. 
These belief systems sat at the core of social life (and to some extent still do) 
and heavily influenced the management of human reproduction on the basis of 
a divine entity that is both the origin (sacred seed) of human being and being 
responsible for its afterlife. The early scientific striving to explain the mundane 
aspects of earth-bound human reproductivity in context of these powerful belief 
systems did not escape their influence.
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Currently, reproductive theory has developed to the point that all female 
reproductive hormones can be suspended and added back artificially in order 
to time ovulation precisely for IVF. Human ovaries can be hyperovulated to 
maximize chances in IVF procedures. In the quest for abilities to transfer and 
store human gametes and cellular embryos, more has been learned about sex 
cells and their freezing and nutrition outside of the body. The availability of 
entire human genetic codes for research at the earliest stage of development has 
allowed for many developments in human genetics and embryonic development 
and continues to hold out great promise in medical and pharmaceutical appli-
cations. Stem cell lines can now be used to create gametes that can reproduce. 
None of this is possible without both male and female contributions of their 
respective reproductive matter and the socio-politics of reproduction; the ques-
tion remains as to how we value such. Medical students are still taught about the 
“massive and passive egg” and the “brave and motile sperm.” Also important 
is the background pressure from financial interests on theoretical development 
that is quickly spun into lucrative applications in both genetics and new repro-
ductive technologies.
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As first natural philosophers, then modern scientists and medical practitioners 
wrangled over the meaning and function of generation, human reproduction 
continued without hesitation. Typically, women were attended by other women 
in their pregnancy and during birth, and in the months following. The attend-
ing women were usually known as midwives who passed on their knowledge 
and experience to other women. Midwives were equipped with knowledge of 
herbal remedies, techniques for assisting in childbirth, such as turning the foetus 
in utero, and most of all they were equipped with knowledge and experience – 
handed down over centuries – in managing the human body. Midwives also 
attended most people in their communities during illness and near death. How 
then could we reach the point at the start of the 21st century with 98% of US-
based births occurring in hospital under the authority of a physician? How is it 
that pregnancy and birth have become significant parts of medical practice and 
are treated more as a medical concern than a routine part of human life? How is 
it that women as midwives were almost completely replaced by a male-dominant 
medical profession by the start of the 20th century? And, does any of this matter? 
Below we will examine the process of the modern medicalization of pregnancy 
and birth as well as resistance to such. We will see how midwives were treated by 
the emerging profession of modern medicine. We conclude with an assessment 
of where things stand today in terms of common social practices surrounding 
human reproduction.
The meaning of medicalization
In the glossy and dense medical textbook, Clinical Protocols in Obstetrics and Gy-
necology, by the clinical professor and physician John Turrentine, we get a good 
sense of what the current state of medical interventions is in pregnancy and birth. 
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This text, now in its third edition, is designed to prepare American medical 
students to write their board exams in the medical specialty unique to females, 
which focuses on reproductive capacity and health (gynaecology), and pregnancy 
and birth (obstetrics). There are 410 pages of medical conditions and protocols 
associated with women’s reproductivity, “Obstetrics and gynecology A-Z,” 
starting with abdominal pregnancy (a potentially life-threatening condition that 
occurs in one out of 7,000 pregnancies) and ending with the drug Zidovudine 
(used to stop preterm labour). It is a daunting list that includes, for example, 20 
different drug protocols used during labour for pain relief, sedation, heartburn, 
diabetes, hypertension, induction of labour and opening or dilating the cervix. 
After this extensive list is a concluding section to the text, “Know these for the 
boards or stay at home,” which is useful for finding out what is considered es-
sential to the practice of the specialty. Here we find, for example, the “cardinal 
movements of labour,” which render birth as seven fundamental (almost sacred) 
movements of the foetus from “engagement” (with the top of the woman’s pel-
vis) to “expulsion” (from the woman’s body). These movements of labour match 
the mechanical metaphor used widely by science to explain reproduction since 
the 1800s and reflect broader tendencies to reduce and tailor physiologies and 
functions to satisfy broader interests.
As scientific and medical research and clinical development in reproduction 
expanded in the 20th century to include cellular biology, biochemistry, endocri-
nology (hormones) and neurology, pregnancy and birth were increasingly med-
icalized. Many dysfunctions, illness and disease associated with the reproducing 
body were identified, opening up opportunities for medical intervention. Almost 
all of these were in the female reproducing body. Andrology (the male equivalent 
of gynaecology) as a medical specialty was virtually non-existent during the 20th 
century. To understand the extent of medicalization of female reproductivity we 
need to turn to the margins of “home” or “natural” birth movements; we also 
need to understand the process of medicalization and its critics.
The medical textbook on contemporary OB/GYN protocols stands as a prime 
example of how pregnancy and birth are now deemed worthy of considerable 
medical attention. Of course, reproduction or the generation of humans has long 
occurred, and certainly well before the establishment of modern healthcare, a 
fact which has engaged sociologists, philosophers and historians and led to the 
development of critical theories of medicalization. But first, Elliane Riska in her 
analysis of gender and the medicalization thesis notes how the American sociol-
ogist Talcott Parsons coined the term “medical sociology” to flag the centrality 
of medicine to modern social life. Known as someone who viewed the good 
society as a well-oiled, stable and predictable machine of distinct but interactive 
parts or social institutions – such as schools, governing bodies – and normal be-
haviours or norms, Parsons viewed the rising influence of medicine in the social 
world as benign and helpful, and an example of how modern societies were more 
civic and less dogmatic than those that came before. Medicine, not religious au-
thorities, now regulated social deviance, and an individual was not held morally 
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responsible for a diagnosable illness, such as hyperactivity; you were not a bad 
boy but had a medical condition. From this perspective, which dominated social 
studies of medicine from the mid-20th century to the 1970s, clear and consistent 
medical professional roles, a specific division of labour, and formal education 
were parts of the necessary social system for managing health and keeping the so-
cial world stable. So the medicalization of pregnancy and birth was, and largely is 
still, considered a good and necessary thing to properly manage the risky business 
of reproduction, which, in turn, is central to the future of society.
Throughout the 1970s, views on medicalization became more critical. Ini-
tially the critique involved the monopolization of medical knowledge, as by the 
American sociologist Eliot Freidson, who argued that medical knowledge was 
kept secret by medical authorities to protect their professional autonomy. This 
helps explain how the road to the current dominance of physicians in healthcare 
involved wresting authority from long-serving professions, including midwives. 
The sociologist Irving Zola added that the medical system had moved beyond the 
mandate of keeping societies healthy and stable to practising a form of social con-
trol. Rather than this being a conscious programme of the medical profession, 
Zola and others saw this shift as a result of the increased medicalization of daily 
life. This medicalized sociality is based on an implicit social contract between 
patients, healthcare providers and “the medical industrial complex” (identified 
by American physician and social commentator Stanley Wohl). Medicalization 
was presented as necessary to handle increasingly risky life, and egged on by 
commercial interests, the medical industrial complex, which continued to unveil 
threats to human health. One of the impacts of this medicalization thesis raised 
by Zola’s student, Peter Conrad, was that nonmedical issues became defined and 
treated as such. “Treating” pregnancy and birth – even providing these normal 
human functions with their own medical specialty – is a prime example of and 
was at the core of feminist medicalization theories that emerged in the late 1970s 
building on these initial criticisms of medicalization.
The list of protocols in Turrentine’s contemporary medical textbook includes 
“manoeuvres” (the nine methods used to move the foetus into proper position 
for birth) and almost all of these manoeuvres are named after the medical men 
recognized as the creators of the techniques. Besides generating a rationale for 
largely male and exclusive physician authority over pregnancy and birth, this 
modern example of medical reproductive practice effectively erases centuries of 
midwifery practice that included moving the foetus in utero just prior to birth, as 
well as performing caesarean sections (C-sections) as early as the 1400s in France. 
The appropriation and elimination of roles long served by predominantly female 
midwives, followed by the medicalization of female reproduction, drew criticism 
starting in the late 1970s from feminist sociologists of medicine as well as from 
largely white, North American middle-class activists calling for home or natural 
birth. In Europe, as with economically strapped regions throughout the world, 
midwifery continued as a profession, although rarely as independent of the med-
icalization of pregnancy and birth.
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The American sociologist long concerned with women and reproduction, 
Barbara Katz Rothman, noted how the medicalization of birth did not go un-
challenged, even by members of the early medical profession. Initially European 
doctors Dick Grantly-Reed (England) and Ferdinand Lamaze (France) gained 
enormous attention and a strong following by pregnant and birthing women 
for their efforts to pull back on the extent of American-based medicalization 
reached by the mid-20th century. The American practices included completely 
anaesthetizing labouring women, shaving their pubic hair before birth and rou-
tinely cutting the vaginal opening (episiotomy) during birth. More importantly, 
the American approach relied on the birthing woman as a passive and compliant 
participant in birth and created a dependency on medical authorities to make it 
through the process safely: doctors, not mothers, delivered babies. On a related 
matter, this was also the time of the mass marketing of formula feeding babies 
with stamps of approval from medical authorities. Some women and women’s 
groups spoke out against and organized alternatives to these trends, but rather 
than it being a revolution, Katz Rothman describes this resistance as a “refor-
mation.” These calls to “natural” and “home” births worked within rather than 
against the medical model. Typical of this time of quasi-activism is the list of 
instructions prepared by pregnant women for their obstetricians, indicating the 
opted-out procedures such as routine episiotomy and pubic shaving and the level 
of pain relief the women wanted during labour. These requests were often de-
rided by physicians who, by this time, had the legal authority and responsibility 
to act in the best interests of their patients according to the protocols of medical 
training, which heavily medicalized pregnancy and birth: The doctor knows 
best. This public criticism of medicalized birth is actually reflected in the 2008 
Turrentine medical textbook as: “Routine episiotomy is no longer indicated and 
should be used only in selective cases.” The return of a restricted midwifery 
practice in various states and provinces throughout North America is also a result 
of this resistance to medicalization trends.
Within the litigious and private medical healthcare delivery system in the US, 
Yvonne Brackbill (PhD), June Rice (a lawyer) and Diony Young (a childbirth 
educator) wrote a guide in the mid-1980s for “consumer groups” of obstetric 
healthcare to navigate the legalities of high-tech obstetrics and to use them to 
take some control over their maternity care. This tactic points to how increased 
medical attention and technological intervention in pregnancy and birth, espe-
cially in a private healthcare context, resulted in higher rates of litigation when 
the risky business of birth went wrong. American obstetricians pay among the 
highest annual rates for malpractice insurance: in 2020 about $85,000–$200,000. 
Indeed, Gena Corea, a US-based feminist commentator on reproductive health, 
published the book, The Hidden Malpractice, a decade earlier detailing examples 
of largely unabated medical experimentation on women in the name of scien-
tific and healthcare advances, especially as almost all American women enter the 
medical system at some time in their life because of their reproductive capacity. 
The prevailing gender norms resulted in an obstetric-gynaecological specialty 
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whose authority figures were chiefly men, and whose patients, who were all 
people needing obstetric care, were not expected to question authority. Brackbill 
and her colleagues’ guide was designed to help birthing women use this situation 
to their advantage by evoking legal authority.
The level of experimentation and malpractice in women’s reproductive health 
is evident in the thalidomide disaster. In the 1950s, the West German pharma-
ceutical company, Chemie Grunenthal GmbH, developed the drug thalidomide 
initially as an anti-convulsive drug, but which was also found to be effective in 
treating morning sickness during pregnancy. Although the drug was tested for 
overdose (none found), it was never tested for effects on pregnant women or de-
veloping foetuses. It was first released prescription-free (or over the counter) in 
Germany and much of Europe in 1956, and by prescription in the UK and Japan 
in 1958, followed by Norway in 1959, and Australia in 1960. By 1960, doctors 
became concerned about its side effects: patients using the drug long term re-
ported numbness and tingling in their hands and feet, and by 1961 a link between 
the drug use in pregnant women and children born with missing or malformed 
limbs, hands and feet was made independently by two doctors, one Austral-
ian and one German. In the end, 10,000 children were born worldwide with 
thalidomide-caused deformations. The drug was withdrawn from the UK and 
Germany at the end of 1961, with all other countries following suit soon after. 
It was never approved for use in the US thanks to the persistence of a Canadian 
doctor Frances Kelsey, working for the US Food and Drug Agency at the time, 
who insisted that the pharmaceutical distributor demonstrate that it was safe for 
pregnant women; it did not. Ironically, Canada did approve and distribute the 
drug for several months in 1961 and as a result more than 100 people living in 
Canada were born with thalidomide-related disabilities.
Other experiments involving pregnant women include diaethylstilbestrol 
(DES – a synthetic oestrogen hormone) used between 1938 and 1971 in mil-
lions of women to help prevent miscarriage. DES was eventually found to cause 
increased rates of breast cancer, other reproductive cancers and infertility in the 
children of these women. Both of these cases led to more stringent measures for 
testing drugs with particular attention to pregnant and nursing women, but only 
after widespread and tragic consequences.
Concerns for the overmedicalization of pregnancy and birth persist, with a 
current focus on rates of C-section births. According to a 2018 study appearing 
in the highly ranked medical journal, The Lancet, most developed countries have 
a C-section rate of 25%, with the US, China and Australia at about 30%, and 
the Dominican Republic, Turkey, Egypt and Brazil with rates above 50%. The 
global rate has almost doubled since 2000, and many birth activists and physi-
cians are calling for a reduction in unnecessary use of this major surgical inter-
vention in women giving birth. There are also concerns for the foetus born via 
C-section over lost benefits from vaginal birth (chiefly respiratory and immune 
system development). By contrast, in developing countries, criticisms of medical-
ization usually arise in terms of missing or inadequate healthcare infrastructure 
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rather than unnecessary medical intervention experienced at the individual pa-
tient level.
Concern for the medicalization of daily life continues but has altered sig-
nificantly in its approach. Biomedicalization is the term used today to define 
a multi-focal analysis of what is going on in medicine, which according to the 
American sociologist of health, Adele Clark and others, includes the interac-
tion of biomedical knowledge, technologies, services and capital. The addition 
of “bio” to medical knowledge recognizes developments particularly in genet-
ics, and the tight interactions between medicine and genetic science. This gives 
rise to biomedical health (not only illness, injury and disease), and to the ever 
more sophisticated delivery of high-tech healthcare in the name of prevention 
and health enhancement. Finally, biomedicine is seen to effect people in new 
ways, not only as individual bodies but as populations or groups of bodies, both 
with significant consequences for social identities. This recognition that med-
icalization is different and experienced differently among various populations 
according to social and political contexts helps explain the seeming contradiction 
between perceived over medicalization of birth in developed countries and under 
medicalization in sub-developed countries. Many people in sub- or undevel-
oped nations cannot access necessary basic healthcare for the health problems 
stemming from poverty that particularly affect reproducing women and young 
children, such as poor nutrition and heavy-water carrying, leading to malformed 
and small pelvises that complicate birth, and unsafe drinking water which results 
in deadly water-borne diseases especially in newborns and young children.
Midwifery: professionalization and medicalization
The American social critic and activist Barbara Ehrenreich, with academic 
and former editor of the progressive American magazine, Mother Jones, Deidre 
English, documented how women were historically removed from positions of 
traditional authority over healing and birth, starting with the European witch-
hunts in 16th century continental Europe and spreading to England and Scot-
land shortly afterwards. Numbers of chiefly women (estimated at 85% of those 
persecuted as witches) who were put to cruel deaths vary from the hundreds of 
thousands to several million over about 200 years. Various women-denigrating 
rationales came into play to send women to their deaths, including the Original 
Sin of Eve, the demonization of female sexual desire and the blaming of women 
for upsetting natural balances. Women, especially those with any social influ-
ence, were blamed for crop failures, disease, male impotence and “monstrous” 
births. Many of these women derived their perceived power (and threat) from the 
traditional and informal authority vested in them over centuries as midwives and 
healers. Even though throughout the witch-hunt there were male physicians, in-
cluding the first gynaecologists, they rarely practised their art on actual patients, 
and they were protected by their gender. It was typically a woman’s job to attend 
to the pregnant, the ill and the dying. With the developments in science, its 
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increasing authority over knowledge and the development of modern medicine 
as practice, midwives and traditional healers became problematic and symbolic of 
cruder and uneducated times, and the well-being of the human body and mind 
became a highly contested ground.
There is a substantial amount written about midwifery historically, and how 
contemporary midwifery practices compare with the medical model of preg-
nancy and birth. Because of the significant impact of medicalization generally, 
current midwifery practices are not the same as they were. Nor is there a single 
form of midwifery practised over the centuries and in the same way today around 
the world. There are, however, commonalities in how modern medicine and its 
typical male medical practitioner replaced women midwives and took authority 
over what had long been their domain as healers and attendants of pregnant and 
birthing women.
The British historian Jean Donnison provides an overview of midwifery from 
early history – the midwives, Shirpak and Puah, appear in the Torah and the 
Bible written about 400 BCE – to the late 20th century as midwifery was either 
rejected by or assumed into the medical model and made to report to medical au-
thorities. Before this, childbearing was long considered women’s business, as de-
picted in the 2nd-century CE (Common Era) bas-relief or sculpted plaque on the 
tomb of the Roman midwife Scribonia Attica, which shows two women attend-
ing a third woman during childbirth: one attendant holds the labouring woman 
upright on a stool, as the midwife kneels before her with her hand between the 
birthing woman’s legs, examining her. Although we have spotty details about 
midwifery practice from early history through medieval Europe and beyond, it 
is believed that a respected midwife required experience of childbirth herself, 
and the more experience, the better. Also, a mature woman, who had experience 
with the healing arts (usually a combination of rituals and herb-based remedies), 
was favoured. This preference helps explain why midwives were caught up as 
victims in the witch-hunt, as these older women had the respect of their com-
munities for what they knew (neither for their sexual allure nor for their repro-
ductive capacity) and attended moments of life and death as an authority figure. 
They were also early businesswomen who often supported themselves with their 
practice. In an era that ordained masculine privilege, these women were out of 
bounds, and their inquisitors sought to put them back in their proper place.
The professionalization of modern healthcare was predominantly controlled 
and peopled by male physicians, and modern medical practice threatened to 
eliminate midwifery as a competitor for business and authority. However, mid-
wifery was practised almost continuously alongside physicians from the earliest 
known doctors in classical Greece and with the early (barber and barbarous) 
surgeons of the Middle Ages. Physicians, including obstetricians, gynaecologists 
and surgeons, numbered a few women among them from time to time, such as 
the celebrated Greek surgeon, gynaecologist and obstetrician, Aspasia (about 300 
CE), and Cecelia of Oxford who was hired in the mid-14th century as court sur-
geon by Queen Philippa (wife of Edward III of England). And while the fathers 
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of classic medicine, including Aristotle who was among the first to explain the 
generation of humans, relied on midwives for information, especially practical 
experience of pregnancy and birth, women were typically denied access to ed-
ucation that would allow them participation in medicine throughout the ages 
in any meaningful number. Globally, many universities at the turn of the 20th 
century forbade or severely restricted women’s access to modern medical schools. 
In 2017, the Association of American Medical Colleges announced that for the 
first time in its history the number of women enrolled in US medical schools was 
slightly more (50.7%) than that of men. According to the 2018 report of Uni-
versities UK, the rate here is slightly higher at about 58% female enrollment, but 
these figures include dentistry as well as medicine. A key explanation for these 
developments is the extension of public education to girls as well as boys, and the 
emancipation of women in the public sphere of work.
According to Ehrenreich and English, the established medical profession of 
the 19th century turned to “cleaning up” the problem of midwifery (and other 
traditional healing arts) by denouncing it as a sound practice in the face of all 
that science was now unearthing, with only appropriately trained professionals 
capable of handling the complex world of human health, including pregnancy 
and birth. Richard and Dorothy Wertz examined how hospitalized birth became 
the norm in 1920s America as the “fashion changed” and traditional midwifery 
associated with very old rituals and even magic gave way to safer scientific meth-
ods of modern medicine. Less than 5% of women in the US delivered their ba-
bies in hospitals at the turn of the 20th century; today less than 2% of US births 
occur outside of hospitals. Even in countries such as The Netherlands, where 
midwifery never disappeared and functions today independent of oversight by 
physicians, home birth is limited to about 30%.
The regulation of midwifery occurred over two major periods: during the 
14th and 15th centuries with the move from religious authority to civic gov-
ernance, and then again around the turn of the 20th century when medical 
professions were legally recognized and their respective scopes were defined. 
Midwifery came under formal control of emerging governments in Europe as 
early as the 14th century, partly as a reaction to the drummed-up social fear of 
the magic or “witchcraft” (typically incantations and the application of herbal 
remedies) that midwives used while attending women. In the infamous docu-
ment, The Hammer of Witches (1486), the German inquisitors Springer and Insti-
torus claim that midwives “surpass all other witches in their crimes.” During the 
Inquisition, women were accused of and executed for the murdering of babies 
at birth and for killing foetuses in the womb as signs of their compact with the 
Devil. “Monstrous births” (anomalies in foetuses, newborns and stillborn foe-
tuses) were often first witnessed by midwives, and during the religious fervour 
that gave rise to the witch-hunt, they or the mother were often held morally 
responsible. As democracies formed, municipal-level governments were struck 
with health responsibilities, thanks partly to the Plague when bodies and in-
fections had to be managed in densely populated cities and towns (despite any 
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knowledge of sterile technique and little known about microbiological conta-
gion). Midwifery was included as a health concern: the first formal act to control 
midwifery in England came in 1512. About half a century before, there were 
similar moves in Germany and France. Unlike the religious-sanctioned witch-
hunt, these civic regulations were more concerned with the scope of practice al-
lowed to the midwife rather than with the midwives’ moral character. Donnison 
points out how by regulating midwifery in terms of ability and scope or practice, 
the mainly female midwife profession was distinguished from a growing body of 
medical men now interested in birth, and women were effectively barred from 
their traditional body of knowledge, practices and technologies. An important 
but not the sole example of how this shift took place is found in the case of the 
Chamberlen family.
Donnison describes how between the late 1500s and the 1880s, almost the 
entire male membership of the British Chamberlen family tried to insert them-
selves into the rising and potentially lucrative business of delivery practice by 
physicians. In order to make a decent living at assisting women during child-
birth, the Chamberlens focused their attention on the wealthy and the influ-
ential and sold their services as keeping up moral standards of decency during 
birth, which they achieved through a growing custom to drape the birthing 
woman. In 1647, Peter Chamberlen published Voice in Rhama, or, the Crie of 
Women and Children, arguing against traditional midwifery as something lowly, 
and of the uneducated and unrefined. However, this family of birth practi-
tioners (but not physicians) was forced to become licensed as midwives, and 
they never fully won over birthing women’s trust from traditional midwives. 
The family persisted, nonetheless, and further distinguished itself in its male 
midwifery-like practice with a secret device. A visit to most museums of mod-
ern healthcare usually includes a display of the barbaric instruments used in 
early surgery in general, and in particular the devices used to compact and 
extract blocked foetuses during birth. What the Chamberlens offered was a 
device purported to ease troubled deliveries and to save the mother and perhaps 
even the child in the process. Using a scissor-like, spooned tool (what we now 
call forceps), the Chamberlens would attempt to deliver women, especially the 
wealthy and royalty, in a way unmatched in traditional midwifery and even 
in obstetrics. They enjoyed substantial financial success, which was secured 
for over 200 years by keeping the technique and tool from view: the modesty 
drapes no doubt helping, along with a special locked storage box. This tactic to 
keep knowledge and tools away from traditional birth attendants was repeated 
soon after by the emerging profession of medical practitioners that helped effect 
a transfer of authority from traditional midwives to physicians specializing in 
women’s reproductive health and birth.
Contemporary arguments used against the practice of midwifery grew out 
of indicators of social progress defined by the Industrial Revolution. Thanks to 
the development of statistical sciences and bureaucratic methods, rates of health 
and well-being of populations were collected and tracked. The rates of death of 
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mothers at birth (maternal mortality) and the death of infants at or immediately 
following birth (infant mortality) became key players in the near-elimination 
and medicalization of midwifery in the modern period. Up until the first quarter 
of the 20th century, the great majority of births throughout pre-modern Europe, 
colonial North America, Australia and New Zealand took place at home under 
the care of a midwife or wise woman, who may or may not have been licensed 
by earlier regulations; there were very few “lying-in” hospitals used for delivery 
until this point. And mortality rates became significant: The sociologist Cecelia 
Benoit notes how infant mortality in Sweden during the 1920s, for example, was 
recorded at about 60 deaths per 1,000 (today’s rate for Sweden is 2.3 per 1,000). 
Although these initial high mortality rates owed more to the lack of knowledge 
in germ theory and sterile practice along with risky surgical interventions in 
difficult births than to midwifery practice, these rates became powerful weap-
ons in rationalizing the medicalization of pregnancy and birth and in removing 
midwives from the scene.
Infant and maternal mortality rates were only kept reliably once medical prac-
tice started to take hold; hospitalization and medicalization of birth, including 
medically sanctioned midwifery, were included in this data collection. The lack 
of any prior data makes it impossible to compare risk and outcomes between 
traditional midwifery and early medical obstetrics. However, even these early 
attempts to track the cause of infant and maternal mortality rates were tricky 
to read, especially by profession. Some midwives were medically trained, while 
some were not; some were trained effectively, while some were not; some labours 
started with a contracted midwife, but were then transferred to a physician be-
cause of complications; sometimes such transfers were fully documented, while 
sometimes they were not; some attending physicians were obstetrically trained, 
while some were not. But this did not stop many early medical associations and 
physicians from accusing traditional midwives of inferior healthcare and worse, 
and from arguing that childbirth should fall under the authority of physicians to 
improve outcomes for the mother and the child.
The physician and medical historian Irvine Loudon claims that if you asked an 
American obstetrician in the early 20th century what they thought of midwives,
you would have been told that the midwife was typically old, ignorant 
and filthy, ‘not far removed from the jungles of Africa, gin-fingering, guz-
zling… with her brains full of snuff, her fingers full of dirt and her brains 
full of arrogance and superstition’.
Besides employing the force of socially-accepted sexism and racism to demean 
midwives, physicians also downplayed their own interests in the professional 
monopolization of education, techniques and tools; the harmful effects of medi-
cal experimentation; the exposure of hospitalized patients to contagious disease; 
and how poverty and poor nutrition significantly increased risks to women and 
children in or near childbirth.
36 The medicalization of pregnancy and birth
After carefully combing through American and UK statistics in this period on 
maternal mortality rates by who attended the birth, the mother’s class and race, 
Loudon unearths significant contradictions in the medical profession’s claims 
that midwifery provided an inferior quality of maternity care. One contradic-
tion is found in the “reverse social class connection,” which is a higher rate of 
maternal mortality among the middle classes than the lower classes in London, 
UK; as expected, infant mortality rates were higher in the city’s slums, due to 
very poor living conditions, untreated disease and malnutrition. But why would 
middle-class women giving birth be dying at a higher rate than slum-dwelling, 
lower-class mothers? In a 1930–1932 study of England and Wales’ maternal mor-
tality rates according to class, rates of maternal death were the lowest among the 
lowest-class women compared to all women studied for all categories: 3.32 of the 
lowest class of women dying per 1,000 while giving birth compared to 3.70 of all 
other, higher classes of birthing women. This unexpected discrepancy was due 
to the risk of contagious disease (puerperal fever) and illness ripping through ma-
ternity wards in hospitals. Midwife-assisted birth in the home was not exposed 
to this disease.
In the US, which around the same time had the highest maternal mortality 
rate in the Western world, risky birth was complicated by race and the pernicious 
combination of racialization and poverty. The highest rates of maternal mortality 
were found in the South within rural, extremely poor Black communities, where 
Black midwives were the primary birth attendants. Black birthing women in 
South Carolina between 1934 and 1935 died at the rate of 215 women per 1,000 
births compared to 128 for their white neighbours, who were normally attended 
to by physicians at birth. The culprit here was poor training of midwives, espe-
cially in antiseptic practices, to control puerperal fever and infection. Once prop-
erly trained, notes Loudon, these same midwives brought the maternal mortality 
rate below that of areas where physician-attended birth was common.
A 1926 US Department of Labour comparison of 1920s maternal mortality 
rates by the usual attendant (midwife, doctor or a combination of the two) be-
tween north western European countries, the US, Australia and New Zealand 
reveals Denmark with the lowest rate (23.5 deaths per 10,000 births) where only 
midwives usually attend birth, and the US with the highest rate (79.9) where 
doctors predominantly attend birth. The rates are tightly associated with the type 
of attendant: where only midwives typically attend the rates are under 30; where 
doctors predominantly attend the rates are over 60. Where both may attend, the 
rate falls between 30 and 60. Despite the characterization of midwives by mem-
bers of the emerging medical profession as inept, crazed and a risk to reproducing 
women, it was initially far more risky for women to have their children in hospi-
tal under the care of physicians than having their child at home with a midwife.
The effectiveness of midwifery, along with a growing medical practice to tri-
age pregnancies by potential risk, may be the reason why in most countries where 
universal healthcare and a welfare state were established by the mid-20th century, 
midwifery was granted a substantial place within or beside medical obstetrics. In 
The medicalization of pregnancy and birth 37
Sweden by the 1930s, maternity care was publicly funded, midwife-focused and 
in a tiered medical model from midwifery-based centres to physician-focused 
care and hospitalization for high-risk cases. In the Netherlands, maternal care 
was independently operated by freelance midwives, who have been recognized 
legally as independent caregivers since 1865. Later, maternal care was included 
in the medical system for high-risk cases. In the UK, it was a combination of 
the two approaches from the start of modern medical practice with midwifery 
professionally recognized in 1902 and divided between hospital-based midwives 
and community-based midwives with hospital-admitting privileges. In the US, 
where there is no universal healthcare and thus no provision for effective mater-
nal care for all, and where medicine, especially obstetrics, is big business with 
powerful medical lobbies, the recognition of midwifery has always been spotty 
and usually allowed only in places where medicine did not want to venture (poor 
rural areas for example, out of fear by doctors of not being paid). Later, US mid-
wives aligned with the nursing profession to have the practice of nurse-midwives 
legally recognized in 1955, but by far the majority of births today are attended 
by obstetricians in hospitals (about 95%). Australia, as with most British colo-
nies, imported midwifery with its settlers and legally recognized it in 1915; but 
like Canada, midwife-attended home births were largely replaced starting in the 
early 20th century by hospital ones, overseen by physicians who assumed the 
role of typical birth attendant. Canada was last among the Western countries to 
legally recognize midwifery starting in 1994. Here, middle-class, white women 
adopted the critical medicalization perspective (pregnancy and birth are unprob-
lematic and low risk most of the time and do not require automatic and extensive 
medical attention) and lobbied for a de-medicalization of pregnancy and birth as 
provincial governments recognized the potential for significant savings in public 
healthcare (midwives and birthing centres cost far less than obstetricians and 
hospital beds).
Racialized geopolitics of reproductive health and childbirth
The battle for authority over women’s reproducing bodies is complicated by ra-
cialization and geopolitics. Medicalization alongside social stratification fills out 
the picture, and the US provides a brutal example. The historian Marie Schwartz 
explains how between 1808 – when the US stopped the import of slaves – and 
1863 – when President Abraham Lincoln issued the Emancipation Proclamation 
freeing all enslaved people in the US – the interests of slave owners and physi-
cians combined and they jointly turned their attention to slave women’s repro-
ductivity. Despite the end of the slave trade, anyone born into slavery in the US 
before its abolition was considered a slave, so “birthing a slave” was an important 
and urgent business. To directly maintain the fortunes of plantation owners in 
the South and the political economy of the entire nation (especially the North-
east), enslaved Black women’s reproduction became a precious commodity. All 
available resources were brought to bear, including physicians overseeing slave 
38 The medicalization of pregnancy and birth
women’s reproductive health, starting when they reached adolescence and con-
tinuing throughout their childbearing years, all at the slave owners’ cost. This 
investment in human capital was also used to dispel rising criticisms of slavery by 
pointing to how well slave owners cared for their slaves. The near half-century 
opportunity of physicians’ access to Black women’s bodies, against their will, 
played a central role in the medicalization of pregnancy and birth, and to the 
development of gynaecology in and beyond the US.
As with women elsewhere, Afro-American women had a strong cultural his-
tory of community-based, lay women’s attendance during pregnancy and birth, 
and one which continued after emancipation and well into the 20th century. 
Indeed, when slave owners brought doctors in to ensure the future and well- 
being of their slave stock, the physicians often met with resistance and noncom-
pliance. However, these women were slaves and their choices were severely and 
violently limited. This brings us to the Alabama-based doctor J. Marion Simms, 
considered the “father” of modern gynaecology, who served as president of both 
the American Medical Association and the American Gynecological Association. 
Simms surgically experimented, without anaesthetic, on slave women around 
the mid-19th century to address a complication of birth that impeded future 
reproduction. According to the 1850 census, Simms owned 17 slaves, of which 
12 were female. Some were patients and some were assistants to his experiments. 
It is possible some women were bought for the express purpose of experimen-
tation. Simms was investigating a surgical solution to what was then considered 
medically to be one of the most significant obstacles to successful reproduction: 
reproductive fistulae.
As with reproductive theory, 18th-century medical science in general focused 
on the body as a mechanism, and so it was with labour and birth, particularly in 
terms of obstruction of the birthing foetus. The Chamberlen’s forceps were their 
response to this problem, and by the 18th century, these were finally well known 
and widely in use by physicians. Other tools to help remove an obstructed foetus 
included those designed to perform craniotomies on the foetus in utero. All of 
these instruments typically had very poor outcomes, especially at the onset of 
their use. The birthing foetus commonly perished, and often so did the mother 
due to perforations, haemorrhage and infection. The cause of obstructed birth 
was understood as one of size: the pelvis was considered too small and/or the 
birthing foetus’ head was too large. Using European women’s pelvic size and 
shape as a norm, many women of African origin were found to have smaller and 
more shallow pelvises and thus Afro-American slaves were deemed more prone 
to obstructed labour. There is some congenital cause to the formation of bone 
structures, and there are today high rates of complications due to obstructed 
birth and prolonged labour, concentrated in some African countries. However, 
virtually no attention was paid in 19th-century southeastern US states to early 
adolescent pregnancy, chronic malnutrition and heavy work among slaves that 
can result in small and misshapen pelvises and may lead to difficult and dam-
aging births. Today obstructed birth and prolonged labour among chronically 
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malnourished women and in very young women who must carry heavy weights 
(such as water) early on in their lives are understood as tightly interconnected. 
Obstructed and prolonged reproductive labour can tear the tissue between the 
birth canal (the vagina) and the neighbouring bladder (creating a vesico-vaginal 
fistula) or rectum (creating a recto-vaginal fistula). A fistula is not often fatal 
but leaves the woman in a state of chronic leaking from the bladder or rectum, 
which has disastrous social consequences and leaves such women with little so-
cial contact and virtually no chances to continue with intimate relationships. In 
other words, slave women who suffered from reproductive fistulae were often 
no longer reproducing. Instruments including forceps, catheters and the tools to 
perform foetal craniotomy, as well as pessaries (made of bone, metal and ivory) 
placed in the vagina by doctors to keep a prolapsed or extruding uterus in place, 
if not used or placed properly (which was often the case) could also create fistulae. 
At the time when Simms was conducting his experiments (mid-19th century) 
many physicians admitted that most vaginal tearing was caused by inexperienced 
colleagues using instruments during birth.
It was the surgical technique to repair these tears and to return continence 
and a profitable reproductive life to women suffering from them that preoccu-
pied the Alabama doctor in his barbaric experiments on slave women. One of 
these women, Anarcha, underwent 30 surgeries over three and a half years, all 
without anaesthetic. Her initial fistula appeared right after Simms attended her 
extended labour and used forceps, with which he was not very experienced. 
Simms left Alabama in 1852 for a lucrative and illustrious career in New York 
City, where he applied his now successful surgical technique on white women, 
who received anaesthesia and were no doubt enormously grateful to be spared 
the shame and social isolation that reproductive fistulae bring. Some argue, es-
pecially physicians, that the successful development of the technique (widely in 
use today) justifies Simms’ means of perfecting it. Without a doubt, the literally 
captive population of reproducing slave women in the development of medical 
interventions in female reproductivity sits at an extreme and racially violent 
end of a continuum of medical attention to pregnancy and birth. This case 
also demonstrates how broader sets of interests, especially financial ones, figure 
in their medicalization. It was also an isolated period of medical attention to 
 Afro-Americans, which was followed by over a century of medical inattention 
and lack of public health resources to the children of slaves in what became 
a deeply racist and segregated society following their so-called emancipation. 
Deadly inequitable access to reproductive health and medicine according to race 
in the US continues today.
By the start of the 20th century in most Western nations, death rates in 
 general, including infant mortality, were on the decline except for maternal 
mortality, which remained steady. Exposure of women in crowded maternity 
wings and hospitals to experimental procedures and inexperienced physicians 
relatively new to the birthing bedside, along with the germs and disease doctors 
brought with them from other patients, are all likely contributors to the rise in 
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death and infant mortality rates in the early 1900s. What were things like in 
under-developed nations?
Lenore Manderson, a medical anthropologist, unearths a 1936 report of a 
British doctor, Mary Blacklock, on the welfare of women and children in the 
colonies of Hong Kong, Malaya, Ceylon, Palestine, China, Burma and India. 
Blacklock determines that throughout this expansive area with their large and 
diverse populations, colonization did not bring to women and children here 
the benefits of health and education enjoyed at home. Both infant and maternal 
mortality rates remained high, and applying Western standards of nutrition and 
cleanliness was unrealistic as many had only rice to eat and had no access to clean, 
warm water. Precociously in terms of global development, Blacklock pointed to 
the tight connection between the education of girls and positive health outcomes 
for their families, including lower reproductive mortality rates.
This example of the exportation of the modern medicalization of pregnancy 
and birth illuminates the characteristics of modern development practices, namely 
to attempt to transfer the benefits of a developed country to one less developed. 
Maternity and infant mortality rates operated and continue to operate as highly 
significant indicators of development, as they are associated with social levels of 
nutrition, healthcare and education, which, in turn, are connected to broader 
socio-economic and political stabilities. This dominant approach often functions 
at the expense of local traditions, including local healthcare and socio-cultural 
practices surrounding reproducing women.
In 2006, the World Health Organization (WHO) produced the document: 
Reproductive Health Indicators: Guidelines for their Generation, Interpretation, and Anal-
ysis for Global Monitoring. This 63-page document provides the specific statistical 
methods for determining and standardizing rates associated with reproductive 
health that are tracked by this global health watchdog. Some of the indicators 
of what constitutes reproductive health are familiar, such as maternal mortal-
ity, perinatal (newborn) mortality and access to skilled professional healthcare. 
Beyond the confines of medicalization of women’s active reproductivity, a glo-
balized definition of reproductive health now takes into account factors such as 
the general health of women (anaemia, and the presence of sexually transmitted 
diseases such as syphilis and HIV), socio-medical factors (“contraception prev-
alence” and “percentage of obstetric and gynaecological admissions owing to 
abortion”) and one male indicator: “incidence of urethritis in men.” There are 
also indicators for levels of education regarding HIV prevention practices and 
contraceptive use. WHO reports in 2018 that 83 per 10,000 women die from 
preventable causes related to pregnancy and childbirth (the highest risk among 
adolescent women under the age of 15), and that 99% of maternal deaths occur 
in developing countries. WHO’s goal is to reduce worldwide maternal mortality 
to less than 7 per 10,000 births. They recognize the role of medically trained 
midwives as “essential” to meeting this target, likely due to the inability of these 
places to afford the Western medicalization of pregnancy and birth featuring 
physician-based care in a hospital.
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Tensions play through this progressive vision for global reproductive health 
reduced to a list of socio-medical indicators that is culturally and racially prob-
lematic. The profound self-identification of peoples around the world includes 
how they view and live their reproductivity. For example, in a study of con-
temporary indigenous experiences of pregnancy and birth in Canada, edited by 
Hannah Tait Neufeld and Jaime Cidro, “the repatriation of birth” and “birth 
on the land” refer to responses to centuries-long, community-destroying effects 
of Western colonization. “Residential schools” are an infamous part of an in-
tentional and systematic campaign by Canadian governments and the Catholic 
Church that ripped apart ties between Indigenous children and their families and 
communities, their land and the experience of living on it, and which almost 
eradicated their languages, rituals and way of being in the world. The last resi-
dential school in Canada was closed in 1996. In 2021, 215 bodies of Indigenous 
children were discovered in unmarked graves immediately outside a former res-
idential school in British Columbia.
The impact of this cultural genocide on pregnancy and birth involves inter-
generational family breakdown and the loss of support and modelling for new 
parents, substance abuse, poor nutrition due to intergenerational poverty and 
the sexual violation and murder of especially young Indigenous women at rates 
far above national averages. The routine airlifting of women to regional hos-
pitals for pregnancy monitoring and childbirth may provide a stopgap measure 
to the substandard living conditions forced on these people over centuries, and 
certainly addresses high-risk pregnancies and births, but it does little to address 
the socio-culture ruptures in Indigenous peoples’ experiences and traditions sur-
rounding pregnancy and birth. The social anthropologist Rachel Olson, who 
has studied Canadian Indigenous women’s birth experiences and the evacuation 
of Indigenous women from their communities and culture to far away and alien 
hospitals, addresses biomedical risks, but not socio-cultural risks, and prioritizes 
the former at the risk of the later.
Almost identical histories spell out for the Maori in New Zealand where 
Maori maternal knowledges and associated practices are now under a process of 
reclamation. While in places that sit between development and underdevelop-
ment, such as the areas on either side of the Mexico-US border, matters are more 
complex, and contradictions of capital abound. For example, Candace Johnson 
points to how Canadian midwives sought training experience on poor Mexican 
women as Canada slowly came to legally recognize midwifery in the 1990s. 
Johnson explains this contradiction in birth experiences as based in material 
realities: women with economic means have the ability to resist medicalization 
and insist on a return to so-called natural practices as an individual preference; 
pregnancy and birth is a private matter and an individual right. For systemically 
poor women, pregnancy and birth is better understood in terms of intersect-
ing inequalities, such as poverty, the effects of colonization and racialization. In 
Cuba, the UK and Canada, where the medicalization of pregnancy and birth 
is well established and in principle available to all equally through universal 
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healthcare, women of means are found to knowingly negotiate higher-quality 
healthcare and more reproductive choice. All three countries enjoy among the 
lowest maternal and infant mortality rates in the world.
Conclusions
There are two forces at play in the current state of medicalization of pregnancy 
and birth. One surrounds the rise of modern medicine over the last century and 
a half, how it became an authority over pregnancy and birth and how this has 
been received. The other has to do with the professionalization of medicine and 
how that relates to a very long tradition of women attending women during 
pregnancy and birth. Without question our lives are lived far more under the 
sway of medical authority. We have never been so medically screened, and now 
have internalized the responsibility for our health through what we eat, how we 
supplement our diets, how much and how well we sleep, whether we can feel 
suspicious lumps in our bodies, how often we exercise and to what extent in 
terms of heart rate, steps taken and so on. Pregnancy and birth were caught early 
on in this trend of constant monitoring and internalized medical concern. What 
was long recognized as an intense, risky yet everyday matter, became the focus 
of considerable medical attention, alongside illness, injury and disease. Drives 
behind the switch vary, from stated concerns over infant and maternal mortality 
rates to less obvious interests in medical experimentation and financial profit.
During this significant transfer of authority from women birth attendants 
to physicians worldwide, contradictions abound. Although early modern med-
icine claimed it would provide safer outcomes to mothers and babies than what 
traditional midwifery could offer, the initial movement of women to hospitals 
increased mortality rates due to exposure to infectious disease, and to inter-
ventions by physicians using instruments with which they were poorly trained 
or untrained to use. Despite fierce opposition to midwifery by the emerging 
profession of modern gynaecology and obstetrics in some places, notably North 
America, many other countries combined (and continue to combine) midwifery 
and medical practice in stepped systems with varying rates of medical authority 
and medicalization of pregnancy and birth. Although modern medicine was of-
ten presented as a benefit to whole populations, and healthy pregnancies and safe 
deliveries for all citizens remain important indicators of social progress today, 
healthcare delivery, including that surrounding reproduction, is highly deter-
mined by economic means and differs among specific populations within nations 
and between so-called developed and developing nations. Although modern 
medicine’s prime stated objective is the well-being of individuals, the barbaric 
history of early medical attention to Afro-American slaves in the 19th century 
demonstrates how financial interest (involving in this case slave owners, aspiring 
physicians and the American economy) determines medical practice. Finally, al-
though modern medicine is aligned with contemporary principles of science, the 
profession of physicians, initially dominated by white men, monopolized medical 
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knowledge on the basis of shaky theories of gendered and racialized intelligence, 
long preventing many women and others from marginalized populations a place 
in medical practice, including attending women during pregnancy and birth.
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Human reproduction is not determined by biological facts, as seen in theories of 
reproduction which are fluid and sometimes contradictory. Nor is how we repro-
duce determined by social facts, in other words that which is widely perceived 
as the normal social conditions for reproduction, today dominantly idealized as a 
family where the genetic contributors to the child, considered as mother and fa-
ther, live together to raise the child. It is certainly the case that both biological as-
pects of reproduction and the social pressure as to how it should happen play very 
significant roles in how human reproduction is realized, but this is not the whole 
story. In sociology, social control is presented as a tiered process of informal 
expectations (family and immediate community expectations), norms, formal 
expectations (laws) and force that guide human behaviour. Contrary to popular 
belief, the overt threat of violence or legal sanction does not chiefly control social 
behaviour, but it is the internalized and intimately shared norms and the shame 
associated with their breach that most strongly impact how we act. The same can 
be said of the long history of social control of human reproduction where there 
are many evolving norms and tightly held beliefs that underlie and contradict 
formal controls of reproduction and parenting. The key debates within the social 
control of reproduction include who should be recognized as legitimate children 
and parents, and who has the right to control reproductivity, both at individual 
and population levels. Because of uterine pregnancy, and breastfeeding alongside 
the long-held association of women with child rearing, women are central to 
these debates. But not all women are equal socially speaking, and reproductive 
rights have never been the same for all women.
Increasingly, reproductive rights, which typically focus on the individual right 
to choose within formal structures of law, are being replaced by the more ex-
pansive concept of reproductive justice where intersecting social processes such 
as poverty and racialization come into play in understanding how reproduction 
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is enabled and constrained. For example, as chiefly white,  middle-class women 
led reproductive rights movements during the 1960s seeking access to safe and 
effective contraceptives and abortion, Afro-American women in the US also 
sought access to social equity alongside men through the civil rights movement 
in part to provide the means and social stability to raise their families. These 
women’s struggle was complicated by the intersection of race, class and gender. 
Although the pressure from the 1960s reproductive rights movement in most 
developed countries allowed women access to contraception and abortion, less 
was achieved in terms of reproductive justice for all. Women living in risky sit-
uations because of their race, their ethnic background, their class and their geo-
graphic location globally had to weigh their reproductive choices far differently 
than white women with access to economic resources in politically stable en-
vironments. And although today there is more attention given to reproductive 
justice, widespread and systemic injustices remain that restrict women’s access to 
reproductive choice. Also, especially in the US, reproductive rights recognized 
in the 1960s and 1970s are now under attack, and those who suffer the most 
from claw back of legalized reproductive choice are women from marginalized 
groups.
Reproductive rights and social control – dominant 
historical trajectories
We have evidence at attempts to control human reproduction from as far back 
as 3000 BCE. In the ancient Egyptian text, the Kahun Papyrus, there are de-
scriptions of how honey, leaves and lint could be combined and pressed into the 
vagina to block the passage of ejaculate into the womb. The Book of Genesis in 
the Bible speaks of the withdrawal method as a conscious act to avoid pregnancy 
in the story of Onan and Tamar. Other ancient contraceptive methods included 
crocodile dung and acacia gum pessaries (compressed matter placed in the vagina 
at the cervix that would block and repel sperm). A Roman bronze pessary dates 
to 200 BCE, and contraceptive sponges and condoms made from animal skins 
and intestines, fish bladders and linen sheaths were in use in ancient Egypt (about 
2000 BCE); the contraceptive effect of breastfeeding was also known at this time. 
An early form of a gold IUD (intrauterine device) was used in the 1880s, and the 
Industrial Revolution introduced vulcanized rubber as a material for condoms. 
Many of these methods were effective and some continue to be used today: Aca-
cia gum is a known anti-spermicidal and is used in modern preparations as such. 
Condoms continue to be used worldwide by 189 million men, making up 21% 
of contraceptive use as reported by the UN for 2019. IUDs, which still include 
metals such as copper for its anti-spermicidal qualities, were used by 159 million 
women (24% of all contraceptive use). The Pill makes up 16% of all methods used 
globally, but the largest type used is female sterilization at 26%. What this brief 
history of reproduction demonstrates is how long we have sought to control it 
and also the extent to which we do today: 854 million people in 2019.
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Initially abortion was also considered a post-coital form of contraception. 
Herbal abortifacients date back to ancient Egypt and were used along with var-
ious instruments and massage to expel the early embryo from the uterus. Later, 
chemical means including caustics and other agents were directly applied to the 
uterus, and others were developed into pills and tinctures and sold to women to 
“regularize” or bring back their menstrual cycles. For many centuries, abortion 
did not carry the moral and political weight that it does today.
The Pill, a hormonal contraceptive, although not the most commonly used 
contraceptive today, has a significant social impact in European, North  American 
and some Asian countries by making effective contraception widely available to 
women. The development of the Pill relied both on scientific developments in 
the understanding of human hormones and the persistence of especially two 
birth control activists, Margaret Sanger and Catherine McCormick, to create 
an effective oral contraceptive available for women to control their family size. 
Sanger, a long time US activist battling against the American Comstock Law 
(1873) that equated contraceptive information to pornography and outlawed its 
dissemination, encouraged Gregory Pinctus (a researcher in reproductive physi-
ology), John Rock (a Harvard-trained infertility specialist and devout Catholic), 
and Min-Cheuh Chang, a Chinese-American reproductive biologist, to develop 
the Pill. Sanger engaged her friend McCormick (the second woman to gradu-
ate from MIT and who married into the wealthy family owning International 
Harvester) to fund the research into hormone-based contraception and its devel-
opment into the first effective oral contraceptive. The US Planned Parenthood 
network grew out of these two women’s collaboration and functions today to 
disseminate contraceptives and contraception information and to provide abor-
tion. The Pill’s effectiveness as a contraceptive – currently rated at 99.7% – and 
its relative ease of use (a daily oral pill), along with the timing of its release in the 
1960s when strict religious and moral codes surrounding heterosexual activity 
were either relaxed or ignored on a large social scale, helped trigger the so-called 
sexual revolution.
Prior to the 1960s sexual revolution, reproduction was closely monitored and 
socially controlled by a range of norms and legal sanctions determined by a long 
history of Christian, Judaic and Muslim religious beliefs that placed the nuclear, 
heterosexual family as the proper and unique place for sexual activity and repro-
duction. Strict applications of Christian belief led to the outlawing of contracep-
tion around the turn of the 20th century in the US and Canada, and to powerful 
moral stances against contraception in many other industrialized countries. Yet 
at the same time, varied pressure from feminists, communists and socialists, as 
well as those interested in controlling the growth of designated populations for 
eugenic and economic reasons, helped develop effective and accessible contra-
ception as “family planning.”
Contraceptives, chiefly condoms, associated with prostitution (a long- standing 
vibrant business throughout Europe and North America), were referred to as 
the mechanical means of contraception and were carefully distinguished from 
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family-planning contraceptives. So-called natural means of contraception, such 
as knowledge of women’s fertile periods in their monthly cycle or the rhythm 
method, were part of early acceptable attempts at modern birth control. The 
Pill, chiefly because of its origin in science and its dissemination through medi-
cine, was aligned with natural and acceptable modes of contraception. Even the 
Catholic Church briefly entertained accepting it alongside the rhythm method.
The pressure to develop acceptable, effective and available contraception and 
to provide access to safe abortion arose out of dire circumstances, especially for 
poor women. With industrialization came waves of immigration to cities starting 
in the early 1800s in western Europe and continuing well into the 20th century 
in North America and Australasia. The relatively sudden urban intensification 
alongside the sociopolitical effects of industrialization concentrated class differ-
ence in ghettoized areas of the city. The social control of reproduction followed. 
Working-class fathers in these ghettos were prone to underemployment and la-
bour exploitation, leaving their families at great risk due to squalid living con-
ditions, hunger, malnutrition and untreated illness and disease. Alongside these 
material conditions making “another mouth to feed” extremely challenging, 
were so-called moral activists, such as Anthony Comstock in the US, who man-
aged to parlay strict religious beliefs of proper reproductive and sexual behaviour 
into social norms and law. In Great Britain, the same arose out of Victorian-era 
sensibilities surrounding sexual activity – male homosexuality and prostitution 
were outlawed – and social expectations tied women to religiously sanctioned 
and noble calls of marriage and motherhood – in that strict order. The medical 
historian Barbara Appleby finds that before the 1920s, many Christian churches 
(including both Catholic and protestant sects) relied on a theory of natural law 
dating back to the teachings of Thomas Aquinas to argue against contraception. 
Basically, the theory goes, the human body and its organs were designed by 
God for heterosexual reproduction; to interfere with this design was not only 
immoral but sacrilegious or going against the word of God. Sexual desire, with 
woman as the usual object of such, ran the grave risk of altering God’s plan. In 
general, both Islam and Judaism traditionally held heterosexual marriage as the 
only divinely sanctioned place for reproduction, but their religious influence on 
secular society and its laws in most industrialized nations was limited by the mar-
ginalization of Muslims and Jews there. Ironically, these two large, organized 
religions did not adopt the Christian theory of natural law to argue contraception 
as sacrilegious and typically allowed it as long as it was used within marriage. 
Meanwhile the wedding of strict Christian belief with social control severely 
hampered the development and dissemination of safe and effective contracep-
tion making family planning near impossible, especially for women without the 
means to learn about and purchase effective contraceptives illegally. It also led 
to widespread exploitation of women who found themselves “in trouble” with a 
pregnancy outside of marriage.
A healthy industry in the form of homes for unwed women was established to 
deal with those women who strayed from the path of moral reproductive (in other 
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words, sexual) decency. Many religious and other socially concerned groups ran 
such homes, especially in North America, Australia, New Zealand and Europe. 
Here women who had become pregnant (and clearly had unsanctioned heter-
osexual intercourse) were typically hidden from public view throughout their 
pregnancy, gave birth and, shortly afterwards, relinquished their newborns to 
adoption. The weight of shame and exploited labour involved was significant: 
many of these young women had to work hard at these houses to support the 
costs of their stay and as punishment for their moral slip. The Magdalene Laun-
dries (asylums) in Ireland run by the Catholic Church since the 1700s until late 
in the 20th century provide an infamous example. The social historian Frances 
Finnegan reveals the abuse of women there, which led to a national enquiry and 
a formal state apology in 2013, with state compensation provided to the living 
survivors. Houses for “fallen women” and unwed mothers were common in 
newly expanding urban centres and were designed to maintain the appearance of 
reproduction as limited to properly married couples, firmly blaming illicit repro-
duction on women. The children born in these houses also secretly built proper 
families for infertile married couples (it is only relatively recently that adoption 
has been made a more open process). The stigma of pregnancy outside of mar-
riage was great, and often young women went to such places with little resistance 
or right of reply. The surrender of their children to adoption was also inevitable, 
with little to no consent from the birth mother. The mass burials of tiny bodies 
often found at these homes raise questions of profound neglect and infanticide, 
including at some of the Magdalene asylums in Ireland, and at the Ideal Mater-
nity Home in Nova Scotia, Canada, where butter boxes served as caskets. Today 
in the US, 49 states legally allow child marriage which has historically been used 
to “deal with” unwanted teen pregnancies, including having the girl marry her 
rapist. A study by the American organization devoted to ending forced and child 
marriage, Unchained at Last, estimates there were almost 250,000 child mar-
riages in the US between 2000 and 2010.
Under such coercive and shame-bound conditions, women were quick to 
grasp that controlling their family size mattered a great deal to them and their 
families. There is evidence that throughout the 1800s and into the 20th century, 
women exchanged among themselves what information they could gather about 
effective contraception, at considerable risk to themselves. The historian Angus 
McLaren and the sociologist Arlene Tigar McLaren unearthed a 1930s letter from 
a Saskatchewan woman to her friend discussing home-made vaginal spermicides: 
“I don’t believe she used it and I didn’t either because it contains alum [a caus-
tic agent] and I am scared to death of alum. It’s as bad as caustic….” The use of 
condoms and diaphragms made from the newly manufactured vulcanized rubber 
during the 19th century throughout Europe and urban North America effected 
significant and, for many nationalists, disturbing drops in population growth – 
legal or not, obviously many were using contraception. The backlash to dropping 
birth rates included legal bans in Europe and North America on the distribution 
of contraception and contraceptive information rationalized by moral concerns 
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that sexual desire was overtaking especially women’s reproductive and domes-
tic responsibilities, as well as by nationalist arguments that lowering birth rates 
would stunt economic growth. Doctors, increasingly more powerful as keepers 
of medical knowledge, tended not to share what they knew about conception 
and contraception, partly out of adherence to social mores (religious and nation-
alistic) and to laws against contraception, and partly to maintain their growing 
monopoly over medical information and practice.
Three distinct groups with differing reasons were interested in effective and 
large-scale contraceptive use. The first group including women led by the early 
20th-century reproductive control activists Sanger in the US and Stopes in the UK 
saw the control of reproduction as essential to the complete liberation of women 
(alongside winning the right to vote). The second group focused on restricting 
certain populations, including the growing numbers of impoverished people in 
urban centres and the physically and mentally “unfit.” Relying on terms such as 
“degeneracy,” “mental sanitation” and “human damaged goods,” some physicians 
around the 1900s concerned themselves with the protection of the future of the 
human race and national economies through sterilization. Paul Weindling de-
scribes how in 1895 the German physician and eugenicist Alfred Ploetz coined the 
term “racial hygiene” to address the declining German birth rate and the increas-
ing number of mentally ill and disabled people in state institutions, all as economic 
concerns. At this time, things such as intelligence, crime, alcoholism and divorce 
were seen as genetically determined. In the 1930s, the Nazi party took “race” in 
Ploetz’s theory of racial hygiene to represent the dominant Aryan race, and created 
genetic registries and blood banks to prove membership in the Aryan race and to 
justify elimination of anyone considered a pollutant: Jews, gypsies, homosexuals, 
people with disabilities, and mental “defectives.” The Holocaust both relied on 
and helped develop reproductive and genetic theories of the time.
The sterilization of the so-called mentally unfit was also widespread in non-
Nazi Europe and North America; in the same year that Nazi Germany passed its 
race laws (1928), the Canadian provinces of British Columbia and Alberta passed 
laws allowing the forced sterilization of mentally ill and “retarded” people. The 
Alberta Sexual Sterilization Act was repealed in 1972 after almost 5,000 people 
were sterilized under it. In 1906, the Eugenics Educational Society (now the 
Galton Institute) was formed in Britain to further “eugenic teaching and un-
derstanding in the home, in the school and elsewhere.” It worked from the pre-
sumption that reproducing along so-called good and healthy gene lines would be 
to the benefit of society. It helped draft the 1913 Mental Deficiency Act, which 
rejected sterilization of the feeble minded but called for their social segregation. 
Between 1890 and 1920, the US states passed legislation to enforce sterilization 
in the feeble-minded, those with epilepsy, the intellectually disabled and the 
mentally ill. The laws were pitched as measures for social progress. As Angus 
McLaren and Anne Tigar McLaren state, “It was a cruel irony that many of the 
eugenically-minded doctors who opposed the family limitation of the ‘fit’ were 
clamoring for the forced sterilization of the ‘unfit.’”
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The third group interested in contraception were left-wing political groups 
and were studied by the social historians McLaren and Tigar McLaren in 
terms of reproductive politics. Although socialist parties in Europe and North 
 America initially supported contraception at the turn of the century as a path to 
 working-class emancipation through the elimination of poverty associated with 
large family size, the Socialist Standard in Canada published in 1930 an analysis 
of contraception as a tool of capitalism that could control labour supply and 
place the responsibility for eliminating poverty on the shoulders of the poor. 
Those making such arguments were aware of the forced sterilization laws of the 
day and saw such widespread and state-managed birth control as a menace. The 
Canadian Communist Party, also initially in favour of contraception as a form 
of protection for motherhood, changed its position in 1929 and criticized the 
birth control movement as a bourgeois enterprise that distracted attention from 
class struggle; both Stopes and Sanger were indeed upper-middle-class women 
working in poor communities. McLaren and Tigar McLaren conclude that the 
dominant masculine culture in the working class nursed romantic sentiments of 
heading traditional large working-class families and viewed new contraceptive 
methods as unnatural and not of their class. Meanwhile, many working-class 
women remained very interested and involved in controlling their family size.
A similar pattern is found with a fourth group interested in birth control: 
those racially inscribed as inferior. Afro-Americans also identified the public 
acceptance of contraception as a potential menace to their population. Although 
slavery had been outlawed since the Civil War, what followed can hardly be 
called emancipation. The contemporary American essayist Te Nahisi Coates ex-
plains how the US remains a deeply racially divided place, where the ability to 
own property, rates of incarceration and violence at the hands of the police, ac-
cess to healthcare and employment equity remain racially determined. He tracks 
this divide from the time of the brutal plunder of African slaves’ bodies, families 
and their labour, to the immediate clawback of Afro-American’s right to vote 
following emancipation through poll taxes and lynching, through the systemic 
restrictions of their right to own property through real estate red lining, to to-
day’s mass incarceration rate which, according to the National Association for 
the Advancement of Colored People (NAACP), has African Americans impris-
oned five times more than whites. As with the socialists and communists in the 
1920s, those fighting for Black civil rights in the 1960s, especially male members 
of militant arms of the movement, came to see the largely white middle-class 
birth control movement as an attempt to reduce and control Black American 
populations.
Sanger and Stopes made the connection between family planning and pov-
erty, reducing the matter to family size. Their reasoning ran that if women had 
the knowledge and ability to control their family size, they could lift their fami-
lies out of poverty. The Black women’s liberation movement made up of mostly 
working-class women and women on welfare sought protection for motherhood 
through welfare rights and access to decent housing and education. Unlike the 
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white reproductive rights movement, the Black women’s liberation movement 
focused not on the body but on the body politic. This tension in reproductive 
rights remains today, especially in the contradictory geopolitics of birth control 
where poor nations identified with large birth rates are targeted for mass birth 
control programmes by associations funded by industrialized nations responsible 
for the negative ecological effects of mass consumption. Both the African Amer-
ican women’s liberation position in the 1960s regarding birth control and more 
recent critics of global population control programmes gave rise to the concept 
of reproductive justice.
In the meantime, contraception has become an acceptable practice around the 
world, with most industrialized nations lifting legal prohibitions around the late 
1960s. The United Nation’s Population Division reported in 2020 that of 1.1 bil-
lion women of reproductive age worldwide, 851 million are using some form of 
contraception. Significant variations occur: contraception use is 85% in China, 
the UK, the US and Canada but only about 15% of women in Angola, Benin, 
Mali and Somalia were using any form of contraception. The stigma associated 
with pregnancy outside of marriage has also relaxed considerably, especially in 
developed nations. According to the Organisation for Economic Co-operation 
and Development, in 2014 the rate of children born out of wedlock in Chile, 
Costa Rica, Iceland and Mexico was about 70%, while in Canada, the US and 
most European countries about 40% (in Greece, Israel, Turkey and Japan, it was 
less than 10%). The countries with high rates have seen the rates shoot up in the 
last 50 years (roughly coincident with when the Pill became available and the 
sexual revolution began).
With abortion, social control remains far tighter than for contraception. As 
stated earlier, abortion has not always carried the moral weight that it does today, 
especially in US politics and among certain Christian religious sects. Central to 
the contemporary debates surrounding abortion is the definition of human life 
and its moment of origin. We know that conception as understood today results 
from relatively recent developments in reproductive theory. This development 
involved the ability to see and to understand microscopic gametes (the egg, and 
sperm) and the early embryo, all of which are normally deeply hidden inside 
human bodies and are difficult to watch in action. Relying on animal models, 
we learned a lot about conception and early embryo development in mammals 
throughout the 19th and 20th centuries. In 1965, Lennart Nilsson’s photograph 
of an 18-week-old human embryo blazoned the cover of the very popular photo 
magazine, Life, and sold 8 million copies in the four days following its publica-
tion. The image was used three years later in the major motion picture, 2001 – A 
Space Odyssey, as an emblem of human potential. It was made using a very small 
lens on the end of a lit tube, an endoscope, a medical tool that had just started 
being used in medicine to visualize various body cavities and vessels requiring 
only small incisions. Nilsson took photos of a live four-month-old foetus inside 
the womb, exposing it to public view for the first time. Today, a variety of pho-
tographic techniques assisted with computer imaging can capture the moment 
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the sperm are permitted entry through the egg’s zona pellucida or egg covering, 
the first cell division of a fertilized egg, and the days-old cellular blastocyst at-
taching to the mother’s womb lining. Commonplace in the medical manage-
ment of pregnancy now are realistic computer assisted ultrasound images in the 
mother’s uterus of the developing foetus, revealing details as small as eyelashes 
and tiny fingernails. Foetal pharmacology and fetal surgery are available in most 
developed countries. And genetically we now know more than ever before about 
how genes are exchanged during human reproduction and we have developed 
ways to engineer that process. All of these developments over the past 50 years 
have generated a tension between those who claim moral guardianship over the 
embryo and foetus as God-given people, those who wish to access and control 
embryonic and foetal development including reproductive physicians and genet-
icists and the woman growing the foetus and typically bearing the brunt of daily 
responsibility for the person born.
These multiple claims over the foetus colour the mechanisms of its social 
control. But this was not always the case. First-trimester (the first three months 
of pregnancy) abortions have long been sought and to varying degrees secured. 
Early abortifacients (materials that bring on the expulsion of the foetus from the 
uterus, usually at an early stage of pregnancy) included herbs, sharp instruments 
and massage or pressure applied to the uterus. In the Ramayana, an ancient Indian 
epic text (first appearing about 600 BCE), abortion is mentioned as practised 
by barbers to save the life of a pregnant woman. This position on abortion is 
often justified by an understanding of pregnancy in terms of “the quickening” 
or the time in the pregnancy when the pregnant women feels the foetus move 
inside of her, or what Sarah Knott describes as “the first certain sign of being 
pregnant.” This concept developed long before hormone assays and computer- 
assisted ultrasound came into practice. For centuries, many, including Christians, 
considered this point in the pregnancy, normally occurring between the fourth 
and fifth month of pregnancy, as the moment of conception. Before this time, 
the prospects of the foetus were not certain, and indeed this is the time when 
spontaneous abortion or miscarriage typically occurs. Just as using various meth-
ods to prevent pregnancy were accepted early on, so was the discontinuation of 
pregnancy until the foetus was felt moving within the womb. And terminating 
a pregnancy to save the pregnant woman was also acceptable over two and half 
thousand years ago.
In the 19th century, as with contraception, social norms surrounding abortion 
shifted; it was rendered a significant threat to the natural order of reproduction 
and was considered immoral and made illegal. The UK first criminalized abor-
tion in 1803, France in 1810, Australia in 1861, Canada in 1869, in Germany in 
1871 (when it became a country this year) and in the US it was criminalized state 
by state around the turn of the 20th century. Initially the influential British law 
recognized the quickening principle, allowing for women to “regularize” their 
menstrual cycles in the first trimester. The quickening principle was dropped in 
1837, and women aborting their own pregnancies were criminalized alongside 
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abortionists in 1861. Despite these legal roadblocks, there continued a healthy 
commerce in the mail-order business of tablets and tinctures to “regulate” wom-
en’s menstrual cycles, and hundreds of physicians were charged with the crime 
of committing an abortion. McLaren and Tigar McLaren refer to a complaint 
by Judge Winchester of Toronto in 1908 that hardly a week went by without a 
doctor being so named in the crime.
As the contraceptive pill was made commercially available in the 1960s, and 
legislation barring contraception was dropped in most developed countries, 
abortion was also decriminalized, but in fewer countries and with notable re-
strictions that reflected a bowing to religious, especially Christian, authorities. 
Typical laws from this period allowing abortion forced women to appear in front 
of hospital panels to make the case that their mental and/or physical health was 
in jeopardy if they continued with an unwanted pregnancy, or to go through 
mandatory state-approved counselling, which continues in Germany and the US 
today. In some places, the limitations remain extreme, allowing abortion only in 
cases of incest and rape. In Ireland (and ironically Northern Ireland which is po-
litically a part of the UK) and parts of Latin America abortion remained strictly 
prohibited until the early 2020s, even if the life of the pregnant woman was at 
stake. It remains strictly prohibited in the Dominican Republic, El Salvador, 
Nicaragua and the Holy See.
With modernity, what were long considered private matters among women, 
including contraception, pregnancy, birth and the termination of pregnancy, 
were widely and decisively moved into the public realm where they were strictly 
regulated. Initially religious authorities assumed formal control over these repro-
ductive moments; then, as medical science and practice gained moral authority 
over the mind and body, physicians became significant players and eventually 
functioned as the moral arbitrator over life. It is difficult to account for how 
many women have been maimed and killed in desperate attempts to control their 
troubling and shame-bound reproductivity. Home-based abortion techniques 
used by Canadian women at the turn of the 20th century ranged from placing 
the feet in hot water, to turpentine and carbide douches, to using lead pencils, 
knitting needles and crochet hooks to dislodge the well-embedded embryo in a 
blood-rich uterine lining. How many women died as a result of bungled, back-
street and self-induced abortions? It is very hard to tell. Such deaths were often 
reported by coroners as naturally occurring maternal mortality, sometimes to 
protect the woman’s family, sometimes to protect a doctor involved. McLaren 
and Tigar McLaren make a careful estimation from reported maternal mortalities 
that between 1921 and 1946 in Canada, 4,000–6,000 women died from botched 
abortions despite there being a safe medical procedure available since the turn of 
the century.
But women did not take this lying down. As calls for civil rights and nuclear 
disarmament hit the streets throughout North America, Europe and beyond in 
the 1960s, so did women’s right to reproductive control. The women’s move-
ments of the 1960s were largely focused on reproductivity partly because of its 
54 The social control of reproduction
impact on women’s ability to fully participate in a public sphere of work where 
pregnancy and children did not normally belong, but mostly to wrest back con-
trol over their bodies including reproduction and abortion. As explained above, 
not all women took part or were included in this movement. Afro-American 
women were forced to see the problem differently due to entrenched socio- 
economic racism. Also, abortion was lumped in with contraception by Black, 
male-dominant activist groups as white-orchestrated genocide of Black peoples. 
None of this deterred Afro-American women’s interest in controlling their re-
production, including access to contraception and abortion, but racism made the 
matter more complicated.
“Our bodies, ourselves,” “pro-choice,” “keep your laws off of my body” and 
“if men could get pregnant, abortion would be a sacrament” are common slo-
gans stemming from the 1960s reproductive rights movement. They emphasize 
two things: reproductive matters are both private and political, and control of 
reproductivity is primarily the control of women. This movement, which con-
tinues today due to constant pressures to reel back reproductive rights – chiefly 
abortion in the US – is characterized as a matter of choice by those in favour of 
a woman’s right to choose her reproductive status versus a matter of morality by 
those who believe that no one should interfere with God-given reproductivity. 
In the US, arguably the world’s most developed nation and one founded on 
principles of democracy and human rights, the right to abortion is described in 
terms of a war. Here all reproductive rights are ruled state by state, even though 
the precedent-setting Supreme Court case, Roe v Wade (1973), made access to 
abortion a constitutional matter of every American women’s right to liberty of 
the person. In Alabama, abortion is almost completely banned under the 2019 
Human Life Protection Act, which recognizes all unborn children as persons 
and allows for abortion only when the foetus is stillborn or when the pregnancy 
presents a serious risk to the life of the woman, which must be affirmed by a 
physician first. There are no exceptions made for cases of rape or incest. Other 
states, including Georgia, Mississippi, Louisiana, Missouri, Kentucky and Ohio, 
have recently replaced the quickening principle (when a pregnant woman feels 
the foetus move) with “heartbeat” provisions (externally detecting the heartbeat 
with instruments) to limit abortion. In 2019 in Georgia, a month after Governor 
Brian Kemp signed a heartbeat abortion ban, lawyers for the American Civil 
Liberties Union, Planned Parenthood and the Centre for Reproductive Rights, 
and lawyers for the state filed a suit challenging the law. These heartbeat abor-
tion laws limit abortion up to six weeks (when an electric muscle pulse can be 
detected in the tissue that will become the heart) even though many women do 
not know they are pregnant at this stage. In June 2021 Texas passed its heartbeat 
abortion law, which was upheld by the Supreme Court the following September. 
Some American states have also adopted “management” measures in abortion 
clinics, effectively chipping away at Roe v Wade, forcing patients through days’ 
long waiting periods and required “counselling” sessions, some of which attempt 
to mislead women into associating abortion with cancer, serious mental health 
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outcomes and infertility. Many abortion clinics operating in these states do so 
under duress, with no local doctors willing to suffer the consequences of being 
known as an abortion provider, by constant picketing by anti-abortion protestors 
who harass patients and health providers, and with violence. In 2015, The New 
York Times reported that at least 11 people had been killed in attacks on abortion 
clinics in the US. Meanwhile, criminal cases of foeticide brought against preg-
nant women are on the rise in the US, where women suffering from miscarriage 
and stillbirth have been charged with murder.
This war, argues the sociologist Carol Joffe, is also between “the two Americas 
of reproductive health.” There is one population that is typically urban, educated 
and with the means of securing access to effective contraception on a regular 
basis, and to safe abortion without question. And there is the other America pop-
ulated by those living in rural areas, in poverty and with less chances for higher 
education, who do not have the means to pay for, or to access, contraception and 
abortion services. These two Americas also fracture along racialized lines. And 
the final irony: when asked in a 2017 survey, most women in the US seeking to 
terminate a pregnancy said they do so for financial reasons – they cannot afford 
to raise a child or another child –leaving those the most in need of family plan-
ning as the least likely to get it.
Globally, access to legal abortion varies, but there are trends in some South 
American countries similar to the situation in the US to strictly limit abortion 
access. The Professor of Law Michelle Oberman describes that unlike the ear-
lier history of botched abortions that relied on home-made instruments (the 
infamous coat hanger, for example), self-administered dangerous chemicals 
and back-alley practitioners with little medical training and no regard to sterile 
technique and follow-up, abortion access has recently been transformed by the 
abortion pill: RU 486 or mifepristone. Administered properly, this normally 
prescribed medication is 98% effective, and the rare cases of excessive bleeding 
or incomplete abortion that may result can easily be treated by a doctor without 
evidence of an abortion attempt. In El Salvador where in 1998 abortion was 
completely banned, the abortion rate did not drop as women accessed mife-
pristone through the Internet. What Oberman also discovered was that doctors 
under the 1998 legislation were recruited to police women’s reproductivity, in-
cluding cases of suspected self-induced miscarriage/abortion despite being una-
ble to prove if vaginal bleeding or miscarriage was a result of using mifepristone 
or not. Poor women and girls were criminalized as a result. In a country where 
both public and private healthcare are available, Oberman discovered that out of 
129 prosecutions of women and girls for illegally attempting to abort between 
2001 and 2011, the majority of which were triggered by doctors’ reports, not a 
single one came out of the private healthcare sector. Some of these cases involved 
women who had spontaneously miscarried and sought medical attention and 
were wrongly imprisoned for having attempted an abortion. When evidence of 
an early abortion attempt is difficult, if not impossible, to distinguish from a nat-
urally occurring miscarriage, doctors effectively become judges as well as a form 
56 The social control of reproduction
of reproductive police. Some publicly funded doctors were found not to report 
cases when they believed a woman or girl had made an abortion attempt, instead 
upholding their Hippocratic Oath to do no harm to their patient and to treat 
them medically to the best of their ability. However, patients who could afford 
private healthcare did not run the risk of policing and judgement by their physi-
cians at all. An almost identical class-based discrimination occurs even in places 
where abortion is not criminalized, and in the US, it is complicated by race.
Today, women suffering spontaneous miscarriage in the US are also being 
caught up in the justice system in states where there are fetal infanticide laws 
combined with new legal provisions strictly limiting ( just short of outlawing) 
abortion. And here too money matters. Money can buy you travel to a state with 
less stringent abortion provisions. It can allow you access to mifepristone over 
the Internet, and money usually furnishes women with the knowledge and con-
fidence to self-administer the drug. This has for long been the case. Historically 
throughout North America, Europe and Australasia some doctors and coroners 
did not report botched abortions as such, either out of concern for the women 
or to profit from keeping quiet. Women with enough money could buy access 
to safe abortions either locally or abroad; doctors have known how to perform 
abortions safely since the turn of the 20th century. Women of means with access 
to paths of privilege could pay for confidentiality and freedom from persecution 
for illegal abortion. Up until the 1960s and 1970s and the legalization of abortion 
in most developed countries, a dilation and curettage (D&C) was a minor gynae-
cological surgery used to control excessive uterine bleeding following a miscar-
riage or from fibroids, which also served as a safe and masked form of abortion.
With the advent of re-restrictions on abortion and the recent move to crimi-
nalize alleged abortion attempts based on shaky evidence and effectively outside 
of court, Oberman’s argument – what is happening in El Salvador will likely 
happen in northern and western countries as well – does not seem at all far-
fetched. In places where national and state politics are heavily influenced by re-
ligious organizations focused on banning abortion, the procedure will continue 
to be practised, but secretly or out of state or country; it will be limited to those 
who can afford and access not only the drugs and safe procedures but also the cost 
of keeping the matter confidential. Medical practitioners will determine who 
will be reported for violations, and snitching on a woman’s reproductivity could 
be opened to all around her. As big data are increasingly involved in managing 
medical information, especially for insurance purposes in the US private model 
of healthcare delivery, women’s reproductive status could also be tracked and 
shared. This helps explain why recently there have been demonstrations, espe-
cially in the US, for women’s reproductive rights featuring women dressed as the 
reproductive handmaids from Margaret Atwood’s dystopian fictionalization in 
The Handmaid’s Tale of a divided US in the not too distant future. In Atwood’s 
telling, a part of the US has evolved into a fascist fundamentalist religious re-
gime preoccupied with declining birth rates, and as a result, the regime strictly 
monitors and controls women’s lives by class, caste and fertility. On May 4, 2019, 
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two American anti-abortion organizations projected live ultrasound images of 
a third-trimester foetus in a womb on large screens in Times Square. Then in 
a full-page ad in the Sunday New York Times they advertised the event with 
people getting a chance to see the images on their cell phones. In the same year, 
California passed a bill requiring all state-funded universities to provide medical 
abortion (mifepristone pills) on campuses. There are a variety of fertility apps 
available where women can track when they ovulate, including Clue, Flo, Eve, 
Glow, Ovia and Sprout. Although these seem innocuous and even cute, the apps 
are prone to the same surveillance (sanctioned or not) and algorithmic treatment 
of personal data as any other.
The Center for Reproductive Rights, an international organization devoted 
to advancing reproductive rights worldwide, divides abortion law throughout 
the world into five categories: on request, on broad social or economic grounds, 
to preserve health, to save a woman’s life and total prohibition. What is in-
teresting is to compare these categories to how many women worldwide they 
affect: total prohibition = 90 million (5%) women; to save a woman’s life = 359 
million (22%) women; to preserve health = 237 million (14%) women; on broad 
social or economic grounds = 386 million (23%) women; and on request = 590 
million (36%) women. Although the last category contains the largest group of 
women, the first three categories where abortion is totally banned or severely 
restricted affect 686 million women, that is, 41% of all women in the world. It is 
also important to note that gestational limits for abortion vary widely, from six 
weeks (Texas, Ohio, Georgia and Missouri, USA) to 24 weeks (the UK). The 
circumstances allowing for abortion also vary; for example, in the UK, there has 
to be medically determined risk to the life, or mental or physical injury to the 
woman or substantial physical or mental health risk to the child if born. The UK 
does allow for socio-economic harm to the family as an indication for abortion. 
What the numbers above reveal is that almost a third of fertile women worldwide 
cannot legally access abortion or can only do so if their life is determined to be at 
risk. And where this is the case is where access to contraception access also tends 
to be compromised.
And what about those who want to reproduce and are not allowed? Michael 
Warner in 1991 coined the term “heteronormativity” or the common and taken-
for-granted social norms of heterosexuality including that children are properly 
born to married, heterosexual couples. Laura Mamo provides a reckoning of how 
lesbians in particular have managed to reproduce despite this social control of 
who should be pregnant and give birth but increasingly cannot without special 
assistance. Those who are married and heterosexual but cannot reproduce draw 
public sympathy and attention, and secret adoptions quietly normalized such 
families with others’ children who were born out of wedlock. However, adop-
tion in most countries where legislation for such exists was long denied to anyone 
not fitting the heterosexual, married norm, including single women, lesbians and 
gay men. It still is the case in many places such as all African countries except for 
South Africa, much of Asia including China and India, many Eastern European 
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countries and Russia. Gay men were and continue to be impeded or banned 
from parenting due to widespread social smear tactics that equate a male homo-
sexual orientation with pedophilia. This discrimination sometimes spills into 
legislation that prohibits openly gay men from teaching and otherwise being 
involved with children. Lesbians are not immune from similar treatment: their 
children have been removed from their care when their sexuality was exposed 
and treated as deviant. Today trans people are fighting for reproductive rights and 
proper medical support.
Becoming a parent and parenting is easier for homosexual women than for gay 
men, both socially and biologically. Initially both homosexual men and women 
hid their sexual preference behind heterosexual marriages of convenience and 
also became parents this way. As moral prohibitions against parenting out of wed-
lock dropped after the 1960s sexual revolution and women’s rights movements, 
lesbians and single women in the UK, for example, began self- insemination 
groups. In San Francisco, the lesbian group, Daughters of Bilitis, held discussion 
groups on lesbian motherhood as early as 1956. The self-insemination process did 
not require medical assistance; it required only a willing sperm donor, tracking 
the ovulation period and a turkey baster. Women could also intentionally ex-
pose themselves to becoming pregnant without letting their male sexual partners 
know. The Sperm Bank of California opened in 1982 and was the first in the US 
to offer services to lesbian and single women; proper semen screening became 
crucial following the identification of HIV and its transportation in bodily fluids 
in the mid-1980s. For gay men, becoming a parent is more complicated as it not 
only requires a woman to agree to bear and give birth to a child she may not 
raise, but also requires legal manoeuvring to have a male sexual partner recog-
nized as a legal parent and to perhaps remove the birth mother’s parental rights. 
Many of these barriers, in addition to widespread discrimination and stigmatiza-
tion, apply to trans people seeking to create families. Despite all of these barriers, 
there are places that support queer family formation: San Francisco, long a centre 
for promoting homosexual and now bisexual, transsexual and nongender-binary 
rights, has a well-established system of services, legal and medical, to help create 
families outside of the heterosexual norm.
Reproductive justice – the social determinants  
of reproductive health
The shift from a rights to a justice perspective in the social control of reproduc-
tion is a move away from formal measures of control of individual bodies, typi-
cally laws, to broader concerns of social justice including the right to sustainable 
living – including food and safe shelter, public safety, education, employment 
– and the right to cultural or community expression or belief. Family planning 
and control over one’s reproductivity and sexual practices are understood within 
the context of these things. In her history of the US reproductive rights move-
ment from the point of view of women of colour, Jennifer Nelson demonstrates 
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how Black women transformed the movement from one of reproductive rights 
to reproductive freedoms. The term reproductive freedom was used in a 1979 
statement of the Committee for Abortion Rights AND Against Sterilization 
Abuse or CARASA (author’s emphasis) and refers to an array of freedoms far more 
expansive than individuals’ access to contraception and abortion. This array in-
cludes the freedom from social discrimination and the policies that arise from 
such that can simultaneously prohibit “undesirable” people from reproducing 
through forced sterilization and an effective control of welfare-dependent Black 
and Hispanic populations. Nelson argues that contemporary efforts to secure 
reproductive freedom must come from the bottom-up and move away from the 
limitations of “choice” as individual women deciding whether or not to be preg-
nant and bear children. Women marginalized by their race and ethnicity com-
bined with systemic poverty often find themselves trapped within policies that 
target their reproductivity as a cause of their problems and do little to address the 
broader issues of systemic discrimination and structured economic inequalities. 
This holds true not only in the US, but among racialized and indigenous popu-
lations in most other developed countries, as well as in populations throughout 
the so-called developing world.
Global population programmes started in earnest following the Second World 
War and are premised on two basic concepts. The first is neo-Malthusianism, 
which states that the world’s limited carrying capacity is threatened by quickly 
expanding populations, especially in developing countries where birth rates are 
typically among the highest worldwide. The second concept is that development 
– understood as economic and social stability – requires controlled population 
growth. In the early 1800s, the world’s population reached 1 billion; in the 1930s 
it reached 2 billion, in the 1960s 3 billion and in 2020 it almost reached 8 billion. 
It is this demographic trajectory that inspired global population planning by 
groups such as the US-based Population Crisis Committee (PCC), which was 
created in 1965 and which continues today under the less threatening name, Pop-
ulation Action International. The PCC was instrumental in creating the Office 
of Population within the US Agency for International Development (USAID), 
the United Nations Fund for Population Activities (now the UN Population 
Fund or UNFPA) and the PCC assisted in fundraising for International Planned 
Parenthood. All of these groups share a perception that population growth is a 
significant threat to the future of humanity, and that the problem lies chiefly in 
underdeveloped countries.
The first national population control programme started in India in 1951 fol-
lowing US President Lyndon B. Johnson’s refusal of food aid to the country 
when famine threatened, due to a perception that the country would do nothing 
to address their growing birth rate. To answer initial suspicion among the so-
called Third World countries about First World control of their populations, the 
message was changed to “a call in the name of humanity for the sake of the entire 
planet.” Distancing population control programmes from any single government 
by running them through the UN helped to sell the idea, and family planning 
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became a powerful sign of progressive societies. By the 1970s, other countries 
joined in with instituting national family planning policies, including developed 
countries such as Japan, Norway, Sweden and the Netherlands.
The challenge in many developing countries, was, and continues to be, the 
lack of infrastructure for delivering safe and effective methods for family plan-
ning. Initially this was seen chiefly as a problem of getting the right means of 
fertility control to large populations. Vertical systems of delivery were typical 
where government officials passed birth rate targets and budgets down to re-
gional authorities who distributed contraceptives and providers to local centres, 
often through medical clinics. These vertical delivery systems tended to engage 
in misleading and coercive measures at the local level to meet regional and na-
tional targets. In Bangladesh for example, the non-governmental organization 
(NGO), UBINIG, discovered that women were being sterilized in exchange 
for bags of rice and saris when food and clothing were scarce. Although popu-
lation control programs did help some in establishing healthcare networks and 
in distributing western-style medical care in economically dependent countries, 
these healthcare delivery systems and the people using them were also exposed 
to unethical drug testing, a practice that according to the NGO investigating 
the activities of multi-national corporations, SOMO, continued into the 21st 
century. Population control programs have also been criticized as misguided and 
self-serving in the targeting of impoverished populations by wealthy populations 
which lead to the 1994 official end to population programs at a UN sponsored 
Cairo conference. Population targets, and the incentives and disincentives used 
to meet them were banned, and in their place arose an expanded definition of 
health and wellbeing, especially for women and girls, that included education 
on fertility and contraception. Many development strategies in underdeveloped 
countries engage with this education-based model alongside programs designed 
to make effective contraceptives (including long-lasting ones) more readily avail-
able. This despite the fact that the annual growth rate of the globe’s population 
has halved from 2% to 1.08% since the late 1960s. Although the actual number of 
people still grows each year, it does so at a slowing rate: the UN predicts that it 
will take until 2057 for the global population to reach the 10 billion mark.
Do underdeveloped countries deserve the continued attention they get in 
terms of population control programs? Since the inception of these programs 
in the mid-20th century, concern for the environment and consumption have 
entered the equation. Initially, underdeveloped nations were also blamed for 
environmental degradation: coal use, deforestation for fuel, poor sewage man-
agement, pollution of water ways, and so on. In the 1970s Paul Ehrlich, the pop-
ulation scientist famous for publishing The Population Bomb, and John Holdren, 
a scientist concerned with environmental change and energy who later served as 
President Obama’s senior advisor on science and technology, argued that deteri-
orating environmental conditions (typically understood as pollution in the 1960s 
and 1970s) were caused by three factors: affluence (A), population (P), and tech-
nology (T). This generated the formula to measure rates of environmental impact 
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(I) as I = P + A + T, commonly referred to as IPAT. Ehrlich and Holdren gave 
the greatest weight to population. The left-leaning and feminist environmental 
policy scholar, H. Patricia Hynes, pointed out in 1993 how developing countries 
are chiefly associated with the population variable, while developed nations are 
responsible for most of the affluence and technology figures. She saw the need to 
distinguish within the affluence variable between those who consumed luxury 
goods versus those who consumed to survive. She also argued to include military 
technology (MAT) and its significant polluting effect. This rendered a different 
formula: I = (PAT)survival + (PAT)luxury + MAT. Then she called to recog-
nize the effect of environmental support and conservation (which then typically 
came from small and local groups) as C: I = C − (PAT)s + (PAT)l + MAT. She 
concluded that to indicate the lack of women’s agency in virtually every variable, 
P should stand for patriarchy. Her main point, compatible with the reproductive 
justice approach, is not to lay blame for degradation of the planet due to explod-
ing populations at the feet of women, especially poor women.
In various explorations of maternities and modernity in Asia and the Pa cific, 
Kalpana Ram and Margaret Jolly argue how dominant ideals of maternity within 
a Eurocentric view of linear development are attempts to re colonize or neo- 
colonization. For example, in post-independent Malay, mothering becomes an 
individualized activity among an array of state-sponsored programs by pro-
moting maternal health according to a western medicalized model and a newly 
focussed attention by the state on the child and her welfare. These moves to mod-
ernize (westernize) and develop nations relies on the construction of a split be-
tween old (traditional, rural, extended family mothering, home health) and the 
new (modern, western, nuclear family mothering, medicalized maternity and 
infant care). Newly self-governing, formerly colonized countries adopt the split 
and work to bring their populations up to a level of development like those in 
the West. The formal social control of reproduction, from conception to raising 
a child to adulthood, is a key part of the process, and follows dominant notions 
of development. Whereas what especially women experience in the processes of 
maternity and modernization is more complex and based on shifting meanings as 
both traditions and the medicalization of birth are questioned and adapted. The 
ideology of reproductive care and child wellbeing as social progress is also active 
in marginalized populations within so-called developed, western countries.
In 2015 the Canadian government accepted the federally sponsored Truth 
and Reconciliation Commission’s Report as a way of addressing the country’s 
treatment of Indigenous people through enforced residential schooling that was 
designed to wipe out their cultures and language and exposed over 150,000 
children to horrific treatment, including forced separations from family, com-
munity and homeland, intentional starvation, and sexual abuse. The last federally 
run residential school was closed in the late 1990s. Another, and often hidden 
aspect of Canada’s treatment of Indigenous people, is the forced sterilization of 
Indigenous women especially those from remote and northern parts of the coun-
try, which led to a Saskatchewan-based class-action lawsuit in 2019. Based on 
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research by Karen Stote, the suit alleges sterilizations without women’s consent 
occurred as late 2018 throughout Indigenous populations in Canada. Stote de-
scribes the widespread practice as an act of genocide as well as colonization. Up 
until 1969 in Australia, Aboriginal people especially mix-raced children, were 
removed from their families under the White Australia Policy (1901–1966) in the 
hopes that their Indigenous bloodlines would be “washed” out as their genetics 
were absorbed into a white genetic pool. Referred to as the “stolen generations” 
these children are often compared with the Indigenous children forcibly placed 
in Canadian residential schools. Aboriginal girls in Australia were encouraged to 
marry white men in order to physically “whiten” the population and eventually 
eradicate the Indigenous population. As late as 2018 the UN also called on Aus-
tralia to abolish forced sterilization of women and girls with disabilities, as well 
as intersex people. These are all aspects of contemporary colonization through 
the lens of reproduction.
How we socially control reproduction also extends to pro natalist policies, or 
policies to encourage certain people to reproduce. Since the rise of the modern 
nation and nation-based global economics, low population rates have been a con-
cern to the developed state. Western European birth rates dropped significantly 
following the First World War due to the war itself, as well as to rising interest in 
and the availability of the means to control family size. According to the World 
Bank, although the global birth rate rose after the Second World War to an all-
time high of just over five children per woman in 1965, it has been dropping 
steadily ever since. By 2017 it dropped to under 2.5; North America, countries of 
the European Union, China, Australia and New Zealand, South Korea and Rus-
sia all have rates of 1.8 or lower. A rate of 2.1 is considered necessary for a stable, 
replacement population. Despite important variables to consider in measuring 
the impact of birth rates, including geo global location, impact of consumption 
on the environment, rising life expectancy, lower infant and maternal mortality 
rates, some countries have adopted pro natalist policies or strategies. They do so 
to stabilize or strengthen national economies, to address the imbalance between 
increasing aging populations and diminishing younger working populations, and 
to protect language, ethnicity, religion and national identity. In 1966 Romania 
prohibited abortion and created incentives for women to have children, includ-
ing improvements to working conditions and maternity leave. Because France 
experienced a falling birth rate earlier than most other European countries with 
the advent of industrialization in the 1800s, it was among the first to create a 
pronatalist policy. Between 1920 and 1940 it rolled out a national education 
program directed at children and young adults about falling birth rates and their 
national impact under the direction of the National Alliance for the Growth of 
the French Population, and passed the pronatalist law, Code de la famille in 1939. 
In 1988 the Canadian province of Quebec put a pronatalist policy into effect to 
protect its unique French culture and language within the dominant English 
North American context. The policy included escalating, at-birth payments, a 
family allowance for all children under 18 years, and an additional allowance for 
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children under six. The first of Singapore’s pro natal policies to address one of the 
lowest birth rates globally (1.2) was in 1987, and were followed by revisions and 
enhancements in 2004, 2008, and 2013. In 2019 The Hungarian government 
announced pro natal incentives, including removing taxes, reducing credit pay-
ments, and increasing access to credit for mothers with more than three children. 
The Russian political leader, Valdimir Putin put a pronatalist policy in place in 
2007 including an escalating cash incentive on the birth of each child, increased 
parental leave, and compensation for daycare costs. Increases to this policy were 
enacted in each of the following six years.
And in between population control and pro natalism lies a more complex 
management, chiefly by women, of the pressures social control brings to repro-
duction. In Canada the care of pregnant and birthing Indigenous women has fi-
nally started to come under criticism, for example by the Indigenous scholar and 
midwife, Karen Lawford for separating women from their families, communities 
and way of life as women are routinely evacuated thousands of kilometres to ur-
ban centres for medicalized birth and neo natal care. Now some modern medical 
contexts are welcoming Indigenous family and community members and their 
rituals into birthing rooms. While reproductive justice, including decent hous-
ing, clean water, Indigenous-controlled child welfare, and access to modern re-
productive healthcare and education under Indigenous peoples’ terms, form part 
of continued demands by many Indigenous communities across Canada within 
a heightened awareness of abuses and neglect of Indigenous people through wel-
fare and medical systems as well as by Residential Schools. Tamil women on the 
coast of southern India struggle with both the impact of a longstanding caste 
system and criticism from modernized westernized medical practitioners for the 
backward ways of their midwives. As the Tamil scholar who works among these 
people, Kalpana Ram states, “the project of reform… is not only an emanation 
of colonization but also bears certain important continuities with much older 
precolonial forms…”. And yet, these women work to evade the negative impacts 
of both pre and post colonialism by shifting their religious practice to Christi-
anity to escape the negative effects of the caste system, and by sustaining their 
communities through traditional activities including fishing, trading and local 
midwifery despite and sometimes in conjunction with westernized medical care 
and standards of childrearing.
The social management of identity also plays a role in the control of repro-
duction, especially in terms of social justice. We have seen how many countries 
interested and engaged with eugenic ideals adopted policies to improve national 
populations since the turn of the 20th century, culminating in the widespread 
horrors of the Shoah. The Nazi program in the 1920s and 1930s to ethnically 
cleanse the German population of Jews also included people with disabilities, 
homosexuals and those without a permanent claim on the land (gypsies). A con-
siderable portion of western developed nations adopted eugenic policies to in-
hibit birth rates among the disabled (those considered mentally and physically 
unfit) allowing forced sterilization. In the UK male homosexuality has long been 
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outlawed, one way or another, from 1533 to 1967 (lesbianism was outlawed 
in 1921) and initially punished by death and “cured” in the 20th century by 
chemical castration. Gay, lesbian, bisexual, trans sexual and nongender binary 
people continue to be formally and informally persecuted in places throughout 
the World: In Russia, the motivation for increasing its population rate arises out 
of the typical concerns for a stable internal economy, as well as out of Putin’s 
conservative, homophobic nationalism. This has led to the Russian Orthodox 
Church joining forces with the state in promoting “family values” and in re-
stricting reproduction to heterosexual and married couples, and outlawing ho-
mosexuality. The battle for reproductive rights for LGBTQ2+ people has only 
emerged recently and typically in places where their sexual identity is legitimized 
and protected. Finally, migrants, especially undesired immigrants, continue to 
be read as problematic in terms of their numbers (“wave” is a common descrip-
tion of them as a group). Many developed nations are formally and actively re-
ducing or refusing their entry into local populations as a perceived threat to the 
reproduction of the ideal state.
Paternity claims and paternity rights, or the rights of fathers, have long formed 
a significant part of the social control of reproduction by identity, as they inter-
sect with patriarchy and the powerful norm of heterosexuality. The historian, 
Nara Milanich has produced a comprehensive history of the continual hunt for 
certain paternity from Ancient Roman law to Internet-available DNA pater-
nity kits. According to Roman law, Pater semper incertus est (the father is always 
uncertain), mater certissima est (the mother is always certain), and therefore, pater 
est quem nuptiae demonstrant, or the father is whom the marriage identifies. And 
so, as Milanich states, paternity is always embedded more in socializing fictions 
than biological fact, and that “the quest for the father [is] deeply politicized, cul-
turally fetishized, and now thoroughly commercialized.” Despite the surety that 
today’s DNA testing promises, paternity remains more than a biological link, 
and even genetic markers are not always certain. The political philosopher, Mary 
O’Brien, bent the Marxist theory of historical materialism – or how we make 
sense of ourselves socio-politically in the material world – to feminist analysis. 
As maternity is usually certain (although with the advent of new reproductive 
technologies, this is less the case), and paternity has long been uncertain, O’Brien 
describes paternity as a social fiction generated to protect male interests and to 
inject some paternal certainty into the picture. All children born of a heterosex-
ual, sanctioned union were of the husband as indicated by the globally common 
paternal surnaming of children and in the determination of inheritance rights 
and privileges. This is how men leave their mark historically, whereas women 
mark their time through the birth of their children, which forms an intimate and 
certain relationship with regeneration and with history.
Milanich demonstrates that even when obvious signs of racial difference are 
used to challenge paternal claims, other considerations carry more weight, as 
in Italy when inter racial children were born of white Italian mothers and the 
Black American soldiers liberating Italy in the Second World War. Despite strong 
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public opinion that such “mulattini” or mixed children were obvious signs of 
women’s infidelity and Black men’s sexual predation and aggression, Italy’s need 
to centre the family in re-righting the nation after the war (a position shared 
by both the socialist government and the Catholic Church) turned away from 
obvious fact. In the famous case of the “little Moor of Pisa,” Antonio Cipolli, 
despite being born with what many around him, most notably the husband of 
his mother, considered Black features (dark skin and curly hair) and proof of his 
mother’s infidelity with one of the Black soldiers from the nearby American base, 
the courts eventually appointed the husband, Remo Cipolli, as the legal father, 
and so named the child out of protection of the nation’s interest in preserving 
the family as a pillar of social stability, no matter what the biological paternity.
Another side of hidden paternity is the exploitation of it by those who control 
artificial insemination or AI. AI has been part of medical practice since the turn 
of the 20th century and involves inseminating women, thus bypassing hetero-
sexual coitus as a way of becoming pregnant. The process allows for any sperm 
to be used, and in cases where in a married heterosexual couple the male was in-
fertile, donor sperm was used. Elizabeth Yuko explores the ethical ramifications 
of the first reported case of successful AI with donor sperm, which was in 1884 
by an American doctor who used the sperm from a medical student considered 
the best looking of the class. The woman inseminated was unconscious for the 
procedure and was unaware that she gave birth nine months later to a child bi-
ologically unrelated to her husband. The husband was informed by the doctor, 
William Pancoast. And later, the 25-year-old son was informed of his biological 
parentage by one of the former medical students present at the insemination just 
before he published his account of the insemination in 1909. Sperm donation has 
since become an international, multimillion-dollar business typically controlled 
by legal protection of donors from paternal responsibility for custody and inher-
itance to any biological offspring. It is also now a typically open medical practice 
in that inseminated women, their partners and often the offspring are aware that 
the social father (he who the marriage indicates) is not the biological father. But 
hidden paternity also persists. It can be the intentional choice of women seeking 
to become mothers without the biological father involved in the rearing of the 
child. It can be the result of shame associated with a pregnancy that results from 
rape and sexual assault, including incest. And it can be a result of contemporary 
malpractice by doctors.
Sarah Zhang and Jacqueline Mroz independently report on how regularly 
cases arise where doctors who practice AID (artificial insemination by donor) do 
not rely on the careful management of donor sperm through registered sperm 
banks, but supply the donated sperm themselves, giving rise to public moral 
outrage, to uncertain genetic lineage with potential health implications, and to 
interbreeding minefields especially when the communities are small. In 2019 the 
Ontario fertility doctor, Norman Barwin, had his license revoked for insemi-
nating 11 women with his own sperm, while a court case in the Netherlands 
involving the fertility specialist, Jan Karbaat, finally released evidence following 
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his death in 2017 that he was the biological father of 49 children. In the 1980s, 
the American reproductive specialist, Cecil Jacobson, was found to be genetically 
related to 15 of the children of his patients seeking fertility treatment, while 
the Indiana-based doctor, Donald Cline, was found to have fathered at least 48 
children through his fertility clinic between 1979 and 1986. Notably in this last 
case, the court found no criminal wrongdoing nor any human rights breech in 
the practice; only professional misconduct for deceiving his patients. In 2019 the 
state made such malpractice illegal, while in Texas, Eve Wiley, the biological 
daughter of her mother’s fertility doctor there, is advocating that such practice 
be considered criminal sexual assault. During the atrocities of the Bosnian War 
between 1992 and 1995 up to 12,000 Muslim women were raped, chiefly by 
Serbian fighters. Not only was this considered torture of the women by the In-
ternational Criminal Tribunal for the former Yugoslavia, it was also identified as 
a Serbian-sanctioned attempt at ethnic cleansing through forced insemination, 
which was used intentionally by the Serbs to disrupt Muslim communities as a 
Muslim woman pregnant with the child of a Serb risked rejection from her com-
munity along with her child.
Today, Milanich points out, paternity testing is more accurate and commer-
cially available than ever before. A van containing a mobile DNA testing unit 
with the loud proclamation on the side, “who’s your daddy?” has been trolling 
New York City’s neighbourhoods since 2012. DNA fingerprinting, central to 
forensic identification in both real and the many fictionalized accounts of crimi-
nal investigation, was originally developed in the 1980s for paternity testing, and 
is now offered online for about $80 USD, as well as by New York’s ice cream 
truck-like DNA testing van. Interest in DNA fingerprinting for paternity has 
spread worldwide from the US: the company EasyDNA offers Internet kits with 
mail-in testing in 39 countries, while the UK-based website Nimble Diagnos-
tics explains paternity testing today in 36 languages. The service is also availa-
ble from Chinese and Indian companies. And what is this information serving? 
DNA fingerprinting is used by governments and courts to help decide in cus-
tody and child support cases, as well as to determine immigration and citizen-
ship claims, including the recently state-sanctioned denaturalization of citizens. 
There is not much public interest in fictionalized investigation series exploring 
these applications of paternity (and now maternity) testing. Paternity and its 
tricky status have long been wrapped up in the social control of reproduction of 
the family, from individual cases of alleged infidelity to the reproduction of the 
state and the geopolitics of migration.
Conclusions
The social control of reproduction is complex. It pulses constantly from the in-
timacy of individual families through medicalized reproductivity to state and 
global imperatives and protections. It reinforces existing inequities between peo-
ples distinguished by race, sexuality, income, religious belief and so on. It is 
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simultaneously the restriction of undesirable populations – usually characterized 
as unproductive economically, a threat to the environment and global safety, and 
often brown or black – and the promotion of others –normally characterized by 
economic wealth, high consumption and education rates, and whiteness. And 
in between, people manage to assert their reproductivity despite impediments: 
women create self-help insemination groups, gay men and lesbian women swap 
reproductive capacities to help each other form families outside heteronorma-
tivity, women in former colonized contexts step carefully between tradition and 
modern medicalization to get what serves them and their children best, and some 
doctors aid women in controlling their reproductivity despite legal sanctions. 
Reproduction is not always controlled through the passage of laws, and not all 
laws protect all people’s reproductive rights. Reproductive justice does not look 
the same everywhere, and it is not the same for everyone.
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The relationship between human reproduction and sexual desire has long been 
socially mediated. Undoubtedly the introduction of morally acceptable, le gal, 
effective and widely available contraception starting in the mid-20th century 
 followed soon after by lifting of restrictions on abortion in many developed 
countries had wide-reaching social impacts on human reproduction. For the 
first time since prehistoric cultures worshipped a feminine divine as fertility, 
reproduction was split from heterosexual intercourse: this type of sexual activ-
ity did not have to result in pregnancy. Heterosexuality began to be publicly 
challenged as a powerful social norm that had long confined sexuality to only 
married men and women and that assumed women were natural at child-rearing 
and confined them to the home. Allowing for the planning of parenthood in 
the second half of the 20th century helped women to work outside the home 
in record numbers. Young people around the world joyfully formed the 1960s’ 
sexual revolution liberating heterosexual desire from shame and the binds of 
matrimonial- sanctioned sex. Then, gradually, gay rights advanced, eventually 
including the call for reproductive rights for non-heterosexuals as deeply rooted 
definitions and practices of kinship continued to be challenged. And throughout 
this period, money is to be made: hormone-based contraception has been a big 
pharmaceutical-based business that seeks new markets with the possible suspen-
sion of monthly menstruation and the medicalization of male sexuality.
Unhinging reproduction from heterosexuality
Family planning pioneers Marie Stopes (UK) and Margaret Sanger (US) helped 
start a worldwide movement at the start of the 20th century that allowed women 
to decide if, when and how often they would be pregnant by calling for wide-
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point was widely illegal and often considered amoral. This was no small feat and 
is clearly laid out in the social historian Elaine Tyler May’s history of the Pill. 
Not only did this movement have to address the medical monopolization of 
knowledge at the turn of the 20th century which extended to understanding the 
particulars of human reproduction including knowing when women were fertile 
in the monthly cycle and what could prevent sperm from meeting and combin-
ing with the egg. Laws prevented this information from being distributed out of 
moral concerns: the US Comstock Laws prevented the distribution of contracep-
tive information as pornographic, a legacy from the historical association of con-
traception with prostitution that was widely shared throughout western Europe, 
North America and Australia. Stopes and Sanger shifted the moral debate to 
poverty and socio-economic well-being. They argued that planned family sizes 
would allow those living in poverty to move up economically. Their strategy was 
to place clinics in poor neighbourhoods where they initially dispensed contra-
ceptive information and built up women’s confidence to assert their reproductive 
choice at home, ostensibly only those married to men.
Decades later came the development of an effective contraception without the 
historical contamination of prostitution practices: the Pill. Due to the fundrais-
ing and organizing efforts of Sanger, the hormonal contraceptive was developed 
and made available to women as patients (not impoverished citizens) by the early 
1960s. Sanger succeeded in securing the funds required and brought together 
willing scientists and a physician to make it happen. In May 1960 the US ap-
proved the Pill for medical release; in 1961, 400,000 women were taking it, four 
years later the number jumped to over 3 million and in 2019, the UN estimated 
that 151 million women worldwide used the Pill as contraception. Although 
not the cause of the sexual revolution, the Pill certainly played a key part as the 
risk of unwanted pregnancy was significantly reduced by the effectiveness of the 
drug, and as a physician-controlled medication, it was distanced from the legacy 
linking contraception with prostitution. The widespread uptake of contraception 
in the 1960s not only required the technical means for safe and effective control 
of pregnancy, it required a relaxing of moral and legal restrictions on individual, 
especially women’s, reproductive control. The reproductive rights movement 
that arose in most industrialized nations – democratic, socialist and communist – 
reflected a turn towards the rights of women away from the sanctions of chiefly 
large, organized religions who had long held positions of authority over human 
reproduction. But increased medicalization of women’s reproduction, including 
contraception, left women contending with medical authorities over their repro-
ductive choices.
The sexual revolution was more than the means to control reproduction; it 
was also a move to liberate sex from shame under the main slogan of the move-
ment: “free love.” Premarital sex throughout much of the 20th century and in 
most developed countries carried significant shame. So-called “unwanted preg-
nancies” and the centuries-old cottage industry in homes for unwed mothers 
are testament to the power of that shame. The ability to enjoy heterosexual sex 
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without the threat of pregnancy was a great release and was felt widely through-
out a politically active and resistant middle class, chiefly in white college culture 
in North America, western Europe and Australasia, while women in socialist and 
communist states including the USSR and China were not only granted access to 
contraception but also to safe and widely available abortion.
Foundational to this newly won heterosexual freedom are two significant 
social movements and growing unrest internationally. The first is the US-based 
civil rights movement starting in the mid-1950s and lasting well into the 1960s 
which was led by Afro-Americans demanding the realization of the freedom and 
rights promised to them by the Emancipation Proclamation of 1862, but which 
instead was followed by a brutal and persistent racialized regime. The second was 
the women’s liberation movement during the 1960s and 1970s which focused on 
securing reproductive rights (to contraception and abortion), sexual liberation, 
equal access to work and fair pay and gaining political influence generally. Both 
movements occurred during heightened criticism of especially American influ-
ence in geopolitical conflicts and the growth and dissemination of capitalism 
globally. Notable protests included the Kent State University protest against US 
involvement in the Vietnam War where American troops fired on and killed 
their own citizens, and the May 1968 uprising of university students alongside 
labourers in Paris. The world was changing, and government authorities were 
being challenged by their own, relatively young populations of reproductive age.
Notably absent from these demonstrations, protests and civic actions were 
those seeking an end to the stigma and abuse associated with homosexuality. 
Although gay men and lesbians (the chief components of non-heterosexual iden-
tity at this time) were certainly present and to some extent were forming their 
own social groups, they remained largely hidden from public view, including in 
protest, until the Stonewall Riots of 1969 in New York City. Stonewall is the 
name of the Greenwich Village club where gay men, lesbians and drag queens 
met to socialize, usually with protection from police interference by the mafia 
who owned and profited from the bar (unlicensed), which featured extremely 
watered-down drinks and virtually no attention to hygiene provisions includ-
ing clean washroom and running water behind the bar to wash glasses. Gayle 
Pittman provides an artefact-based history of gay life in New York City, lead-
ing up to and including the riot that became a watershed for gay rights in the 
US and beyond. On June 28th the bar was not warned of an impending police 
raid and 13 patrons and employees were roughly rounded up and arrested while 
cross-dressing patrons’ sex was checked by police in the bathrooms. Patrons and 
others living nearby reacted violently and forced the police, a few prisoners and a 
local journalist to take refuge in the club as rioters outside tried to burn it down. 
The riot was quelled with no one seriously hurt, but it has since become known 
as a galvanizing force that led to the US-based gay rights movement: the days of 
being holed up in substandard closets and always vulnerable to police brutality 
were coming to an end for those who defied the heterosexual norm. In 2016, 
President Barack Obama designated the area surrounding the Stonewall Inn as 
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a national monument to gay rights. Although this movement did not initially 
address reproduction, it would have been very difficult without it to assert re-
productive and parenting rights for members of the LGBTQ2+ communities, 
especially gay men and transgender people.
Donald West and Richard Green bring together a significant collection of in-
ternational comparisons of sociolegal developments in homosexuality. Lesbians’ 
struggle for sexual-based identity rights was typically not the same as that of gay 
men. This had to partly do with patriarchal assumptions of what constituted sex-
ual acts. For example, in a long history of addressing non-heterosexual activity 
from the Roman conquest of Britain to Victorian England, only male-to-male 
sexuality is addressed: King Henry VIII passed the Buggery Act in 1533 making 
homosexuality between men punishable by death. The Act was repealed in 1861, 
and replaced in 1885 by the Criminal Law Amendment Act banning sexual acts 
of “gross indecency” between males, which expanded the definition of criminal 
sexual behaviour among men beyond buggery. Only in 1921 did the British Par-
liament extend sexual gross indecency to females, and in 1956 recognized sexual 
assault between women as a crime. Cross-dressing and passing as the opposite 
sex have long been practised in the UK and elsewhere, sometimes with deadly 
 consequences – the cross-dressing Englishman, Kenneth Crowe, while wearing 
his wife’s wig and dress, was beaten and strangled to death in 1950 by a boxer John 
Cooney when he found out Crowe was not male. Sexual confirmation surgery 
in Britain started in the 1930s, but transgender people remained deeply closeted 
throughout most of the world until the 2010s. A similar trajectory of severe  legal 
prohibitions against especially male homosexuality is found  throughout the world 
and persists in places such as Russia and some African countries. Also, v iolence, 
harassment and discrimination against non-heterosexuals continue despite some 
legal recognition of LGBTQ2+ rights, most notably the right to marriage.
Not only was non-heterosexual desire criminalized for a long period and 
remains so in various places worldwide, establishing legally recognized non- 
heterosexual kinship has virtually been impossible. As with the UK, throughout 
the 19th and 20th centuries many developed countries established laws defining 
and protecting marriage as a heterosexual union and the proper place for repro-
duction and the raising of children: the creation of kin. It was not until the late 
20th century that the gay rights movement, combined with lesbian, bisexual 
and trans groups and then later with queer and two-spirited associations, formed 
what is commonly referred to as the LGBTQ2 community. Today those refus-
ing or questioning a dualistic approach to gender, those who are androgynous 
along with a growing number of forms of gender expression are indicated as 
LGBTQ2+. Although hardly a single community, the collaboration between 
non-heterosexual interest groups in many developed democracies globally has 
helped secure sexual and reproductive rights beyond the dominant male–female 
dyad. Between 2001 and 2020, same-sex marriage was legally recognized in 27 
countries, including in the UK in January 2020. Earlier, legal recognition of 
same-sex couples, parenting and reproductive rights were only possible through 
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a heterosexual masquerade: gay men and lesbians would marry and have children 
legally recognized through the marriage. Even if they eventually divorced their 
opposite-sexed partners, gay people’s sexual orientation had to remain hidden 
in order to maintain their parental rights; so-called sexual deviance and obscen-
ity are powerful legal tools used to remove parental rights. Prior to the 1970s, 
adoption was also limited to married, heterosexual couples. Today, same-sex 
couple joint adoption is allowed in 27 countries. However, the legal recognition 
of same-sex marriage and all the rights and privileges that come with marriage 
such as inheritance, insurance as well as parenting continue to be a struggle in 
many parts of the world.
Kinship unhinged
The public recognition of the Stonewall Inn as a national monument to gay 
rights marks a significant progression from the 1885 UK criminalization of male 
homosexuality as buggery and other legislative bans on sexual practices. But 
there is continued persecution of LGBTQ2+ people such as the US Orlando gay 
night club shooting in 2016 that left 49 people dead and 53 seriously hurt. Today, 
in many African countries and in Russia where homosexuality is criminalized, 
the punishments for violating heterosexual norms are harsh and violence against 
LGBTQ2+ people is on the rise even in places where it is legally protected. On 
the other hand, significant LGBTQ2+ rights have increased in places including 
in the US, Canada, the UK and most of western Europe. Notable among these 
are the right to reproduce. As contraception marks the major shift in the relation-
ship between sexuality and reproduction for modern heterosexuals, conception 
and the making of queer families marks what sexuality and reproduction mean 
for homosexuals and trans people. The American queer studies scholar Elizabeth 
Freeman takes this a step further and argues that the origin of the so-called 
modern family is at the intersection of kinship (how relatedness is recognized and 
practised) and sexuality, which allows us to tie together sex and reproduction in 
radical new forms.
Freeman asks whether non-conforming sexually identifying people actually 
change the rules of kinship when they seek the same structures as those in place 
for heterosexuals: naming and rearing children in dyads of parents who are le-
gally responsible for the child, limiting state and financial support to legally 
recognized couples and so on. Is the answer to restricted access to kinship to 
expand membership to include gay and lesbian fathers and mothers or to get rid 
of the clubs based on the kinship model of heterosexual, nuclear families? Or 
is it more complicated? Freeman traces queer theory to the French philosopher 
Michel Foucault’s characterization of the history of sexuality as a “regime of 
sexuality” that emerged in the 19th century and managed in many ways (legally, 
morally, medically) the meaning of sexual desire and experience: the criminali-
zation of buggery, the casting of especially gay men as perverse and ungodly and 
categorizing homosexuality as a mental illness. Freeman argues that this regime, 
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however, sits apart from a regime of “alliance” or kinship, which controls matri-
mony and legally sanctioned reproduction.
What, asks Freeman, would a regime of queer affinities or kinship look like? 
Queering or radically twisting the structure of kinship is not limited to the 
LGBTQ2+ community, although the feminist philosopher of sexuality Judith 
Butler does ask if “kinship is always already heterosexual?” With both questions, 
Freeman and Butler are acknowledging the powerful social effect of assumed 
kinship norms: the heterosexual dyad of parents raising children expected to be 
genetically related to the parents and to each other. In Canada the power of this 
norm was tragically expressed in the so-called 1960s “scoop” of tens of thousands 
of Indigenous children from families deemed unfit to raise them. Reasons for 
removal of these children from their families, their communities, their language 
and their culture included perceived infractions of the kinship code: children 
sharing beds with siblings and adults other than biological parents such as aunts, 
cousins and older children taking responsibility for raising the children. The 
scoop relates to what Freeman calls affinities over space: we can recognize oth-
ers, including LGBTQ2+ people, in normal kinship roles such as mother, father, 
parent and partner, but not beyond to menages a trois, quatre, or cinq, friends as 
parents, or raising children in cliques, communities and tribes. Normal affinities 
or kinship also span time in prescribed ways. We can recognize children of gay 
or lesbian parents when they are adopted from the generation below, but what if 
that rule of descent is not obeyed and contradicts “normative generationality?” 
Why do we have difficulty grasping the concept of adults adopting each other in 
parenting and child roles?
The radical reformation of kinship or the social recognition of who relates to 
whom also relies on socio-technical developments in reproductive and sex-trait 
hormones, called the “pharmaco-pornographic regime” by the philosopher of the 
science of sexuality, Beatriz (now Paul) Preciado. Preciado paints a picture of a 
“post-industrial, global and mediatic regime” emerging after the Second World 
War that includes the medical coining of the term gender and the discovery that 
any child’s sex can be changed up to 18 months (1947), and the first demographic 
study of “sexual deviation” (1941). In 1953, Hugh Hefner begins publication of the 
first North American pornographic magazine, Playboy, to be distributed alongside 
daily newspapers; Marilyn Monroe is featured nude on the front cover. The 1972 
pornographic film Deep Throat becomes the most watched film of all time and 
helps launch a multibillion dollar industry in porn. In 1941, natural molecules of 
progesterone and oestrogen are distilled from the urine of pregnant horses, and 
soon after are synthesized and mass produced for the contraceptive pill, and for 
“treating” transsexualism during the 1950s and 1960s. Following several failed 
attempts at physically managing penile erectile dysfunction, the vasodilator drug 
Sildenafil (commercially known as Viagra) was approved for treatment in 1988. As 
Preciado states, “the political management of body technologies that produce sex 
and sexuality can be seen to progressively become the business of the new millen-
nium.” And this sexual regime is assumed as heterosexual.
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When the North American psychiatrist John Money coined the term gender 
and differentiated it from biological sex in the late 1940s, it was part of the wider 
regime of normalizing, celebrating and profiting from the sex industry described 
by Preciado. But first feminists in the 1970s and then early queer theorists seized 
on the plastic term to challenge sexism (“the exaltation of masculine labour and 
domestic maternity),” heterosexism and the persecution of homosexuality. With 
increasing pressure from homosexual rights groups and a progressive psychiatric 
subgroup, homosexuality was declassified as a mental illness in 1973 (although a 
decade later “gender identity disorder” or transsexuality was added in as a dis-
order). Between the 1970s and 1980s, lesbians formed self-insemination groups 
in San Francisco and London, UK, while other women continued to fight for 
control over their reproductivity (on-demand abortion, for example) and for eq-
uitable, paid employment and childcare to allow them to work in the public 
domain. The relative stability of biologically based sex difference (now differ-
entiated form the social construction of gender) is then challenged in the early 
1990s with attempts to find the genetic determinants of sex. The sociologist of 
science and technology Joan Fujimura examines these studies and finds that they 
are based on and reproduce social assumptions of sexual difference: “Sex, even at 
the genetic level, is a sociomaterial process and product.” Socially the challenge 
to sex and gender dichotomy occurs with the coming out of transsexuals and 
their calls for access to the pharmaceutical and surgical means to sex affirmation. 
Meanwhile, LGBTQ2+ people hijack new reproductive technologies designed 
to reinforce heteronormativity to generate different families. The following 
question remains: Do these discoveries and reformation of sex affinities represent 
a new and progressive kinship? Or as Mamo and Alston-Stepnitz ask, does this 
represent a repopulation of the same kinship structures with different actors that 
also perpetuates the commercialization of reproduction with new markets, as 
well as the exploitation of others through contractual surrogacy?
Capitalizing on reproduction and sexuality
In the early 2000s, contraception moved beyond the realm of family planning 
to the medicalization of lifestyle management. In December 2005, the Canadian 
national magazine, Macleans, featured a cover with the provocative statement: 
“The End of the Period – Menstruation Will Soon Be Optional.” It was refer-
ring to the oral hormone-based contraceptive pill used as a way of reducing the 
number of times women menstruate during the year. Typically, women shed the 
lining of their uterus about once a month. When taking the oral contraceptive, 
the female reproductive system is effectively tricked into thinking the body is 
pregnant and therefore the necessary preparation of the uterine lining to accept 
a fertilized egg does not take place. Since its inception, the monthly pack of the 
Pill has contained seven placebo pills (differently coloured) and women are in-
structed to take these following three weeks of the contraceptive pills. By ceasing 
the pill with the active hormonal ingredients, a minor irritation in the uterus 
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occurs and there is some bleeding as a result called a withdrawal bleed. This is not 
an actual period or shedding of the uterine lining when no implantation of a fer-
tilized egg occurs. But it looks like one and is kept there to maintain the fiction 
of menstruation. The possibility of not bleeding at all has always been present 
with the Pill; many people who menstruate but would rather not typically be-
cause of work responsibilities, such as pilots, astronauts and surgeons, do not take 
the placebo pills but continue on with the contraceptive ones and never bleed.
Manufacturers of the Pill marketed this option to a much broader market 
than busy and heavily responsible professionals who may have found managing 
vaginal bleeding a significant hindrance to performing their duties. Seasonale is 
one such product released in 2003, and one of its ads features a young woman 
twirling carefree in her purple-dotted white dress, the dots falling to the ground 
around her. The ad explains that, “unlike other daily birth control pills, SEA-
SONALE lets you have four periods a year.” This leaves the woman free to 
enjoy: “disco.tango.hip-hop.nonstop.” And presumably leaves men to enjoy sex 
with a rarely menstruating woman. In 2004, the pharmaceutical company Barr 
made $87 million selling Seasonale. The 2005 article in Maclean’s Magazine raises 
the medical advantages of “menstrual suppression” and refers to the Brazilian 
gynaecologist Elsimar Coutinho, who in 1999 published the book: Is Menstru-
ation Obsolete? How Suppressing Menstruation Can Help Women Who Suffer from 
Anemia, Endometriosis, or PMS. Here, it is pointed out how the modern woman, 
due to delay and limitation of childbirth, earlier onset of menstruation and a 
far lower maternal death rate than her 19th-century counterpart, experiences 
far more menstrual cycles: 400 for the modern woman compared to 50 for the 
19th- century woman. And menstruation is blamed for making worse anaemia, 
migraine headaches, endometriosis and polycystic cysts. The conclusion: men-
struation is a risk to modern women’s health. The solution: suspend it through 
the constant medication of menstruating women.
The sociologist of medicine Jennifer Fishman tracks Viagra as the biomedical-
ization of impotence as medical attention in general shifted from life-threatening 
illness and disease to focus on life-limiting conditions, such as the medicalization 
of menstruation. Traditionally, impotence was accepted within the 19th-century 
medicine as an inevitable part of male ageing, a sort of biological winding down. 
We have seen how during the early part of the 20th century, the discovery of sex 
hormones and their relationship to sex traits, including penile erections, led to 
crude methods of distilling sex hormones (from slaughtered animals initially) to 
be used by physicians and others to reverse the effects of ageing, including sexual 
performance in men. Since then, the increased reliance on pharmacy in medical 
practice, the “molecular turn” in medical sciences, along with a struggle between 
psychologists and physicians to define and control the condition, transformed male 
impotence as an expected part of ageing into erectile dysfunction. This became a 
concern to men of all ages, and so medicalized male sexuality.
As pregnancy and birth were increasingly medicalized especially after the 
Second World War, Fishman tracks how sexuality became a significant part of 
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medical and psychological research. Studies by the biologist and sexologist Alfred 
Kinsey (1953) and the gynaecologist William Masters and sexologist Virginia 
Johnson (1960s and 1970s) were landmarks in normalizing and bringing sexual-
ity to the practice of medicine, providing typologies and pathologies and laying 
the ground for medical treatment. As we saw in the history of contraception, 
sexual activity, even in morally condoned arrangements such as heterosexual 
marriage, has long been hidden from public view and prone to slipping from its 
proper place with serious social consequences. Information about how to engage 
in heterosexual sex without the risk of pregnancy was illegal in the US when 
Kinsey released his report on the naturalness of human sexuality. In the 1950s, 
abortion was a deadly back-street activity, and children born outside of marriage 
were usually put up for adoption amidst the shaming and social ostracization of 
unwed mothers. To bring sexuality into medicine was a step away from the long 
moralist hold over sexual activity by dominant organized religions. As sexuality 
was recognized as a part of human health, notes Fishman, both mental and phys-
ical wellness and illness were attributed to sexual practices. And sexual discrim-
ination received the stamp of medical authority: a year before Kinsey released 
his report, homosexuality was included in the first edition of the  Diagnostic and 
Statistical Manual of Mental Disorders (DSM) as “paraphillia” (sexual perversion 
and deviation). Women’s sexual desire hardly figured there. This left hetero-
sexual male desire indicated by erectile function as the main cause of m edical 
concern.
That (male) sexual performance is not only a physiological matter but a 
 psychological one as well, gave rise to a territorial struggle over its medical man-
agement. Once sexology was on the table, sexual performance understood as male 
impotence (women’s sexuality remained out of the picture until the 1980s) was 
treated in the 1970s and 1980s through talk therapy by sexologists, psychiatrists 
and psychologists. In the 1980s, urologists, physicians specializing in the urinary 
tract and the male reproductive system, became interested in the p hysiology 
of erections and the possibility of controlling them pharmaceutically. Fishman 
recounts the legendary moment when the urologist Giles Brindley injected his 
penis with phenoxybenzamine and allowed those attending his session at the 
1983 meeting of the American Urological Association to inspect and examine his 
drug-induced erection. This opened the gateway to a host of injections, pumps 
and implants to address an unwanted flaccid penis. It also spurred criticism, such 
as that by the sex psychologist Leonore Tiefer, who in the 1990s described this 
medicalization of male sexuality as a way of normalizing phallocentrism, or the 
reduction of sexual pleasure to penis-based male desire. Ironically Tiefer is also 
credited with changing the term from “impotence” to “erectile dysfunction” in 
an attempt to destigmatize the condition.
Despite feminist criticism, urologists continued to explore methods to cure 
this emerging sexual dysfunction and were looking for something more natural 
than pumps, injections and implants. The oral contraceptive pill was lauded as a 
hidden method of contraception that would not interfere with the mood during 
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sex, and was sold by one of its developers, John Rock, to the Catholic Church as 
a natural method of avoiding conception (contrasted to mechanical methods such 
as condoms). The same occurred with erectile dysfunction: It was presented as a 
medical way to extend erection-based sexuality into older age in a non-invasive 
manner. As with many pharmaceuticals, the drug that was to become Viagra was 
first developed by Pfizer for another purpose: treating heart angina (which also 
requires management of smooth muscle tissue and blood flow). Fishman outlines 
how Jacob Raifer, a urologist, and Louis Ignarro, a pharmacologist, who worked 
on nitric oxide in cardiology, also published in 1992 an article on how it managed 
the smooth muscle function of the penis, enabling erections. In 1998, Ignarro, 
along with several others, received the Nobel Prize for his work that identified 
the role of nitric oxide in the cardiovascular system. Pfizer capitalized on their 
development of sildenafil and released it as the erectile dysfunction drug Viagra 
the same year. By 2003, five years later, Viagra had earned Pfizer $7.4 billion. 
Typically, each pill costs $30 and $60, although some l ower-priced, low-potency 
variations are now emerging (the US patent expired in 2020). Now the treatment 
of this relatively newly described dysfunction of male sexuality will be more 
accessible financially. Not only does erectile dysfunction reduce male sexuality 
to a single function of the penis while continuing to feed a phallocentric view of 
sex, it medicalizes male sexuality for men, young and old. And beyond medicine, 
it has become a significant component in maintaining a particular masculine 
lifestyle in the face of ageing, drug and alcohol abuse and social expectations of 
what constitutes male sexual desire.
Conclusions
Sex, sexuality and reproduction have long comingled in our societies over the 
millennium. For at least 2,000 years we have understood that there is a causal 
connection between heterosexual copulation, pregnancy and birth. What we 
have made of that connection has varied, and what we have done to manage that 
connection, especially in the last 50 years, is significant with important  impacts on 
the socialization of sexuality and reproduction, especially in  developed  nations. 
First, we managed to prevent reproduction technologically with the advent of 
effective and widely available contraceptives, especially the Pill. S ocially, there 
was a release of requirements to limit heterosexual sex to marriage,  followed 
by a decriminalization of homosexuality and moves towards de- stigmatization 
of and anti-discrimination against non-heterosexuality. By the new millen-
nium the release of sexual desire from bounds, heterosexual,  homosexual and 
 beyond, led to considerations of new reproductive contexts or kinship. The 
same  pharmaceutical regime that grew since the Second World War to man-
age  conception and sex trait expression for the heterosexual norm was hijacked 
to serve queer people in their gender affirmation and to help non-heterosexual 
families with having  children. This regime also developed new norms of phar-
maceutically managed femininity (suspended fertility and reduced menstruation) 
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and masculinity (penile erection-focused sexuality available from youth to old 
age). And whatever the social norm, there were markets to be capitalized. The 
 so-called new reproductive technologies entered the scene in the middle of 
all of this. Assisted conception medicine (as it came to be called as conception 
was next medicalized) quickly took up its place in the regime and grew into its 
own  successful enterprise. It too was exploited not only economically, but by 
those seeking access to kinship outside of the heterosexual norm. It was also 
exploited for genetic research and application, leading to the establishment of a 
new  regime: replication.
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In 1978, Louise May Brown, the world’s first “test-tube” baby born using in 
vitro fertilization (IVF), came into the world. At the same time, most women 
in developed countries had become accustomed to giving birth in hospital with 
specialized doctors in attendance. Caesarian rates were on the rise and radical 
hysterectomies were common treatment of uterine fibroids in women. Effective 
contraception was legal and widespread in these same places, with abortion often 
legally available but typically in hospitals requiring approval by physicians. Gay 
men and lesbians were less closeted but still highly socially marginalized with no 
legal rights to form families; although some groups of lesbians organized self- 
insemination groups in London, UK, and San Francisco. The human genome had 
been identified for over two decades and geneticists had started exploring how to 
identify genetic-based disease. Reproductive hormones were used by gynaecolo-
gists and obstetricians on women in heterosexual couples who were unable to get 
pregnant; there was very little research in the area of male factor infertility. The 
average wage gap between Black and white American males was almost 30%. 
Caps limiting welfare according to restricted family size were in place in the US, 
and global aid was tied to reducing birth rates in the developing countries where 
rates were high. There was talk of creating a male hormone-based contraceptive 
to match the Pill, but nothing came of it. In 1964, four years after the Pill was 
approved by the FDA, the drug company Searle netted $24 million. By 1980, the 
pharmaceutical giant Pfizer indicated sales worth $2 billion primarily for the sale 
of antibiotics, but less than two decades later it made over $1 billion in a single 
year for the sale of Viagra alone. Genentech, the first firm to use human genes, 
was created in 1976, and by 1982 marketed the first recombinant DNA drug: 
human insulin. Obstetrics and gynaecology, like pediatrics, was low on the list 
of medical specialties compared to cardiology and neurology. But all of this was 
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going to change with the advent of a technology that brought human conception 
outside of the human body. IVF allows for human gametes (eggs and sperm) and 
very early conceptuses with complete and unique genetic codes to be transferred, 
examined and engineered.
But what seems drastically new in reproductive medicine and human genetic 
engineering is not so in reality. In order to understand the significance of IVF 
in humans as a threshold to so-called new reproductive technologies, we need 
to link it to previous applications in animal husbandry, to the development of 
reproductive medicine and to a shift in genetics from exploration to engineer-
ing. It helps to see all three of these areas as interlinked and inter-influential. It 
is also important to examine the considerable economic incentives in each of 
these areas.
The externalization of conception: IVF in humans
The historian K.J. Betteridge provides a careful map of the history of embryo 
transfer and clearly links reproductive science with the business of meat and 
dairy production. To begin, Walter Heape, the 19th-century biologist, in 1890 
successfully transferred a rabbit embryo from its genetic mother to another rab-
bit host, where success meant only establishing a pregnancy, not bringing the 
 transferred embryo to term and a live birth. Heape’s experimentation was scien-
tific and designed to advance reproductive biology which became a significant 
driving force in the early 20th century for making animal breeding for food 
more  efficient and more lucrative.
It was not until 1951 when the synchronization of hormones between the em-
bryo donor and the host was better understood that the first transferred mammal, 
a calf, was born. Prior to this, in the 1920s, sheep semen was mailed to farmers 
throughout the UK and to mainland Europe and America for artificial insemi-
nation (AI – the injection of semen into or near the opening of the uterus) which 
was already in wide use by livestock breeders in Russia by the 1930s. As inter-
national demand for primarily cow and sheep semen rose globally, techniques to 
freeze, store and transport semen were quickly developed. And there was little 
hesitation in moving from AI to embryo transfer; this would extend the ability 
to capture and distribute desired genetic traits to female farm animals without 
destroying them to access their eggs. By 1949, a Texan farming and research unit 
had attempted embryo transfer in over 750 cows over seven years anticipating 
the commercial prospects for controlling and transporting embryos with desired 
genetic traits in both parents. Because male and female mammalian reproduction 
differs, it took longer to perfect the techniques required for embryo and egg re-
trieval, freezing and storage. Rat viability tests at Yale University in 1933 helped 
develop hormone synchronization between embryo donors and recipients, while 
cancer research in mice in 1935 helped with embryo transfer techniques. Almost 
a decade later and just as the Second World War was coming to an end, cow 
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embryos were produced using hyperovulation: artificially increasing hormones 
to stimulate ovulation or the ripening of eggs in the ovary so that more than the 
usual number of eggs mature at once. In 1951, a group of University of Edin-
burgh scientists started using embryo transfer in mice during their research into 
the new territory of the double helix and gene-carrying DNA. One of these 
genetic scientists was Robert Edwards commonly considered “the father” of IVF.
Edwards was not the only one interested in medically applying reproductive 
theory developed since the early 20th century. The popular historian of medicine 
Robin Marantz Henig provides a detailed account of the New York-based phy-
sician Landrum Shettles and his early 1970s clumsy attempts at IVF years before 
Edwards announced his success in 1979. However, as his biographer Martin John-
son explains, Edward’s story is the best known and is also an important example 
of how IVF merged the once separated activities involved in genetic science and 
reproductive medicine. The human gene had been described mid-century, the 
Western world was picking itself up after the Second World War and Edwards was 
exploring, chiefly in mice, genetic pathologies or how things can go wrong genet-
ically at the point of conception. He believed there was a relationship between egg 
maturation and genetic formation; any problem in the process of egg maturation, 
especially with the “chromosomal dance,” could become a genetic problem. This 
is why Edwards eventually worked with the ovulatory hormone human chorionic 
gonadotrophin or hCG: he wanted to try and replicate the internal process of egg 
maturation outside the body so he could study it. He succeeded, as had the repro-
ductive contraceptive developers Pincus (in the 1930s) and Min-Chueh Chang (in 
the 1950s) with rabbit and human eggs, respectively.
As you learn more about how to prevent conception, so you learn more 
about how to activate it; they are two points on opposite ends of the same axis 
or seesaw. In 1963, Edwards moved his research to Cambridge University and 
continued to work on hyperovulation in a climate much more favourable in 
contraception than in conception. His work there throughout the 1960s was 
funded by the US Ford Foundation, which was looking for ways to implement 
world population control policies. In the 1970s, Edwards continued to work 
on hyperovulation protocols with his wife, the scientist Ruth Fowler. Edwards’ 
Cambridge University research group expanded their work to examine the hor-
monal influences on follicle development and early pregnancy. His biographer, 
Johnson, maintains that throughout this time, Edwards was keen to succeed with 
IVF in humans. Although human eggs may have been hyperovulated before, 
none had been fertilized, implanted and brought to term – as had been the case 
with rabbits, hamsters and cows – largely due to the difficulty in getting access 
to human eggs, especially in the UK. It was this barrier that led Edwards to the 
US to work with the fertility specialist couple, Georgeanna Jones (a reproductive 
endocrinologist) and Howard Jones (a gynaecological surgeon and infertility spe-
cialist), for six weeks in 1965. Because of their gynaecological practice, the Jones 
had regular access to human eggs. They were pleased to allow young Edwards 
the chance to confirm his egg maturation findings in human reproductive tissue. 
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The next hurdle was to prepare or capacitate the sperm for external or in vitro 
fertilization of matured eggs, which Edwards and his team managed to do three 
years later. Now the problem was clinical: they needed a woman to impregnate. 
And they needed a valid reason to do so.
According to the Embryo Project at Monash University in Melbourne, Aus-
tralia, the gynaecologist Carl Wood achieved one of the world’s first IVF preg-
nancies in 1973 and the first full-term IVF pregnancy from a frozen embryo 
in 1980. The Jones were also instrumental in developing IVF techniques and 
fostering the medically assisted conception in the US. And before the two Jones, 
Shettles and Wood, there was Miriam Menkin, who may have been the first to 
succeed in externally fertilizing human gametes. Menkin, although medically 
trained, ended up as a lab technician working for the US obstetrician and gy-
naecologist John Rock, who, besides being instrumental in developing the con-
traceptive Pill, was working at the same time on infertility, the other end of the 
seesaw. Menkin’s job was to expose human eggs to human sperm in a glass (Petri) 
dish to see if a fertilized egg would result. The science journalist Rachel Gross 
reports that in 1944, Menkin forgot to time the exposure, which was meant to 
be limited to 30 minutes, and left the human gametes together for over an hour. 
The cells fused and the eggs started to divide.
Johnson describes Edwards as “a man of extraordinary energy and drive,” 
while Henig describes him as “one of the youngest of the IVF mafia don.” And 
it was this drive and competition among the reproductive mafia that ultimately 
led to Edwards striking up a partnership in his home country with the gynaecol-
ogist Patrick Steptoe; the birth of Louise Joy Brown gave them widespread and 
almost folkloric recognition as the fathers of IVF. Edwards also played a central 
role in the establishment of the European Society of Human Reproduction and 
Embryology (ESHRE) and in the creation of one of the world’s first stand-alone 
IVF clinics, Bourn Hall. And it was Edwards who was awarded the Nobel Prize 
in 2010 for the development of IVF in humans.
Once the world heard about the first “test-tube baby,” the floodgates opened. 
Edwards and his clinical partner Steptoe established the private fertility clinic 
at Bourn Hall near Cambridge in 1980. About the same time, the two Jones 
established the first US IVF clinic at the Virginia Medical School, Norfolk, Vir-
ginia. At Monash University in Melbourne a very successful early IVF practice 
was established in 1984 by Wood. Between these three key sites in IVF’s early 
development, a robust competition emerged: the first American IVF baby was 
born at the Jones’ clinic in May 1981 but with very few to follow in the years 
immediately following. The embryologist Alan Trounson was among the first 
worldwide to encourage and develop early hormone protocols for hyperovula-
tion in IVF practice. This explained the Australians’ early success in establishing 
IVF pregnancies. Initially, hyperovulation was a lab technique used in mice to 
generate as much research material as possible and a technique used in animal 
husbandry to create as many valuable embryos for implantation as possible. It 
would quickly become commonplace in medical practice.
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Despite Edward’s success in the lab with hyperovulation during the late 1970s 
and early 1980s, it was not used initially in IVF practice in the UK, including 
in the birth of Louise Brown. Multiple eggs meant more embryos, allowing for 
multiple implantations at one time, and a higher implantation rate. As a result, 
the initial rates for establishing a pregnancy, for take-home babies and for multi-
ple births were higher in Australia than in the first clinics in the UK and the US. 
Very quickly, hyperovulation became the norm in IVF practice, as the number 
of gynaecological clinics offering IVF and related services, as well as stand-alone 
infertility clinics, began to multiply; ten years after the birth of Louise Brown, 
there were over 50 clinics practising IVF in the UK alone. The reason for human 
IVF was now clearly established: assisted conception.
Before the birth of the first test-tube baby, the state of modern infertility 
medicine was spotty to say the least. Advances in the knowledge of reproduc-
tive hormones since the early part of the 20th century allowed for a fairly crude 
application of drugs derived from female reproductive hormones responsible for 
the ripening and release of human eggs from the ovary: hCG. Harvard-based 
Menkin initially worked with Rock’s partner Pincus in developing the Pill, and 
then worked with Rock on distilling hCG extracted from rabbit pituitary glands. 
Pincus was able to hyperovulate rabbits to create and implant embryos. Apply-
ing this knowledge and technique medically led to the development of the drug 
Clomid (Clomiphene) in the 1950s by the US chemist Frank Palopoli. It was 
not unusual for obstetricians and gynaecologists to prescribe a treatment with 
Clomid (commonly known as a fertility drug) in women who had difficulty 
conceiving (diagnosed when a heterosexual married couple tried for several years 
with no success at pregnancy). Usually there was little workup for these women 
in terms of assessing reproductive hormone levels, testing the viability of fallo-
pian tubes and examining the state of the ovaries and the pelvic area in general. 
Men were rarely tested at all for their fertility, and the tests available were limited 
to observing with a common microscope how sperm looked and moved and in 
extraordinary cases seeing if the sperm could fertilize a hamster egg (the hamster 
test). If exposure of a woman to the hyperovulating fertility drugs resulted in a 
healthy baby, all was forgotten; usually there was neither careful exploration for 
the cause nor follow-up on the condition that led to the difficulty in conceiving. 
Among the first of mother’s helpers were the fertility drugs, implanting another 
man’s sperm without the woman’s knowledge to discreetly address male infertil-
ity and secretly adopting a child from the single mother pressured to give their 
child up. This left developing a medical indication or rationale for when IVF 
should be used with little data to back it up: there was a great deal of unknown, 
untested infertility in both men and women, including environmental factors, 
which very few were considering at this time.
In the profession of modern medicine, obstetrics and gynaecology sat fairly 
low on the hierarchy of medical specialties post-Second World War, just above 
pediatrics and family medicine and far from the very high ranking, emergent 
specialties of brain and heart surgery. By this time pregnancy and birth had been 
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almost completely medicalized in most developed and developing countries, so 
although the specialty was densely populated by physicians and support staff, 
what they were practising was considered mostly routine and mundane, until 
IVF arrived with its powerful adjunct, genetic engineering.
The public health systems in the UK and Australia did not initially approve 
IVF on their lists because the technique was seen as highly experimental, expen-
sive and with very poor success rates (0 to 5% chance of taking home a baby after 
at least three IVF attempts). In the US private healthcare system, the financial 
concerns were similar: private health insurers were unlikely to pay for an expen-
sive service that did not work (provide a baby to take home). It is not surprising 
that clinics, in both public and private healthcare systems, did what they could to 
improve success rates. One way to improve success rates was to play around with 
the definition of what constituted a success. Initially many clinics measured suc-
cess in terms of chemical pregnancies signalled by very early hormonal changes 
in the woman, but which failed to continue or miscarried within five weeks 
after fertilization. This reporting practice drew critical attention from within the 
growing profession of fertility experts as illustrated by a 1985 article published 
in the prestigious medical journal, Fertility and Sterility, by Michael Soules, the 
Director of Reproductive Endocrinology at the University of Washington, titled 
“The in vitro fertilization pregnancy rate – Let’s be honest with one another.” 
“Competition appears to be the root of the problem,” states Soules. Clinics ad-
vertising over 50% success rates based mostly on chemical pregnancies would 
draw far more clients than ones reporting that the chances of taking home a baby 
were zero to 5%. Also, there is a dropout rate at every stage of IVF, and it makes 
a difference how you calculate that percentage: do you include all women who 
started the procedure or only those who became clinically pregnant?
Hyperovulation did improve the rate of successful implantation with the plac-
ing of multiple days-old embryos into a uterus at the same time instead of just 
one. But how many embryos were optimal? That took time to determine, with 
some clinics placing up to ten embryos in a single cycle and then “selectively re-
ducing” embryos when many implanted. The norm today is limited to three to 
four embryos per implantation. Hyperovulation was also used in procedures sim-
ilar to IVF, like gamete intrafallopian transfer (GIFT) and zygote intrafallopian 
transfer (ZIFT), where again, very high success rates were reported. In GIFT, 
eggs are collected after hyperovulation, and then combined with sperm and im-
mediately injected back into the fallopian tubes (where it is believed that concep-
tion normally occurs) in the hope that embryos would result and then implant. 
ZIFT is basically the same procedure, but the mixed eggs and sperm are left in a 
growth medium for up to 24 hours before the mixture, not identified embryos, 
is placed in the fallopian tubes. With both techniques there is no waiting for nor 
any assessment of the fertilization of the gametes (sperm and eggs). In the early 
days of assisted conception, remarkably high rates of success were reported with 
GIFT, but the question of indication enters here. Who is medically eligible for 
these IVF-related techniques? Many women who were directed to GIFT had 
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unknown causes of infertility, and it may have been the fertility drug effect of 
hyperovulation that explained the success or that the procedure addressed male 
infertility by chance.
Edwards claimed he pursued the application of IVF in humans to assist women 
with blocked or missing fallopian tubes in getting pregnant. That is what IVF 
does; it circumnavigates the functions of the fallopian tubes by taking the rip-
ened eggs from the ovary, fertilizing them and then placing embryos in the 
uterus for implantation. Today, as it was in the 1980s, it is generally understood 
that one-third of the causes of infertility reside with females (primarily with 
ovulation; tubal factors account for about 15% of female infertility), one-third 
with males (due chiefly to low sperm count and poor sperm motility) and one-
third due to either a combination of male and female factors or are unknown. 
So, the indication to use IVF both then and now would be low if used only in 
diagnosed cases of missing or non-functioning fallopian tubes, which accounts 
for 5% of all infertility. The World Health Organization estimated that globally 
10% of women trying to become pregnant without medical assistance for a year 
cannot, and if the measure is moved to trying for two years, the rate increases by 
2.5 times which means that one in four women worldwide cannot get pregnant 
when they intend to. The US Centers for Disease Control and Prevention esti-
mates based on data from 2015 to 2017 that about 12% of women of reproductive 
age in the US have experienced impaired fecundity (failure to achieve a preg-
nancy after one year of unprotected heterosexual sex). So why not try IVF to see 
if it could help, as it seemed to with fertility drugs and GIFT? Indication for IVF 
use in women quickly expanded beyond blocked and missing fallopian tubes to 
include unexplained infertility in men or women. This radically increased the 
potential number of eligible IVF patients from 5% of the infertile population to 
at least 60% which includes anyone with unexplained infertility.
Another important factor in the development of IVF as a clinical tool is 
the use of transvaginal ultrasound. Steptoe was widely considered a pioneer in 
safely adapting the laparoscope in the mid-1960s for obstetrics and gynaecology, 
 ironically initially used for sterilizing women by cutting the fallopian tubes. Lap-
aroscopy is a minor surgical technique that allows access to the abdomen through 
several small incisions and has proved invaluable for practising IVF early on in 
its development and practice. But despite Steptoe’s prowess with the technique, 
it still requires a fully staffed operating room. This was both expensive and diffi-
cult to schedule with women’s spontaneously ripening eggs. Meanwhile another 
soft-tissue visualizing technique was lifted from the Second World War military 
underwater sonar technology and developed for medical applications, initially in 
cardiology and gastroenterology: ultrasound. By the mid-1970s, ultrasound was 
capable of scanning internal organs and generating moving pictures that were 
visually improved with the aid of computers. Ultrasound works best with a fluid 
contrast medium, and so obstetrics, especially the visualization of the foetus in 
utero, was an ideal candidate for the new technology (the foetus floats in amniotic 
fluid). As ultrasound was quickly adopted in the routine monitoring of normal 
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pregnancies, early IVF practitioners seized on the technique for assessing and ac-
cessing the ripening of eggs in the ovaries. They developed a transvaginal probe 
to enter the woman’s body with a retracted aspiration needle riding  piggyback 
to be extended to extract the ripened eggs once they were located with the 
probe. This procedure, transvaginal ultrasound, required no operating room, 
no  general anaesthetic and could be performed at fairly short notice in a clinic 
setting, unlike laparoscopy.
Finally, developments in IVF hormone protocols allowed IVF practitioners 
to suspend all spontaneous female reproductive hormonal activity and to ex-
ternally control when egg maturation occurred by adding back the appropriate 
hormones in sequence, which made the running of clinics far more efficient. 
Initially naturally occurring reproductive hormone cycles were the norm in IVF 
(except in Australia where they were among the first to hyperovulate the ova-
ries). By the 1980s, and thanks to veterinary science and breeding practices, 
a great deal had been learned about the hormones required to stimulate egg 
maturation or ripening in mammals and about the cycle or dance of the various 
hormones involved. The cycle starts within the hypothalamus at the base of the 
brain. The hypothalamus controls body temperature and the release of hormones 
required to begin the complex process of egg maturation. It releases pulses of 
luteinizing hormone-releasing hormone (LHRH) to the pituitary gland where 
gonadotrophic cells respond by releasing gonadotrophins into the circulatory 
system, which is why blood and urine testing are such a central component of 
reproductive medicine, and especially IVF. The cycle can be read in terms of 
which hormone is present and in what quantity. Also, the health of the cycle can 
be checked this way, and often is used today to determine women’s suitability for 
IVF. Once the gonadotrophins are in circulation, follicle stimulating hormone 
(FSH) and luteinizing hormones (LH) are released and reach the ovaries through 
the blood supply. Eggs mature and then release a hormone of their own: oestra-
diol. This signals the hypothalamus to slow down its gonadotrophin release, and 
eventually stop the release of FSH from the pituitary gland. The dropping FSH 
levels are thought to diminish most of the eggs’ fertility, leaving usually one fully 
mature egg ready for release from the ovary or ovulation. This egg continues 
to produce oestrogen and triggers an LH surge which became the marker of 
imminent ovulation in IVF practice. It was also a bane to many early IVF prac-
titioners, especially when relying on laparoscopy for egg retrieval, as it meant the 
eggs would be released within the next 24–36 hours and they needed to get the 
woman into surgery quickly. Once eggs are released from their ovarian sacs, it 
is near impossible to retrieve them; IVF relies on extracting the ripened egg or 
eggs just before ovulation.
This so-called natural-cycle IVF (relying entirely on a woman’s cycle to pro-
duce the usual single egg) was quickly dropped in favour of hormone-enhanced 
cycles. In these early days of IVF, a great deal of experimentation occurred in 
developing hormonal protocols designed not only to ripen more eggs at one time 
and improve chances of implantation, but also to know exactly when eggs were 
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ripe before ovulation so they could be extracted before disappearing down the 
very narrow fallopian tubes and into the uterus unfertilized. Hyper- or supero-
vulation involves externally administered doses of FSH and maintains the expo-
sure of the eggs to FSH longer than normal in order to ripen more than the usual 
single human egg per cycle. Sometimes women were given human menopausal 
gonadotrophin (hMG) which contains both FSH and LH to mimic the LH surge 
and to control the time of ovulation. In early IVF programmes there were fixed 
and non-fixed hormonal regimes designed to try to match and control ovula-
tion. Fixed regimes were favoured in low-cost units (usually programmes that 
were part of a hospital department and had a research arm). These regimes were 
based on a preset plan for the administration of injections and tablets containing 
various hormones and hormone stimulators and were used without assays or test-
ing of the blood for hormone levels and without ultrasound monitoring of the 
ovaries for the ripening of egg follicles. Instead, these protocols relied on what 
had been learned about the female reproductive cycle, especially the timing of 
hormone release. By contrast, and typically in private clinics, non-fixed regimes 
relied on monitoring blood and the ripening follicles in the ovaries to prescribe 
exactly when to administer the various hormones involved in stimulating ovula-
tion and the ovulation of multiple eggs at once, and when to gather the eggs im-
mediately prior to ovulation or release from the ovary. These clinics argued that 
such precision led to a better quality of egg and more success with implantation.
With the discovery of a higher-level hypothalamic hormonal trigger of ovu-
lation, speculated in 1955 by G.W. Harris, and isolated as LHRH by A.V. Schally 
in 1971, came the development of an LHRH analogue (a common brand is 
Buserelin produced by the pharmaceutical Hoechst) which allows for the ex-
ternal suspension of all reproductive hormonal activity. In IVF practice, this 
meant that all hormonal phases could be administered and controlled externally, 
which improved the predictability of imminent ovulation. So, women were not 
booked for egg retrieval according to when their bodies released an LH surge 
but were booked for the procedure according to when LH was administered. 
Buserelin was also identified as a treatment for prostate and breast cancers; this 
analogue, which tells the hypothalamus in the brain to stop signalling repro-
ductive hormonal activity, also lowers the production of testosterone and oes-
trogen hormones which play roles in the growth of prostate and breast cancers. 
In IVF, it practically eliminated spontaneous LH surges that ended in missed 
opportunities to gather eggs in time and made for more efficient clinical practice 
with precise fixed regimes. Clinics were pleased with these developments that 
led to the routinization of vaginal ultrasound, and the suspension of all female 
hormone activity with the required hormones artificially added back. However, 
the side effects of LHRH analogues were downplayed, which include early on-
set of menopause and an increased risk of osteoporosis. And initially the use of 
human-derived hormones led to a spread of a deadly disease: Creutzfeldt–Jacob 
disease or mad cow disease. Transmission of this deadly disease remains of con-
cern in infertility medicine.
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The final component leading to the development of assisted conception as 
common clinical practice involves pharmaceuticals and what they stood to gain. 
Soon after the birth of Louise Joy Brown, the pharmaceutical firms Organon 
and Serono cornered the market on the hormones used to hyperstimulate ova-
ries to mature more than the typical single egg: follicle stimulating hormone 
(FSH), human chorionic gonadotrophin (hCG) and luteinizing hormone (LH). 
Serono (later Ares Serono) was already a major supplier of hCG distilled from 
the urine of pregnant women, which was used to treat people with pituitary 
gland failure, chiefly those with dwarfism. IVF and the need for human embryos 
allowed lateral integration of its market into reproductive medicine. In the mid-
1980s, it cost between $250 and $300 to provide hormone stimulation for one 
cycle of IVF. John Elkington in his 1985 analysis of the “gene factory” estimates 
the worldwide pharmaceutical sales for reproductive hormones reached $25–$30 
million. By 1995, it was predicted that Ares Serono would control 90% of the 
global infertility market.
Towards the end of the first decade of the use of IVF in human reproduction, 
fertility clinics had become routinized in large teaching hospitals throughout the 
UK, the US and Australia and in private clinics spotted throughout the world 
where Western-style medical care was offered. But very rarely was IVF offered 
as part of publicly funded healthcare. Eight years after the birth of the world’s 
first test-tube baby, the National Health Service (NHS) in the UK offered IVF 
and related procedures like GIFT on a trial basis only at one hospital: St Mary’s 
in Manchester. The clinic was soon overwhelmed by requests nationally, and 
ended up limiting access to local residents, women under 40 with a male partner 
no older than 50, women with no children including adopted children and those 
who had a complete fertility workup prior to being considered. Quasi-public 
clinics were established in large teaching hospitals where some costs were cov-
ered by the NHS but patients had to pay a considerable fee largely to cover the 
cost of hormones (about £3,000.00 per ovulation cycle). And then there were 
totally private clinics, like Bourn Hall and most clinics in the US, where all 
costs were covered by the patient (about $20,000 per cycle). In 1988, Serono 
announced it was buying two prestigious, private IVF clinics in the UK: The 
London-based Hallam Medical Centre (a favourite among wealthy patients from 
Arab states) and Bourn Hall in Cambridge.
New access to human genes
In June of 1986, over 650 scientists and doctors met in Brussels in a well- 
organized and well-funded conference on human reproduction: The Second 
Meeting of the European Society of Human Reproduction and Embryology 
(ESHRE). ESHRE, of whom Edwards was a founding member, had been es-
tablished the year before and included medical practitioners, embryologists 
(human and non-human), endocrinologists, a variety of support professionals, 
such as medical and laboratory technicians, and geneticists. This remarkable and 
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innovative combination of scientific and medical professionals is a sign not only 
of the broad scope of interest in new reproductive technologies and embryo 
research, but in particular of how genetics and IVF-based reproductive technol-
ogy have been interrelated from the start. It was interest in genetics that helped 
drive the application of IVF in humans; Edwards was a geneticist interested in 
the genetic expression in gametes or reproductive cells (eggs and sperm). And 
very quickly as IVF medical practice moved to hyperovulation from the so-
called natural cycle approach, the potential for working with human genetic 
material at its earliest and formational stages was recognized. “Spare embryos” 
was a term quickly picked up in IVF clinics to refer to the embryos not used for 
reproduction. Patients signed consent forms allowing their spare embryos to be 
diverted to scientific research, often with the promise that such research would 
help improve IVF techniques to help other infertile couples. A whole area of 
law developed to handle this human material. And various types of scientists, 
initially geneticists and embryologists, had a new, powerful and very promising 
field to research.
As IVF as medical practice became publicly known, so too did the prospect of 
embryo research. Fears of Frankenstein babies and embryos in the lab enduring 
research procedures filled newspapers in the early 1980s. The British Voluntary 
Licensing Authority that initially controlled IVF in humans and human embryo 
research used a full-page photo in its 1987 annual report featuring a giant spike 
(the magnified tip of a pin) with a relatively small, luminous, two-sphered hu-
man embryonic cell cluster hovering above it to quell fears of embryonic people 
being experimented on. This was the “pre-embryo,” a term coined by the Direc-
tor of the British Medical Research Council’s Mammalian Development Unit, 
Anne McLaren. The “primal streak” and “embryonic disk” are other terms used 
by embryo researchers and in early legislation of IVF and embryo research in the 
UK to dampen public fear and to open the way to public acceptance of embryo 
research. The streak and disk refer to the development of the spine and central 
nervous cord (the source of sensation), and it was argued that before their devel-
opment, the pre-embryo had no ability to sense pain. Therefore, it was deemed 
ethical to allow research on such embryos. Typically, the disk and streak do not 
appear until 14 days after conception, and so 14 days became the standard limit 
for allowable pre-embryo research. Scientists are now approaching that limit in 
terms of keeping embryonic cells alive, so this particular ethical question has 
emerged again, albeit in a changed social context with routinized assisted con-
ception and less fear of genetic engineering.
The promise of genetic cures was also used to open the way to embryo re-
search. By developing markers to identify genetic-based disease in early embryos, 
it would be possible to control the continuation of such disease by choosing 
embryos before implantation on the basis of such and thereby avoiding bringing 
a child with a serious genetic disease into the world. Given the state of genetic 
engineering in the mid-1980s, there was also the much fainter possibility of 
repairing such genetic damage in cellular embryos. Relatively common genetic 
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diseases such as multiple sclerosis (MS) were trotted out as possible candidates for 
the first markers to be used in pre-implantation genetic diagnosis (PGD). Rid-
ding a world of a disease that ends in a very difficult and painful death is offered 
as a sign of hope and progress. And at about the same time, the possibility of 
mapping the human genome appeared on the horizon, giving way to a powerful 
marriage between IVF and genetics and the promise of control of what the Cam-
bridge University anthropologist Sarah Franklin calls “life itself.”
There are two basic types of cells in our bodies: sex cells (sperm and eggs) and 
somatic cells (all the rest). The significant difference between the two is that if 
you alter sex cells, you alter all progeny or beings that are reproduced from that 
cell. If you alter somatic cells, you only alter the cells in the being from which 
the cells were taken (including those in a cellular human embryo). Using genetic 
engineering in very young embryo cells for medical purposes (screening and 
controlling for genetically linked disease, for example) was designed initially 
for somatic gene therapy only. Altering sex cell lines remained, until 2019, a 
daunting prospect with far-reaching and unpredictable consequences for human 
genetic lines that geneticists did not want to try on embryos destined to be im-
planted in uteri for development into a living and breathing human being, and to 
this day it is largely prohibited. But the genetic engineering of embryonic cells 
(altering the genetic makeup of spare embryos) for research purposes only was 
another matter.
PGD was quickly identified as a companion offering to IVF. It differed from 
genetic diagnoses of foetuses in utero, such as amniocentesis (in development 
since 1959 to confirm foetal health and used successfully with the use of ultra-
sound in 1972) and chorionic villus sampling (first performed in 1983). Both 
of these earlier techniques can only be administered once the pregnancy has 
reached at least 15 weeks (amniocentesis) or 10 weeks (chorionic villus sampling) 
because of the risk of harming the developing foetus. The amniotic fluid and villi 
or threads from the placenta surface are removed and tested for chromosomal 
abnormalities, chiefly Down’s syndrome, spina bifida and cystic fibrosis. There 
remains a considerable risk to the pregnancy in performing these tests – about 
one in two hundred pregnancies are lost due to the amniocentesis test and 22 out 
of 100 with the CVS test; this helps explain why amniocentesis became the much 
more commonly used procedure to genetically check the foetus. The advantage 
of CVS, risky as it is, is that the genetic disease is discovered sooner and the op-
tion of terminating the pregnancy may be easier to consider.
Once days-old embryonic cell clusters were outside the body, identifiable and 
with the ability to carve off single cells for genetic screening for genetic inherita-
ble disease, the means for screening embryos before implantation and pregnancy 
was possible. It was hoped that the menu of possible genetic diseases to screen 
would substantially increase. Lesch Nyhan syndrome, an inherited genetic dis-
ease usually found in males (x-linked), was an early candidate for PGD. One of 
its symptoms is self-mutilating behaviour (those with the disease may chew on 
their finger tips and lips as their neurological ability to sense pain weakens), and 
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when trotted out as a PGD candidate, made it difficult to argue against develop-
ing and using the procedure. Who would not want to control for such a disease? 
And the advantage of PGD is that the affected embryo would not be implanted, 
making the question of pregnancy termination moot. Chromosomal anomalies 
increase substantially once women reach 35 (women are born with all of their 
eggs and the eggs age along with the woman), so women over 35 seeking to be-
come pregnant are not only likely to have more difficulty than younger women 
in becoming pregnant and maintaining the pregnancy due to hormonal changes, 
they are under increased scrutiny for chromosomal anomalies, especially Down’s 
syndrome, due to their ageing eggs. These people become good candidates for a 
combined PGD and IVF procedure.
At the same time PGD was being developed alongside clinical IVF came 
the prospect of a new research material: the entire human genome, life itself, 
contained in a cellular embryo considered spare to medical use. Types of early 
embryo research included exploring the elusive early stages of human devel-
opment and determining genetic abnormalities and disease. Patricia Spallone 
indicated that during the mid-1980s, both academic scientists and scientists from 
the bioengineering industry perfected the techniques required to detect specific 
genes and enzymes (chemicals produced by genes) in days-old embryos. Also, 
important to later developments in stem cell maturation and the development of 
so-called artificial embryos was the application of cloning and twinning tech-
niques to the human embryo. These techniques involved splitting the cluster 
of embryonic cells apart, which at such an early stage of development would 
typically go on dividing as identical replications or clones of each other. These 
techniques had been developed in the meat and dairy industries to propagate 
livestock with desirable genetic traits such as high butterfat content in milk and 
valuable characteristics in certain muscle types for meat. This helps explain why 
a bioengineering industry was already in place when IVF was first applied in 
humans, and why a reproductive medical technique was associated with genetic 
engineering from the start of IVF.
Genentech, a US-based biotechnology company, was formed in 1976 by a 
venture capitalist (Robert Swanson) and a biochemist (Herbert Boyer) and is 
considered the first publicly owned biotech company founded by “gene jock-
eys” described by Nicolas Rasmussen in his 2014 account of the rise of biotech 
enterprise. Scientists here were the first to artificially produce insulin (1979), 
were active in patenting molecules found in nature (first in plants and then in 
mammals), allegedly the first to develop an artificial human growth hormone 
(1985) and among the first to develop drugs designed to combat the symptoms 
of genetically linked illnesses including cystic fibrosis, as well as the first phar-
maceutical treatment of some forms of MS (2017). Genetech is most noted for 
its development of chemotherapies (late 1990s to the present). Common to all of 
these developments is the role played by human genes: Genentech’s founders cap-
italized, literally, on the recombination of DNA or the engineering of bacteria to 
become factories for making specified genes, including human genes. Between 
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1980 and 2001, Genentech’s shares appreciated by 2,700%; in 2004 the company 
earned $785 million in profits. In 2009, the mega pharmaceutical firm, Roche, 
bought Genentech for $47 billion. In 2018, it released antiviral medications for 
two types of flu, and in the fall of 2020 was at Phase III of a clinical trial of a 
vaccine for COVID-19.
By the 1980s, the manipulation of reproduction, including genetic engineer-
ing for desirable traits in the meat and dairy industries, was well developed; with 
the advent of IVF medicine, bioindustry now had access to the entire and living 
human genetic code. Previously, human genes could be extracted from human 
tissue, including from dead foetuses. With the externalization of human concep-
tion through IVF, live human cellular embryos and the force of their develop-
mental capacity were now available for the first time. In the period around the 
first human application of IVF, the potential for scientific and medical enterprise 
was quickly recognized. Although the initial promise of screening all embryos 
before implantation for all genetically linked disease has not been realized, pre-
implanted spare embryos opened the way to a large genetic industry in stem cells, 
and with the advent of CRISPR Cas9 genetic engineering technology, gave 
hope to radically alter how we approach disease and illness.
About 20 years after the first successful implantation of a human embryo, scien-
tists figured out how to remove stem cells from human embryos and generate em-
bryonic stem cell lines. An embryonic stem cell is a multipurpose or pluripotent 
cell found in three- to five-day-old embryos. In normal development, stem cells 
start to specialize after five days into the cells the fully formed being eventually 
requires. This explains why a very early human embryo looks like a clump of cells 
and not a human or a homunculus as once believed by reproductive theorists; the 
cells have not yet differentiated into the over 200 specific cell types that make up 
the organs, the circulatory system, eyes, hair, bone structure, muscles and so on. 
Cells that can develop into any specialized cell are very valuable if you can control 
for their specialization and sustain their continued replication as a cell line. Not 
only are there medical applications such as the promise of creating pancreatic cells 
to cure those suffering from diabetes and neurological cells for treating spinal 
cord injury but also for taking DNA from adult cells to re-programme them to 
an embryonic, pluripotent state and creating powerful genetic development re-
search models, induced pluripotent stem (iPS) cells, to replace research on humans 
including drug testing. The Columbia University-based genetic biologist Dieter 
Egli, who was among those who pioneered human embryonic stem cell line re-
search, is quoted by David Cyranoski in Nature as saying that embryonic stem cells 
“will lead to unprecedented discoveries that will transform life.”
Conclusions
The age of new reproductive technologies sprang from the well-developed, 
commercially motivated manipulation of reproduction in animals feeding the 
meat and dairy industries. In order to make the transition into medical practice, 
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several barriers had to be surmounted. The first was to sell to a reluctant pub-
lic the idea of externalizing human conception and to allow for the distribu-
tion of human gametes and embryos. This was achieved primarily by selling 
the prospect of solving the relatively new medical problem of infertility and 
enhancing this so-called treatment (it actually does little or nothing to treat the 
root causes of infertility) with the prospect of controlling for horrific genetically 
linked diseases. Another barrier was the low initial success rates with what was a 
largely experimental practice. This was approached and by and large dealt with 
by improving techniques both surgical and pharmaceutical that made the clini-
cal practice more efficient and easier to control. Once practitioners admitted to 
altering the measurement of success to their, not the patients’, advantage, large-
scale growth in assisted conception practices followed. Genetic engineering and 
the promises that accompany it have followed IVF and its adjunct technologies 
throughout. Despite not meeting the promise of pre-implantation diagnosis, ge-
netic engineering continues to draw considerable speculation and interest and 
may be on the brink of realizing some of its potential with the advent of CRISPR 
Cas9 and other developments in genetic manipulation techniques. Meanwhile, 
pharmaceutical companies hold an impressive stake in assisted conception prac-
tice and profit considerably from both the clinics and the sale of required hor-
mones involved in the procedures.
Missing from this scene is any consideration of the effects of IVF on women 
who undergo exposure to increasingly invasive hormonal protocols, repeated 
piercing of the vaginal and bladder walls and ovarian surfaces and multiple preg-
nancies resulting from implantation of several embryos at a time. Then there 
is the socio-psychological dimension of undergoing a procedure likely to fail; 
women are often left feeling responsible. Long-term studies of the effects on 
the health of children born from the procedure indicate raised levels of abnor-
malities. And quietly and unwittingly, women and men have become important 
providers of research material to a burgeoning genetic-commercial complex. So, 
how to control this brave new world of NRTs?
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Legislating and regulating science and technology is not easy, especially if the mat-
ter to be regulated involves microscopic manoeuvres and entities unrecognizable 
to untrained eyes. Once human eggs, sperm and early embryos were available to 
manipulation outside of the human body, it was and remains a significant challenge 
with new reproductive technologies and genetic engineering of human material. 
Besides regulating exo corporeal (outside of the body) reproduction and genetic rep-
lication, there is also the matter of managing kinship as a result of NRTs, especially 
with gamete and embryo donation as well as with surrogacy where reproduction 
becomes contractual and unhooked from genetic lineage. With the advent of NRTs 
in the 1980s, the UK and Australia were among the first not just to legislate the 
recent developments, but to use the opportunity to legislate a host of reproductive 
technologies, including older ones such as artificial insemination. And right from 
the start, NRT regulation included genetic engineering and embryo research while 
existing reproductive legislation – regarding abortion and contraception chiefly – 
also had to be taken into account, giving rise to different regulatory frameworks 
worldwide. The UK led the way for most western European legislators, as well as 
for Australia and Canada. Unlike, large developed countries including Brazil and 
the US that have not adopted overarching legislation nor have they created central 
licensing authorities for NRTs and genetic engineering. In places like this, there is a 
tendency to let markets determine practice with minimal restrictions.
Forming umbrella legislation for reproductive  
technologies; new and old
As we saw in the social history of birth, midwives, typically women attend-
ants at birth for at least 2,000 years, held control over the practical aspects of 
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reproduction, but not over its meaning. This was taken up chiefly by reli-
gious authorities, who along with traditional midwives had to give way to the 
growing profession of medicine as a de facto authority over matters of con-
traception, abortion, pregnancy and birth. Despite moves globally to legalize 
contraception, religious belief continues to hold a powerful place in the con-
trol of reproduction, especially over abortion and kinship. When IVF arrived 
externalizing conception, it generated something of a moral and religious 
panic over the embryo’s dignity and safety. And with IVF came the possibility 
of transferring gametes and early embryos, thus removing family formation 
from the platform of heterosexual intercourse and also inciting profound risk 
to the sanctity of marriage. So it is no surprise that when the NRTs arrived, 
its legislation took the opportunity to reinforce dominant beliefs regarding 
kinship and embryo rights.
One of the ways that pregnant people have controlled their reproductivity 
is to become pregnant out of the norm, typically understood as within the 
legal or religiously sanctioned institution of marriage. Artificial insemination 
by donor (AID) is one old reproductive technology that allows for this fam-
ily formation. Of course, technology is not always required in heterosexual 
relations, but some of those who wanted to become pregnant without the 
sperm donor being involved as a parent and or who wanted to avoid hetero-
sexual coitus relied on simple methods for transferring the sperm to the uterus. 
Commonly referred to as the turkey-baster method, this technology required 
a willing sperm donor, the timing of ovulation (which was known by the 
mid-20th century) and someone capable of becoming pregnant. Before peo-
ple took up this do-it-yourself reproductive technology, medical professionals 
were also practising it, often without the pregnant person’s knowledge that the 
resulting child was not genetically related to their husband. The regulation of 
NRTs brought the practice of the former, those operating outside of medi-
cal authority, under the same umbrella of legislation for newer reproductive 
technologies under the shared principle of controlled access to reproduction. 
Often couched in concerns for safety, due to the potential for spreading dis-
ease through infected semen, undetected ectopic pregnancies and unrecorded 
and untrackable genetic links, AID is often included in the widened legislated 
scope of reproductive medicine.
NRTs, like abortion, raise questions about the legal status of the embryo 
outside of the human body, and as it or human gametes (eggs and sperm) are 
transferred between bodies and become subjects of research. In regulating 
NRTs, although abortion rarely figures, the same type of questions as used 
in the regulation of abortion figure, including the definition and viability of 
human being near the time of conception. And, as with abortion, NRT regula-
tion can weaken pregnant peoples’ rights by placing them in conflict with new 
reproductive partners such as contracted parents, as well as with social controls 
over kinship and the status of the embryo.
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The UK model for NRTS and GE worldwide
The UK was the first to hold a government enquiry into new reproductive 
 technologies following the birth of Louise Brown in 1978. The Committee of 
Inquiry into Human Fertilisation and Embryology was established in 1982 under 
the chair of Mary Warnock, a philosopher of morality at Oxford University who 
wrote on existentialism. The Report of the Committee, commonly known as 
the Warnock Report, was released in 1984 followed by the government publica-
tion of a framework for legislation based on the Report in 1987. Three years later, 
the Human Fertilisation and Embryology Act (HFEA) was passed into law and 
the interim (Voluntary) Licensing Authority became the Human Fertilisation 
and Embryology Authority (HFE Authority). The Warnock Report and the leg-
islative model that came from it provided an influential model for the regulation 
of NRTs worldwide, especially in most developed countries with established 
Western-style medical systems.
The central principle guiding the regulation of NRTs, according to Warnock, 
is the question of reproduction as a human right. This question is pursued in the 
context of a medical condition, infertility, rather than the social condition of kin-
ship or the right to form a family. Throughout the Committee’s deliberations, a 
heterosexual kinship is assumed and protected, but not as a need or a human right 
in itself, but in terms of people’s rights to seek medical assistance in dealing with a 
health- related problem. The emphasis on infertility as a so-called medical condition 
brought the matter into the legal-medical domain. Infertility, for those who are 
normally expected to procreate (initially defined under the HFEA as members of “a 
stable, heterosexual relationship”), is perceived as a hardship, and the extraordinary 
measures represented by IVF and its adjunct technologies are deemed worthwhile to 
alleviate the suffering of those unable to reproduce their own genetic lines.
Warnock considers how her committee deliberated over cases (some actual 
and some hypothetical) of people deemed unsuitable to parent, and what should 
a physician do when such people seek reproductive technologies to alleviate 
their childlessness. An infertile couple who are both blind, but who have care-
fully thought through what measures must be put in place to properly raise their 
child, are considered suitable. Warnock points to how, both in the work of the 
Committee and in resulting legislation, “the good of the child is paramount.” 
Warnock also welcomes physicians as the gatekeepers to access to NRTs, along 
with the older technologies such as artificial insemination and abortion that are 
included in the new legislation. Physicians are granted the authority to deter-
mine access on both moral and social grounds, such as in a case where a pro-
spective parent has a history of abusing children. In this case, Warnock upholds 
the physician’s right to deny access to the technologies and to the creation of a 
genetically related family, although, she adds, criminals can reform and may be 
allowed access as a result.
Non-heterosexual families are not found in this section, but under a discus-
sion of naturalness and Darwinism, or the evolution of biological beings. By 
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refusing to grant reproduction or family formation as a right and indicating that 
physicians have the right to deny access to technologies that could help people 
do that, Warnock, and much legal regulation of reproductive technologies today, 
along with embryo research, leave a great deal of power at doctors’ and scientists’ 
discretion. However, Warnock in 2002 revoked her earlier claim that single and 
lesbian women should not be allowed access to any reproductive technology (in-
cluding AID) out of potential harm to the child, and states that public fears over 
non-heterosexual parents “do not constitute a moral imperative to prohibit it.” 
However, she adds, these fertile homosexual people should have to pay for the 
service. In 1998, the Human Rights Act was passed in the UK which effectively 
forced the Authority to provide access for non-heterosexuals and single people 
to reproductive assistance. In 2009, the Act allowed same-sex and unmarried 
couples to be recognized as legal parents without having to adopt children born 
from assisted conception techniques. Another significant principle in establishing 
Britain’s act controlling reproduction involves the tracking of human gametes 
(now more adrift than ever) through a central licensing authority to make sure 
they are clearly identified in terms of the biological parents. The Human Fertil-
ity and Embryology Authority now does this and under the Act also authorizes 
who and under what conditions can practice-assisted conception and embryo 
research, how human gametes and embryos are stored and the outcomes of the 
medical treatments (success rates).
Another key principle considered by the Warnock Committee and involved 
in most legislation of NRTs globally is the status of embryo. As IVF brings days-
old human embryos into the light of day and outside their normal place – the 
uterus of a person – questions about the status of the embryo and the need to 
protect it emerged. The main difference between the considerable knowledge of 
human embryonic development and pregnancy developed over the last century 
and a live early embryo outside the human body is that with the latter there is 
now a much more readily available research subject that was quickly recognized 
by well-established scientific and medical professions as valuable to their pursuits. 
Public attention, as well as that of regulators, immediately focused on the e mbryo 
as out-of-its-element and at risk of wanton and potentially monstrous manipu-
lation. The 1985 UK Interim (Voluntary) Licensing Authority over NRTs and 
embryo research featured a full-page photo of a highly magnified human embryo 
cell cluster next to the looming aspect of the tip of a pin in one of its early an-
nual reports to quell public concerns that tiny recognizable human beings were 
involved in embryo research. Meanwhile, public and popular media accounts 
of IVF and embryo research raised fears of monstrous outcomes (cloning, and 
mixing human with nonhuman gametes), trafficking of human embryos and the 
artificial management of human reproductivity, including bringing in genetic 
lines from outside recognized marriages.
Warnock asked the following question: What is the moral status of the em-
bryo? to which both women and embryo researchers shuddered. The sociologist 
Lorna Weir calls this a matter of biopolitics where, “the threshold of the living 
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subject” shifts from the perinatal (around the time of birth) to around the time 
of conception. Many recognized how increased legal protections for the early 
embryo could contribute to increasing obstacles to abortion based, especially in 
the US, on embryo viability arguments that effectively reduced the window of 
opportunity in a pregnancy when an abortion would be allowed. If the rights of 
newly gestated embryos were protected, how could you defend abortion? Mean-
while, scientists eager to work with a complete and replicating human genetic 
code worried they would be denied legal access on moral grounds to a powerful 
research material that held great promise for the development of genetic knowl-
edge with significant medical applications such as genetically targeted chemo 
treatment, the cure for inherited disease including cystic fibrosis and cycle cell 
disease and the reversal of degenerative disease such as diabetes.
In the UK legislation, a 14-day-old embryo research limit was established to 
address the growing moral concerns over using live human embryos for scientific 
experimentation. Embryo research was allowed on so-called “spare embryos” 
(leftovers from fertility procedures) up until the embryos were 14-days-old, 
which is when the primitive streak first appears. The primitive streak signals one 
of the earliest signs of the developing central nervous system and when sensa-
tion may be present. As Warnock rightly indicates, this was a position adopted 
initially only in the UK; many places elsewhere do not recognize this timing as 
significant to the regulation of embryo research probably because initially there 
was no need. Newly gestated embryo cell clusters did not survive for much more 
than five days outside of the body, unless frozen. The HFEA also prohibits the 
creation of human embryos for research, the implantation of embryos or gametes 
on which research has been performed and the creation of admixed embryos 
(combined human and nonhuman gametes and sex line cells) unless specifically 
approved and only for research.
The UK legislation also brought in abortion to their HFEA, confirming pre-
vious legislation’s requirement for medical authorization on the basis of health 
or social risk to the potential parent and family, and this law provides one of the 
longest windows of availability worldwide: 24 weeks. The influential and early 
British legislation of NRTs, although initially restricted to heterosexual couples, 
was able to distinguish interests of potential families from those of research-
ers and did not use the scientific possibility to externalize conception from the 
body to support moral arguments used in anti-abortion campaigns. This model 
also increased legislative oversight of reproductive activity, such as artificial in-
semination, and established medicine as an authority over such matters. As this 
regulatory model was adopted and adapted variously throughout the world, it 
restricted reproduction and increased its medicalization. The UK Act also rep-
resents significant reach in the state control of scientific exploration and medical 
application in a new microbiological terrain that is difficult to police.
In the same year that the Warnock Committee was established in the UK 
(1982) to address state control of NRTs, The Committee to Consider the Social, 
Ethical and Legal Issues Arising from In Vitro Fertilization was established in 
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Australia’s second largest state, Victoria. Louis Waller, a professor of law, chaired 
the Committee and, reflecting the competition between the UK and Australia in 
developing IVF, declared Victoria as the first legislative body worldwide to reg-
ulate IVF and embryo research with the Victoria Infertility (Medical Procedures) 
Act, 1984. The significant difference between these two leaders in the regulation 
of NRTs, the UK and Australia, reflects their different forms of government. 
The UK is a unitary state with a single parliament, whereas Australia, Like Can-
ada, is a federation of states with both national and state parliaments. The UK’s 
regulation of NRTs is national, whereas the development of regulations in Aus-
tralia has chiefly been state by state, with Victoria being the first to create law. 
There is national Australian legislation impacting surrogacy, and all Australian 
clinics using NRTs are licensed and monitored through its National Health and 
Medical Research Council. The medical practice and scientific research involved 
with NRTs is controlled by individual states. Of the six Australian states, the 
four most populous states have passed NRT legislation: Victoria (1984), South 
Australia (1988), Western Australia (1991) and New South Wales (2007).
As with the UK, Victoria initially mandated (1984) that NRTs be available 
only to married heterosexual couples. The legislation also called for counselling 
of couples prior to treatment, and that before being accepted into treatment they 
had to have tried to become pregnant for at least 12 month without success. 
It allowed what it called “destructive experimentation” on embryos as long as 
embryos were not created for that purpose. Later, Victoria passed The Infertility 
Treatment Act 1995, which established a centralized state authority, the Infer-
tility Treatment Authority, to license and monitor medical professionals, coun-
sellors and clinics handling NRTs, as well as research scientists using embryos. 
Initially South Australia banned embryo research outright along with Western 
Australia, but both states expanded access to unwed heterosexual couples living 
together at least five of the last six years.
Key ethical principles underlying the legislation of NRTs in Australia now are 
as follows: the welfare of the child born from use of the technologies, an aversion 
to commercial exploitation of either the couples using the technologies or the chil-
dren born as a result of using them, providing access to information about genetic 
parents, maintaining the health and well-being of those accessing the technologies 
and no discrimination against those seeking to use the technologies based on sex-
ual orientation, marital status, race or religion. Despite this last stated principle, in 
2020 the legacy of restricted access remains in Australia. Initially it was common 
to various state acts that only those medically infertile could access reproductive 
technologies (including AID) which had long been used by physicians as a valid 
reason for refusing access to non-heterosexuals who were categorized as “socially 
infertile.” By 2008, as in the UK, human rights provisions sanctioned against 
such discrimination that has been largely, but not totally, eradicated in Australian 
NRT legislation and practice. Across Australia, commercial surrogacy and gamete 
donation are banned and children born from donated gametes and embryos have 
the right to exchange identifying information with the donors.
102 Regulation of reproductive technologies
Canada, like Australia, has a combination of a national parliament and 
 federated provincial parliaments. Discreet powers are identified as provincial, in-
cluding health, and all other responsibilities fall under national parliamentary 
jurisdiction. With NRTs, both jurisdictional levels of legislation come into play 
with the licensing and tracking of NRT clinics, embryo research and genetic 
engineering as a federal responsibility, while assisted conception medicine is a 
provincial matter. In 1989, the Canadian Royal Commission on New Repro-
ductive Technologies was struck and reported four years later in a two volume, 
1,275-page report aptly titled, Proceed with Care. There are 293 recommendations 
from the Report including a division of powers between provincial and f ederal 
 governments. The guiding principles behind the Report include: i ndividual au-
tonomy (the management of social identity and kinship), equality (access to single 
women), respect for human life and dignity (gametes and embryos),  protection of 
the vulnerable (embryos) and the non-commercialization of reproduction. Both 
the UK and Australian legislative processes prioritized the health and safety of the 
child; Canada was one of the first to legislate access to single women and recog-
nized that women have a more involved physical role in reproduction than men.
Pending the crafting and passing of legislation based on Proceed with Care, in 
1995 Canada put in place an interim moratorium on prohibited practices asso-
ciated with NRTs including cloning of human embryos, the implantation of 
embryos used in research, the mixing of human and nonhuman sex line cells, 
human sex line genetic engineering, the sale of human gametes and embryos, 
egg donation and paid surrogacy. Legislation was tabled first in 1996 and again in 
2003, and eventually passed as the Assisted Human Reproduction Act (AHRA) 
in 2004. Six years later, the Provence of Quebec succeeded in a Canadian Su-
preme Court case challenging the Act on the basis that some of its sections fall 
under provincial legislation of healthcare. In 2012 the AHRA was amended 
accordingly. This division of legislation of new reproductive technologies and 
genetic engineering between regional governments responsible for healthcare 
and federal governments responsible for criminal activity has become a common 
model and reflects the challenges of governing the new technologies as more 
than medicine.
In their 2017 study of European legislation of NRTs, Patrick Präg and Melinda 
Mills note first that, worldwide, over half of all NRT procedures first occurred 
in Europe, which is “the only continent where legal regulation of ART is wide-
spread.” Importantly they point to how not only legislation but also professional 
guidelines and practice norms as well as medical insurance effectively control 
the use of NRTs. The professional organization ESHRE (European Society of 
Human Reproduction and Embryology) has established a European-wide moni-
toring body: European IVF Monitoring Consortium (EIM). And although NRT 
use and legislated access vary widely across European countries, the Consortium 
does allow for a comparative analysis. In the 2017 study, Nordic countries (Den-
mark, Iceland, Sweden and Norway) were among the top six users of NRTs, with 
Denmark at the top with over 17,500 IVF cycles per million women; Belgium 
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has the second highest rate at almost 15,000 cycles per million. Eastern European 
countries (Poland, Montenegro, Macedonia, Albania and so on) tend to be at the 
lowest end of this scale, with Poland at 2,500 and Moldova at about 1,000 cycles 
per million. Notable is that Germany, Austria, Ireland, the UK and the Ukraine 
are clustered around the 2,750 per million mark. A country’s relative affluence 
does not automatically mean that NRTs will be more commonly used. Cost to 
the patient, lack of information about male-factor infertility, as well as norms, 
religious belief and laws related to the status of a human embryo help explain 
these rates of NRT uptake. These factors also influence the kind of NRTs that 
are available across Europe. For example, in Italy, egg donation is forbidden (but 
not artificial insemination by donor). In Germany, because of its history with 
early genetic experiments during the Holocaust, genetic screening and diagnosis 
had been forbidden since 1990, but in 2011 the German government allowed 
for limited applications. Pre-implantation genetic diagnosis (PGD) is conten-
tious in all European countries and restricted to the control of inherited disease 
where allowed. Throughout Europe are legal sanctions against using NRTs for 
gender preference and for genetically altering embryos designated for implanta-
tion. Initially, as with the UK, there were strict limitations of NRTs to married, 
heterosexual couples by law or through professional discretion throughout most 
European countries. There has been some movement in European countries to 
allow access to unmarried, but “stable,” heterosexual couples. Single women and 
members of the LGBTQ2+ community remain outside of legislated access to 
assisted reproduction in most European countries: 10 of the 22 countries allow 
access to single women, and seven allow access to lesbians.
The International Federation of Fertility Societies (IFFS) monitors NRT use 
and regulation worldwide and reports on such once every three years. Referred 
to as the triennial Surveillance Project, it was initiated in 1998 by key IVF devel-
opers: Howard Jones and Jean Cohen. These reports provide a useful overview of 
global trends in NRT development and rates of application, legislation and policy 
developments, along with medical insurance coverage. In the 2020 report, we 
learn the numbers of centres where NRTs are practised by country. Countries 
where there are relatively high number of centres are Brazil (200), China (400), 
India (1500), Japan (574), Russia (200) and the US (450). The UK registers only 
82 centres and in Australia there are 100. The countries above report among the 
highest number of centres by nation worldwide, which can be explained by NRT 
policy and legislation regulating access as well as by variations in services provided 
and the relative costs to the patient (a different kind of accessibility issue).
Taking this last issue first, within the six countries selected here with high 
numbers of centres (India with the most worldwide), there is a clear divide 
 between those who offer partial to complete publicly funded coverage ( Russia, 
Japan and China) and those who offer none (the US, India and Brazil). It is 
 assumed that China completely reimburses patients for NRTs, as elsewhere in 
the Report it is indicated that all 400 of their NRT centres are located in  public 
hospitals. In both Brazil and India, all costs are born by the patient (there is 
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neither public nor private health insurance coverage), while in the US some states 
cover some of the costs and there is private health insurance coverage. Globally, 
the IFFS reports for this period that 51% of reporting countries have a national 
health plan covering NRT costs, 23% have regional or state health plans, 27% 
rely on private health insurance and 18% have a combination of public and pri-
vate insurance coverage. The NRTs most covered, whether by private or public 
funds, are diagnostic evaluation, fertility medication, IVF and ICSI (the injection 
of individual sperm into the egg). This leaves the costs associated with surrogacy, 
gamete donation, cryopreservation and transfer, and genetic screening largely 
unreimbursed. In their study of the European rate of NRT use compared with 
cost to the patient, Berg Brigham and colleagues found that for 2009: the higher 
the public funding of NRTs, the greater the utilization; the greater the demand 
for publicly funded NRTs, the higher the number of restrictions to access; and 
the higher the cost to the patient, the greater the rate of cross-border reproduc-
tion of the transnational shopping for reproductive services. Cost regulates.
So, how does policy and legislation vary in the six countries singled out above? 
Internationally 62% of countries where NRTs are practised do not require a “sta-
ble or recognized” relationship (heterosexual married couple) to access the tech-
nologies. China and Japan do. Russia allows access to stable heterosexual couples 
and single women only, while India also allows access to single men, chiefly 
surrogacy. Brazil and some states in the US allow access beyond heterosexual 
couples to same-sex couples, single men and women, as well as to transgender 
and intersex people. Here we can begin to appreciate what lies behind a growth 
in assisted reproduction tourism or cross-border reproduction.
It is common globally for professional policies and oversight to stand in place 
of legislation for the cryopreservation of gametes and pre-implanted embryos, 
and for control of the number of embryo transplants per cycle. Often a single suc-
cessful embryo implantation requires multiple transfers; the numbers have ranged 
from one per cycle in the early natural IVF cycle as used in the birth of Louise Joy 
Brown, to up to ten embryos implantations at one time. The higher the number 
of embryos transferred, the more likely it is that multiple embryos implant. This 
leads to selected reduction or abortion of some of the implanted embryos; multi-
ples in pregnancy and birth carry greater risks to both the foetus and the mother. 
In contrast with abortion, the control of numbers of embryo transfers per cycle is 
regulated only in Russia; in Brazil, Japan and the US it is regulated through pro-
fessional guidelines, and in countries with relatively very large numbers of NRT 
clinics, such as India and China, there is no regulation at all.
Finally, the Report indicates almost a third of reporting countries have 
changed some aspect of NRT legislation in the past three years. This change 
chiefly involves donated gametes, developments in genetic engineering (and 
their role in embryo research as well as in pre-implantation genetic screening) 
and surrogacy. Less common types of regulatory changes, but significant none-
theless, include increased access based on marital status and sexual identity, and 
increased controls over cross-border reproduction, posthumous reproduction 
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(the use of gametes and embryos for reproduction following the death of the 
donor or donors) and cloning.
Key regulatory developments since 1990
Surrogacy, not strictly a new reproductive technology, has become a key focus of 
recent NRT legislation. Surrogacy has long been practised and is mentioned in 
the Book of Genesis when, due to infertility, Sarah turned to her servant Hagar to 
serve as the biological mother of her husband Abraham’s child. This is now char-
acterized as “traditional surrogacy” and has long been arranged among family 
members and friends as acts of altruism. It was also carried out among slaves as 
argued by legal scholar Anita Allen who states that, “as a result of the American 
slave laws, all black mothers were de facto surrogates. Children born to slaves 
were owned by Master X or Mistress Y and could be sold at any time to another 
owner.” With the advent of IVF and the ability to transfer gametes and embryos, 
surrogacy no longer needs to involve a genetic connection between the so-called 
surrogate mother and the resulting child; the child can be genetically related to 
both of its contracting heterosexual parents. And with developments in genetic 
transfer technologies, this could soon extend to same-sex and trans contracting 
parents. Since modern surrogacy met with NRTs, its regulation has chiefly fo-
cused on determining the rights to parenthood and the potential commercial 
exploitation of children and to a lesser degree to the exploitation of women who 
carry these children for others. In the 1980s, in countries where there has been 
firm regulation of all aspects of NRTs, the tendency was to initially prohibit 
commercial surrogacy and to provide the legal means to recognize the rights 
of the commissioning (heterosexual and often married) parents, a new form of 
adoption. In early modern surrogacy arrangements, the surrogate mother was 
typically genetically related to the foetus she carried. This was largely due to 
initial difficulties in freezing and storing eggs. In such cases, in the US, for ex-
ample through case law, the surrogate mother’s parenting rights were effectively 
transferred to the commissioning parents. Since then, with success in egg cryo-
preservation it has become the norm, especially in non-altruistic surrogate cases, 
to use an egg donor different from the gestational carrier, as surrogate mothers 
are now called. With pressure from the LGBTQ2+ community to recognize 
their family rights (the legitimation of gay marriage and adoption, for example), 
there have been legislative moves in many developed countries to open access to 
surrogacy for the purpose of family formation among single women, single men 
and members from the LGBTQ2+ community. Surrogacy forms a key part of 
this queering of the genetically linked, heterosexual nuclear family norm.
Initially modern surrogacy associated with NRTs was regulated to mimic 
dominant family forms that included married, heterosexual parents, often 
characterized as “stable.” Given the relatively high costs associated even with 
so-called altruistic surrogacy where the woman bearing the child receives reim-
bursements for costs, this stability also implies financial stability. But things can 
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go awry in surrogacy arrangements, and they did from the start, perhaps most 
famously with the 1987 Baby M case in the US. In this case, the mother carrying 
Baby M,  genetically related to the child, decided she wanted to maintain her pa-
rental rights and entered into conflict with the commissioning and also biological 
 father of the child who argued that the surrogacy contract overrode any mater-
nity rights she claimed. Since then, there have been cases including whether or 
not to engage a surrogate to bring frozen embryos to term to inherit property, 
or to satisfy the desire of a spouse to reproduce after the death of or divorce from 
the other genetic parent. There have been challenges by commissioning parents 
for authority over pregnancies in mothers bearing children for others where the 
commissioners routinely insist on dietary, employment and sexual activity re-
strictions, as well as enforced medical attention.
In an extreme case in the US, a commissioning parent seeking to selectively 
reduce the number of the three foetuses in a surrogate’s pregnancy to save on 
medical and child-rearing costs, sued and won that right. In the 2015 Cook v 
Harding case, the California Children’s Court ruled to deny any parental rights 
to the woman bearing the foetuses and awarded the commissioning person all 
parental rights including authority over the status of the pregnancy and deter-
mining care for all children born from the pregnancy, including putting the chil-
dren up for adoption. The woman bearing the foetuses offered to parent some or 
all of the children born from the pregnancy. Clearly this is not only a matter of 
reproductive technology and engages with family law and the rights to parent. 
Much of NRT legislation concedes these matters of human rights (the right to 
reproduce) and family law to other jurisdictions and adapts their provisions and 
restrictions accordingly (such as the UK Act) which was forced by a human rights 
ruling to allow NRT access to single men and women. In places where there is 
little, no or spotty legislation of surrogacy within NRT regulation, the courts are 
left to decide, or people try to circumnavigate regulatory obstacles.
Over the past four decades since IVF became medical practice, the increased 
pressure to allow for commercialization of surrogacy, chiefly stemming from the 
US where it has been allowed from the start, has spilled over to many countries 
who initially barred commercialization of gametes or embryos. There is now a 
market for donated eggs (as there has long been for sperm), and techniques for 
egg freezing, storage, transportation and implantation have improved. When 
people seeking to reproduce require surrogacy and are prohibited by law or by 
cost in their country or region, they seek the service elsewhere, especially clients 
from developed countries from women in less-developed countries.
Even though many countries legally ban commercial surrogacy outright, it 
occurs, sometimes where it is illegal. One of the fallibilities of NRT regulation in 
general is its policing. The same holds true for surrogacy. Three legal and health 
policy scholars of family law and reproductive technologies, Vanessa  Gruben, 
Alana Cattapan and Angela Cameron, recently edited a collection examining 
the state of surrogacy in Canada. The Canadian case demonstrates well how leg-
islation weakens in the face of determined individuals and a growing market for 
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surrogacy. As stated earlier, Canada initially banned commercial surrogacy, and 
it remains the case today. However, there is a good deal of latitude in how much 
women are reimbursed for their expenses, which range from maternity clothing, 
medical attention and supplies to food, furniture and lost employment. Legal 
scholar Erin Nelson describes the Canadian Royal Commission’s position on 
commercial surrogacy as “especially pessimistic and disapproving.” This is mir-
rored in the UK legislation, where commercial surrogacy also remains banned. 
However, what has happened in the decades following these early regulations 
seriously weakened these prohibitions. There are two factors: increased pres-
sure to commercialize surrogacy from outside of these jurisdictions (especially 
from the US and developing countries, but also by surrogates themselves seeking 
 compensation) and the serious problem of monitoring and regulating NRTs, 
including surrogacy. In Canada, the attempt to provide federal oversite and reg-
ulation failed at the Supreme Court challenge by the Province of Quebec. As a 
result, there is no national registry of who is providing surrogacy and under what 
provisions. Oversite and regulation of NRTs in general in Canada have evolved 
into voluntary, professional monitoring. As a result, not only is this a difficult 
area to police, there is no reliable data from which to form policy for surrogacy.
In places like the UK where there is a national licensing authority over as-
sisted conception practice, surrogacy is monitored, but in Canada commercial 
surrogacy is banned as in Brazil, Denmark, New Zealand, the UK and most of 
Australia. Bulgaria, Finland, France, Germany, Italy, Japan, Portugal and Spain 
prohibit surrogacy altogether. Globally 45% (22) of reporting countries to the 
IFFS in 2019 said that surrogacy was allowed or permitted, while 16 (36%) said 
they were unsure. Fourteen of the countries where it is permitted (29%) allow 
for compensation beyond reimbursement. Notably, as large providers of NRT 
services in general, China and Russia effectively allow both altruistic and com-
mercial surrogacy. In the IFFS report, it is noted that details of surrogacy in 
general and for compensation in particular, data are lacking; much commercial 
surrogacy activity takes place in underground markets, including in places like 
Germany and Canada.
Just south of the Canadian border, commercial surrogacy is a vibrant business. 
Many US states do not ban commercial surrogacy (except for Louisiana – where 
it is criminal, and in Minnesota and Nebraska); it is most popular as a commer-
cial enterprise in California, Nevada and Washington State, and as of February 
15, 2021, is legal in all of the New England states. It is currently estimated by a 
leading “boutique-style agency” in California, West Coast Surrogacy, to cost the 
commissioning parent(s) $90,000 to $130,000. It can be cheaper in other states 
but may also be more problematic to arrange in terms of family law. In the new 
millennium, surrogacy was discovered to be far cheaper outside of developed 
countries and regions, for example, the cost in India is one-half to one-sixth the 
cost at a high-end Californian boutique clinic. This remarkable discrepancy con-
tributed to a global trade in reproductive tourism that reached such a pitch that 
India, deeply involved in the industry, banned commercial surrogacy for foreign 
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intended parents in 2015 and recently passed the 2019 Surrogacy (Regulation) 
Bill that now allows only altruistic surrogacy for Indian families.
Surrogacy is not the only part of the NRTs that has created a reproductive 
tourism, but it is a dominant reason. Within western Europe and beyond, pa-
tients move between countries in search of greater access to the technologies in 
terms of cost, sexual and family orientation and the level of embryo and gamete 
manipulation allowed. In Präg and Mills’ 2017 study of cross-border reproductive 
care in Europe, they found that, firstly, most Europeans travel within Europe for 
their reproductive services. And secondly, that the flow was predominantly from 
Italy to Spain and Switzerland, from Germany to the Czech Republic and from 
the Netherlands and France to Belgium. In an earlier 2008–2009 study, 24,000–
30,000 treatment cycles for between 11,000 and 14,000 women were tallied as 
cross-border reproductive care. The reasons for the travel reflect those above: cost, 
accessibility restrictions, expectation of better or more timely care, anonymous 
gamete donation and available egg donation and surrogacy. Restricting such re-
productive care travel is, as with most NRTs, difficult to police, especially in the 
Schengen Agreement countries of Europe where people can move freely without 
any tracking at the borders. Similarly, along the longest undefended border in the 
world – between the US and Canada – people also move easily between the coun-
tries for reproductive care, including surrogacy, and in both directions despite 
restrictions, such as the legal prohibition on commercial surrogacy in Canada.
The trade between developed and developing nations has been of particu-
lar concern, especially with surrogacy contracts relying on some of the world’s 
poorest women as gestational carriers. At the start of the new millennium, In-
dia sought to add commercial surrogacy to a growing slate of medical tourism 
services; by 2011, about 2,000 babies were born through gestational surrogacy 
arrangements, with at least half of those children thought to be returning to the 
UK. The total number of foreign surrogacy babies to leave India is estimated in 
the tens of thousands. Because commercial surrogacy is prohibited in the UK and 
elsewhere, people are less likely to report and numbers are difficult to confirm. 
In 2012, the number of Indian clinics offering surrogacy services was estimated 
to be at least 600, with the Indian Council for Medical Research predicting that 
fertility services in India offered to foreigners would be worth $6 billion.
In many government regulations there has been a marked move towards in-
clusivity of access to NRTs. Initially most government regulations and many 
professional guidelines limited access to heterosexual couples in recognized 
 relationships. Following court and human rights challenges, these regulations 
and guidelines have changed markedly, with over 60% of countries taking part 
in the IFFS 2019 study responding that there was no requirement for a stable or 
recognized relationship to access the technologies, including Australia, Canada, 
India, New Zealand, the US and most Latin American and western European 
countries. Notable exceptions include France, Sweden, Switzerland, almost all 
of eastern Europe and most Asian countries including China. Russia will allow 
some NRT access to single women.
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Considered experimental by the American Society of Reproductive medicine 
in 2007, egg freezing was a relative latecomer to new reproductive technologies. 
Sperm, human and nonhuman, have long been able to be frozen and banked or 
stored, thawed and used in reproduction without negative outcomes. The first 
births from frozen human embryos occurred during the 1980s. Notably both of 
these techniques were already well developed in the meat and dairy industries. 
Eggs behave differently from sperm and even embryos when frozen. Initially, 
their cellular structures ruptured and broke down during thawing due to their 
relatively low surface area compared to their volume, the tendency for ice to 
form between the cells, destabilization of vital genetic processes during freezing 
and thawing and a hardening of the egg’s shell after freezing, making fertiliza-
tion more difficult. Although the first birth from a frozen human egg happened 
in Australia in 1986, vitrification or flash freezing, developed about 2008, made 
the process easier and more successful in terms of maintaining the reproductive 
capacity of the egg. By 2000, the British HFEA allowed use of frozen eggs or 
oocytes for reproduction with a ten-year limit for storage of frozen eggs for re-
production. Sperm and embryos are stored far longer, and in some places without 
limit: The Washington Post announced the birth of Molly Gibson in 2020 from a 
27-year-old frozen embryo. There is little in legislation to recognize the effort 
and exposure to health risk with hyperovulation and even less to protect egg 
donors’ rights.
There is a growing industry in egg freezing marketed towards young profes-
sional women. Medically, egg or oocyte cryopreservation is offered to women 
about to undergo cancer treatments (women hold all of their eggs in their ova-
ries since birth; radiation and chemotherapy may harm the oocytes), as well as 
to what reproductive clinics refer to as “age-related fertility decline:” after age 
35, women’s fertility starts to drop; they have fewer eggs and less reproductive 
 capacity, and pregnancies after this age have a greater chance of chromosomal 
 abnormalities. Egg freezing also forms an important part of IVF treatments 
involving donor gametes. The sociologist Catherine Walby points out that 
 although there is no nation that allows for trade in human embryos including 
for research, a trade in human oocytes (eggs) got underway by 2010 with openly 
commercial markets, especially in the US and Russia, demanding from $4,000 to 
$50,000 per egg. Unlike with human sperm, which has long been traded, Walby 
finds there has been relatively little hesitation to assign a cash value to eggs for 
 reproductive donation, fertility preservation and deferral as well as for research. 
And as indicated above, egg donation has become a routine part of surrogacy ar-
rangements to increase the perceived distance between the gestational surrogate 
and the  embryo she grows and births.
The value of human eggs is increasing. In October 2015, the UK became the 
first country in the world to approve the transplant of mitochondrial DNA. Most 
of us know that our cells carry DNA (found in the nucleus of the cell); few re-
alize that there are small energy-producing structures within almost all cells but 
outside the nucleus, the mitochondria, that carry their own distinct DNA called 
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mitochondrial DNA or mtDNA. When mitochondria do not function properly, 
serious health issues result including stroke-like attacks, blindness, deafness, neu-
rogenerative disease, muscular dystrophy and death. With the skills developed 
in transferring components of cells for reproductive processes and genetic re-
search, such as PGS and PGD, and twinning and cloning, it became possible in 
the early 2010s to transfer the nucleus of a recently fertilized egg (zygote) with 
disease-linked mitochondria to a zygote whose nucleus has been removed but 
which had healthy mitochondria. Hence, the DNA of the being created by the 
intended parents is now surrounded only with the healthy mitochondria of a 
third person: a mtDNA transfer. They can also do this with human eggs before 
fertilization as mtDNA passes through the maternal line, effectively replacing 
the faulty mtDNA with healthy mtDNA from a female donor. Because DNA 
is involved, the procedure raised public concern over there being three genetic 
parents. These fears were allayed with arguments that mtDNA contributes only 
0.1% of the total genetic makeup of the newborn and is hardly detectable when 
the donor is a close genetic relative of the recipient. Also, the relatively minor 
merging of three genetic contributors in a single person is often weighed against 
the enormous health and life-saving benefits. Some, like the medical bioethi-
cist Francois Baylis, disagree. Not only will mtDNA transfer interfere with the 
resulting person’s ability to trace genetic lineage, it would influence research 
on migration patterns and demographic histories as the mtDNA would exert a 
ghost-like diversion from the intended parents’ genetic genealogy. Baylis also 
raises the spectre of using the techniques involved to move beyond therapeutic 
indications to control for desired genetic outcomes, for example, introducing 
mtDNA from one lesbian partner so that both have genetic skin in the game. 
Some call this playing God and reject it on this basis, says Baylis, but she says such 
a path is likely to be taken due to the weight of expectation in a liberalized world 
of reproductive options driven by consumerism and a “hubris undaunted by 
failure.” And, with the promise of medical therapy, five years later the procedure 
is legalized, although practised infrequently, in over 15 countries worldwide in-
cluding the UK, China, Russia and Canada.
Since the application of IVF in humans, the human embryo and its entire ge-
netic code have been accessible from inception. This fact was quickly recognized 
and heralded in terms of its potential to control for and eradicate genetic-based 
illness and disease. The valuable research material and development possibilities 
offered with a fully formed human genetic code was not overlooked either. The 
problem was with public fears surrounding research on so-called test-tube ba-
bies. In the early days of NRTs and human embryonic research, there was little 
to no regulation of the genetic engineering involved. Instead, professional associ-
ations and government bodies developed voluntary moratoriums and guidelines 
to control who could access human genetic material and for what purposes – 
 research and medical.
In order to avail public concerns over embryo transfer and research, a distinc-
tion was made between early conceptuses destined for reproduction and those 
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spare to that purpose or “spare embryos.” These were embryos created outside of 
the body for reproduction but were spare in terms of either number or quality to 
that purpose. Because of a quickly established protocol to hyperovulate women 
before collecting eggs for fertilization, there were often more embryos created 
than needed for the transfer for reproduction (which settled into a professional 
norm of transferring three or four at a time). This was especially the case before 
embryo freezing methods had been perfected for use in human reproduction. 
There was also a visual check made under the microscope of newly developing 
human embryos in vitro (in glass) for obvious defects. Any irregular or otherwise 
odd-looking cellular embryos would not be chosen for transfer for gestation but 
kept aside for research purposes. It has become common practice to have those 
undergoing IVF to provide informed consent for spare embryos to be used for 
research purposes.
Again, responding to public concerns for the treatment and fate of early em-
bryos, a time limit was placed on how long in vitro embryos could be researched 
upon. In 1979, the US Department of Health Education and Welfare published 
the first report to recommend a 14-day limit to growing human embryos outside 
of the body, reflecting discussion among researchers, ethicists and theologians 
about the moral status of an embryo at this stage of development. Five years later, 
the Warnock Committee in the UK endorsed this limit without being clear 
about what genetic engineering in human embryos would look like. The 14-day 
limit was chosen for four reasons: this is when twinning or genetic individuation 
occurs (when the mother’s and father’s DNA recombine to form a new code), 
there is no development of the nervous system until this time (and thus it is pre-
sumed there is no feeling), there is a normal substantial loss of embryos within 
this two-week period, and until implantation in the uterine wall is complete it 
was thought that the embryo cannot develop beyond this stage. Although this 
time limit to embryo research was adopted globally either in law or voluntar-
ily through professional agreement, this barrier to in vitro embryo development 
beyond 14 days was surmounted in 2020 and the two-week limit to embryo 
research was lifted by the International Society for Stem Cell Research in 2021.
Initial voluntary bans on certain kinds of genetic research included the cre-
ation of human chimeras (recombining human and nonhuman sex genes or the 
creation of partial human beings) and the implantation of any genetically mod-
ified human embryo for reproduction. Like other places initially considering 
human genetic engineering of embryos, a Swedish government report that be-
came the Genetic Integrity Act in 2006 recommended against human genetic 
engineering except in matters of “gene therapy” or genetic-based medicine. It is 
distinctions like this that opened the way for pre-implantation genetic screening 
(PGS) and diagnosis (PGD) to be approved in many IVF programmes worldwide 
as part of reproductive medicine.
PGS is the screening of pre-implanted embryos whose biological parents are 
considered genetically normal. The embryos are screened for unusual numbers 
of chromosomes; people with Down’s syndrome carry an extra chromosome. 
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This process acts like current screenings, amniocentesis and chorionic sampling 
during various stages of pregnancy, except that with PGS there is no pregnancy 
to terminate: the affected embryos are not implanted. PGD is used when one or 
both genetic parents have a known single-gene disorder (such as cystic fibrosis 
and muscular dystrophy). The embryos are tested for these specific traits and only 
those unaffected are chosen for implantation. There is also currently a move to 
use some of these screenings, particularly for genetic disorders due to structural 
or numerical chromosomal anomalies, to hopefully improve implantation rates 
and reduce spontaneous miscarriages with IVF and to add value to IVF with 
screening against disorders such as Down’s syndrome pre-implantation. Cur-
rently, about three quarters of countries where fertility medicine is practised 
expressly allow for PGS and PGD to control against the reproduction of diseases 
such as cystic fibrosis as well as Down’s syndrome, and nowhere is it forbidden. 
Screening for a donor-matched embryo to become a source of genetic material 
to treat a diseased child is permitted in 21 countries, but forbidden in 17 others. 
Although the 2019 global questionnaire of fertility clinics conducted by the IFFS 
“reflects increased global interest and applications of [PGS and PGD], evidence 
of improved outcomes is lacking, except in small series and selected cohorts, even 
with increasingly sophisticated… technology.” The powerful promise of PGS 
and PGD remains such and is widely permitted by legal provisions or professional 
guidelines.
The regulatory concerns over embryo research quickly extended to embry-
onic stem cells and sparked an ethical firestorm. In 2001, President George W. 
Bush banned the use of federal research funds to create and use new stem cell lines 
and restricted work to existing stem cell lines; however, this ban was lifted by the 
National Institutes of Health in 2016. German and Italian governments initially 
banned the use of embryonic stem cells completely. These moves are a response 
to chiefly moral concerns over the status of the human embryo and the growing 
influence of religious authorities over science policy and g overnment regulation 
of NRTs and genetic engineering. Meanwhile in other countries that allowed 
for stem cell research and development, including Australia, Canada, Singapore, 
Israel and the US (outside of federally funded labs), a cloning technique called 
somatic cell transfer was developed with embryonic stem cells, which provided 
a sort of cellular factory supplying endless amounts of living cells genetically 
related to the donor that could replace their organs and damaged tissue. It also 
provided new avenues of research on the power of pluripotent cells and embry-
onic human development, without disturbing human beings, while “diseases in a 
dish” allowed for the study of genetic diseases in embryo stem cells derived from 
those cells screened out for genetic disease by PGD. In 2007, cellular models 
for thalassemia, Huntington’s disease and muscular dystrophy were developed, 
providing endless cellular research subjects for these diseases. Companies in the 
UK, the US and Denmark are poised to start clinical programmes to treat Type 1 
diabetes or at least reduce reliance on artificial insulin using stem cells; there have 
been promising early results in the treatment of macular degeneration in elderly 
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people with stem cell therapy. To date, about a dozen cell types, all somatic 
(non-sexual or neither egg nor sperm cells), have been generated in the lab from 
embryonic stem cells; great hope is held out for and a good deal of financial spec-
ulation is made on sex cell replication in the lab as these are seen as the building 
blocks of life. Few are speaking of bans.
The business of it all
For all, economics remains a key obstacle in accessing NRTs. In very few places 
globally are the expensive technologies and services associated with NRTs 
 offered through public healthcare schemes. Those that are, such as in the UK, are 
very tightly controlled with strict indications or eligibility requirements (includ-
ing age) and a limited number of IVF cycle attempts (three per person). Options 
such as embryo and gamete freezing and storage, PGD and ICSI are typically 
not covered. As Präg and Mills’ study of NRT utilization and public funding in 
western Europe concluded, “countries with the most generous public financing 
schemes tend to restrict access to covered IVF to a greater degree.”
The Harvard business school professor, Debora Spar, analysed the business 
of IVF in 2006 in her book The Baby Business and was surprised to find that it 
acted like no other. Typically, new businesses, especially those reliant on high 
tech, start with high-priced products whose cost drops as the market grows and 
production cheapens. This happened with the laptop computer, the cell phone 
and so on, but is not so with NRTs. Although the market continues to increase, 
and technologies such as cryopreservation are routinized and cheapened, the 
cost continues to rise because the demand is so high and rising. The investment 
website, Global Market Insights, prices the 2019 global market value for NRTs 
at slightly higher than $26 billion and expects it to expand between 2020 and 
2026 by 4.4%. Another investment website, Grand View Research, speculates 
demand shall only increase with the WHO report that women’s fertility rate has 
dropped from 5 in 1960 to 2.5 in 2012. Spar recommends that the baby business 
needs to be moved out of an exchange context (free market) and into a public 
goods market in order to prevent a classed system of reproduction and genetic 
health. It remains to be seen what the current pressure of rising infertility will 
do to public healthcare embracing high-tech conception costs and its adjunct in 
genetic medicine.
Jamie Metzl, author of the book Hacking Darwin, evokes a new age of eugenics, 
softer in its approach to merge what we know about information and computing 
with the genetic code. Arguably with the advent of CRISPR Cas9 this code 
of life itself can be hacked, and currently, this is widely appreciated as a good 
thing. Genetic-linked diseases, as well as viruses, can be coded which opens up 
possibilities of reprogramming the code as a cure, as well as tracking the code 
and its mutations including those in the COVID-19 virus to keep programmed 
RNA carrier vaccines up to date and fully efficacious. The value of this biopower 
is literally enormous. The expected sales in Covid vaccines manufactured by 
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Pfizer, Moderna, Johnson & Johnson and Astra Zeneca in 2021 alone is estimated 
to be at least $45 billion (and perhaps double that). That is just the vaccine sales 
and does not include what is to be made from genetic tracking (which has been 
done from early January 2020) and Covid testing. CRISPR technologies are 
centrally involved in COVID-19 diagnosis. On the heels of the Chinese-based, 
and non-sanctioned implantation of CRISPR Cas9 engineered human embryos 
(what the journal Nature reports as “The CRISPR-baby scandal”) and in the 
face of a global viral threat, there is talk of using the gene-editing tool to edit 
embryos to disable proteins that allow coronaviruses to enter cells (as the scientist 
He Jiankui announced he had done against the HIV virus in twin girls).
Jennifer Doudna, one of the developers of CRISPR Cas9, and the 2020 No-
bel Prize co-recipient with Emmanuelle Charpentier for the work, describes the 
following:
To edit the human genome in the way [a biomedical entrepreneur] was 
suggesting, a clinician would need only techniques that were already well 
understood by this time: generation of an embryo in vitro…injection of 
preprogrammed CRISPR molecules to edit the embryo’s genome, and 
implantation of the edited embryo into the mother’s uterus… [The entre-
preneur was] obsessed with the power and possibilities of CRISPR.
Conclusions
NRTs provided an opportunity for developing legal restrictions on who could 
reproduce and who is recognized as a parent, regardless whether the so-called 
new technologies were involved or not. Only because of human rights challenges 
based on discrimination according to marital status and sexual identity, some of 
these restrictions were clawed back in some places. The externalization of the 
embryo has heightened legal attention to its status, and in places where person-
hood is awarded to the embryo, it has increased legal protection of the embryo, 
sometimes at the expense of the rights of the pregnant woman. Global flows of 
reproductive tourism have proved difficult to monitor and legally control and 
require individual states to react once a potentially damaging flow is determined.
NRTs, their implications for kinship and the new world of genetic engi-
neering they have ushered forth are also complex and very difficult to police. 
The history of NRT legislation demonstrates how it tends to follow and react 
to scientific development and technological implementation. Also involved is a 
now common refrain that the risky business of NRTs and genetic  engineering 
of preimplanted human embryos is worth the promised medical benefits, in-
cluding acting on infertility, despite little realization of those benefits (the 
highest success rate for IVF remains about 25%). From initial public shock and 
horror with the prospect of externalized and transferable human reproduc-
tive parts and embryos and test-tube babies, we have now reached a point of 
social acceptance. IVF is now routinized and available throughout the world 
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and in some places has been made available to members from the LGBTQ2+ 
 communities. All for a relatively high price.
And increased acceptance of NRTs extends to human genetic engineering in-
cluding the manipulation of embryos to produce children with not two but three 
genetic contributors. Again, this is accepted in the balancing of risk and benefit. 
And this is not only a matter of reproduction but also replication. The potency 
of stem cells has been unleashed, the mysteries of the egg are being unveiled and 
a global pandemic demands scientific attention that benefits from human genetic 
science and reproductive engineering.
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As soon as new reproductive technologies emerged as IVF in the late 1970s, 
feminists, religious authorities and later gay rights activists responded with dif-
ferent opinions on what was at stake. Some feminists adopted positions on NRTs 
through a lens focused on women’s reproductive rights and health, while most 
religious groups defended the dignity of the embryo and proper kinship arrange-
ments. LGBTQ2+ activists saw NRTs as a route to addressing their reproduc-
tive rights. Since initial responses, feminists and others have broadened issues of 
concern within a reproductive justice framework that bridges the so-called old 
and new technologies, reveals the ties between assisted conception and popula-
tion control within national and global socio-economic disparities, recognizes 
the queering of kinship, and questions the ethics of replication through genetic 
engineering.
Initial responses to NRTs
One of the first organized responses to NRTs following the birth of Louise 
Brown in 1979 was by a group called the Feminist International Network of 
Resistance to Reproductive and Genetic Engineering (FINRRAGE). A group 
of women interested in developing issues of reproduction met at the Second In-
ternational Interdisciplinary Congress of Women in the Netherlands in 1984 and 
formed the Feminist International Network on New Reproductive Technolo-
gies (FINRET). The following year the network of women formed the Women’s 
Emergency Conference on the New Reproductive Technologies and 74 women 
from 20 countries met in Sweden. Here they developed a perspective that 
NRTs were tightly engaged with genetic engineering and renamed the group 
to  FINRRAGE to reflect this. Their initial list of concerns included emerging 
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methods of long-acting hormonal implants and injections tied to new strategies 
of population control among the most vulnerable, the level of experimentation 
on women involved in the nascent NRTs, the extension of existing sex selec-
tion during pregnancy (with fetal ultrasound and abortion) to pre- implantation 
diagnosis and ecological and economic threats posed by genetic engineering in 
agriculture.
Among the early members of FINRRAGE were scholars, including scientists, 
as well as a variety of activists: Renate Duelli Klein, a trained biologist and one of 
the editors of Test-Tube Women – What Future for Motherhood (1984), Patricia Spal-
lone, a research biochemist and author of Beyond Conception – The New Politics of 
Reproduction (1989), and Janice Raymond, a feminist medical ethicist and author 
of Women as Wombs – Reproductive Technologies and the Battle Over Women’s Free-
dom (1993). Activists included Gena Corea, an independent feminist scholar and 
journalist focused on exposing violence and malpractice against women and the 
author of The Mother Machine – Reproductive Technologies from Artificial insemination 
to Artificial Wombs (1985), Vandana Shiva, Indian scholar, ecofeminist and author 
of Staying Alive – Women, Ecology and Development (1988), and Farida Akhter, co-
founder of the Bangladeshi community-based equity and justice organization 
UBINIG and publisher of The Comilla Declaration (1989) by FINRRAGE .
This networked array of various feminists concerned with NRTs and genetic 
engineering was global, was quickly engaged with making connections to struc-
tural marginalization and was effective in getting critical views published. The 
feminist sociologist Stevienna de Saille writes a history of FINRAGE, Knowl-
edge as Resistance (2017), where she argues that the group provided a “cognitive 
praxis” in feminist resistance to dominant science and medical trends in repro-
duction. People associated with FINRRAGE argued that NRTs in general and 
surrogacy in particular were what the feminist political scientist Somer Brodribb 
called a “command performance” orchestrated by patriarchal and commercial 
interests with little regard to the women involved, whereas others saw surro-
gacy as an opportunity for women to profit, literally, from their reproductive 
capacities (see the sociologist, Michelle Stanworth’s 1987 collection: Reproductive 
Technologies:  Gender, Motherhood and Medicine). There were also brief overtures 
from  organized religious groups to join forces with women’s groups in opposing 
NRTs; the  crucial distinction being that feminists focused on women’s rights and 
the religious groups valorized maternity under restricted conditions and sought 
the extension of human rights to the embryo.
Much early criticism of NRTs revisited earlier feminist medicalization analy-
sis including experimentation on women and their foetuses as with thalidomide. 
With NRTs, the focus was on the hormones used in the hyperstimulation pro-
tocols of IVF including the transmission of Creutzfeldt–Jacob disease (CJD – a 
brain wasting disease commonly known in cows as mad cow disease). Deadly 
symptoms can emerge decades after exposure and started to appear in women 
who underwent IVF. A pituitary hormone (hPG or human pituitary gonadotro-
phin) derived from dead bodies and used in IVF (as well as in children treated 
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with growth hormones) was the culprit discovered in 1992 by the feminist critic 
of NRTs Klein (also a neurobiologist) and reported by Ian Anderson. Since then, 
fertility hormones have largely been produced in the lab rather than derived from 
human sources. However, in 2011, the Canadian national newspaper, The Globe 
and Mail, announced that especially post-menopausal women’s urine remained 
the source for about two-thirds of fertility drugs and that there was a heightened 
risk for passing on diseases like CJD.
Finally, an update to the medicalization thesis as applied to NRTs would need 
to include the early and critical connection made between assisted conception, 
genetic engineering and commercial interests. A biochemist and feminist critic 
of NRTs, Patricia Spallone and the feminist scholar and reproductive rights ac-
tivist Deborah Lynn Steinberg edited Made to Order - The Myth of Reproductive 
& Genetic Progress in 1987. The entries in this collection cover a range of top-
ics including the disappearance of women in an increasingly normalized world 
of assisted conception and the focus on gametes, embryos and surrogates; how 
NRTs contribute to privileging the interests of developed countries over those 
“requiring” population control; and the prospects of a new era of eugenics and 
genetic-based surveillance and bioweaponry.
The entries are critical of reproductive science and medicine as male- 
dominated and harmful to women rather than any advance in reproductive rights. 
Also, as with earlier criticisms of the medical-industrial complex, these analyses 
point to the financial motivations behind NRTs stemming from pharmaceutical 
companies, a growing business in private fertility clinics and speculation on ge-
netic engineering. This collection appeared less than a decade following the birth 
of the first IVF baby and raised criticisms among feminists about how to proceed 
in this world of fast-paced change in reproductive relations.
One of the world’s first major organized religions to respond to the NRTs was 
the Catholic Church. Their position is based on the tightly held belief that life 
is a gift from God and that man (sic) is entrusted with this gift as a responsibility 
that includes respecting the value of this gift. It is God, and only God, who de-
termines when a life begins and ends and how.
Despite initially accepting IVF as a way of encouraging reproduction in the 
family form acceptable to the Catholic Church (married, heterosexual couples), 
it changed its position in the Instruction on Respect for Human Life in its Origin and 
the Dignity of Procreation, February 22, 1987. Here the Church introduced the 
notion of “responsible science” and brought into question the infallibility of sci-
entific research and technology. It aligned scientific responsibility with long-held 
Church doctrine of “human dignity” and the “integrity of the human person,” 
and extended such to the earliest embryonic forms. The Church’s teaching stated 
that “science cannot set its own rules” and called for scientists to adhere to morals 
and definitions as understood by the Catholic Church, which include the fol-
lowing: Every being is unique; every being is the creation of God; and a human 
being or person begins at the moment of conception/fertilization and thus an 
embryo must be treated as a person.
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The Catholic Church maintains this position today, while many non- Catholic 
Christian sects approve of NRTs and their various components including  embryo 
and gamete donation, commercial surrogacy and pre-implantation diagnosis as 
ways of creating families. These sects’ enthusiasm for the technologies is  normally 
tempered by their views on non-heterosexual unions and trans people. If the sect 
is strongly opposed to such, they would not support using NRTs to allow these 
people to reproduce.
Reproduction is of particular concern to Jews in general post-Holocaust, and 
Israel has the highest number of fertility clinics per capita in the world. Following 
the genocide of 6 million Jews in the first half of the 20th century, and a longer 
time of global persecution, Jews are strongly pronatalist. Many clinical and tech-
nological developments in NRTs now come from Israel where they embrace a 
wide array of technologies including cloning techniques for the transfer of DNA 
from one gamete to another pre-implantation. For those who observe traditional 
Jewish teaching, Halakhah, infertility has long been a source of shame, especially 
for the wife and less often as a sign of failure of the Jewish male’s obligation to 
procreate. For devout followers, a husband or wife’s infertility serves as a reason 
for divorce (typically, women are more often medically investigated and diag-
nosed as infertile than men). As a result, NRTs are welcomed, even in more 
devout sects as assisting a primary role for Jewish families as well as protecting 
the future of Jewish populations and defending Judaism. There are variances 
between orthodox and progressive sects as to what family forms are encouraged; 
more orthodox sects tend to support reproductive interventions only in marital 
unions they recognize.
Islam is not only a major organized religion, but it also serves as a judicial 
component of the Muslim world. The medical anthropologist Marcia Inhorn 
examines two Muslim sects and Islamic law surrounding IVF and gamete dona-
tion. She finds that initially in the 1980s, Muslim communities largely accepted 
NRTs through the dispensation of fatwas (Islamic religious proclamations) as 
long as there was no third party involved (egg and sperm donors and surrogates). 
In Islamic law, the donation of human gametes signifies a third person (or more) 
in the marriage and thus constitutes infidelity, a religious infraction with serious 
consequences, including death. Since the 1990s, however, there has been a split 
between Sunni Muslims (who make up about 85% of all Muslims worldwide) 
and Shi’ite Muslims (found in Iran and parts of Iraq, Lebanon, Bahrain, Syria 
and Saudi Arabia). Sunni scholars follow scripture (chiefly the Qur’an) in deter-
mining Islamic law, while Shi’ite scholars favour individual religious reasoning, 
which can allow flexibility, especially in accommodating new technologies, in-
cluding contraception, organ transplant, transgender surgery and NRTs. In Iran 
(and other parts of the world), Shi’ite Muslims can contract for a temporary 
marriage between an unmarried Muslim woman and a married or unmarried 
Muslim man (men can keep concubines) called mut’ah for a designated time and 
set price. Previously middle-aged and older spinsters and widows relied on such 
unions for financial support, especially during the Iraq–Iran war that created 
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many widows and other women requiring financial support. A leading ayatollah 
(religious leader) in Iran in the early 2000s called for mut’ha to be evoked to tem-
porarily allow egg donation, on a case-by case basis as determined by a Shi’ite 
religious court with all parties present (the IVF doctor, the infertile couple and 
the donor or donors). The husband in this case would be temporarily married 
to the egg donor until the pregnancy in his first wife was established. However, 
sperm and embryo donation would not be permitted as Muslim women are not 
allowed to marry more than one man at a time and planned single motherhood 
is not likely to be tolerated.
This Iranian case opens up further Shi’ite considerations of gamete dona-
tions with various questions arising, most of which deal with the relationship 
between children from donated gametes and their social and biological parents. 
The questions include whether another man can enter the marriage at all (sperm 
donation) or can wives of infertile men temporarily divorce them and briefly 
marry the sperm donor. Who does the child inherit from? Is the child from 
donated gametes related to a social or adopted parent at all (this has implications 
for potential marriage between them, and for proper behaviour between them, 
such as veiling)? Other than issues arising from genetic origins, most Muslims 
embrace NRTs and do not see it as a matter of humans playing God as does the 
Catholic Church. Unlike the Catholic Church, Islamic law carries more weight 
among its followers.
There are two waves of reproductive movements among the LGBTQ2+ 
 communities that have influenced reproductive rights. The first wave began 
alongside the recognition of same-sex unions in the form of human rights-based 
court challenges. The second wave is much more recent and involves transgender 
people and their rights to secure formal identification according to their gender 
identification. Reproductive rights come into play as some nations hold these 
peoples’ reproductive rights ransom for securing recognition for their desired 
identities.
Before the recognition of non-heterosexual unions, lesbians had been 
self-managing access to reproduction in a variety of covert ways and there was 
no public call for reproductive rights. As non-heterosexual marriages gain legal 
status around the world, so does the pressure for securing reproductive rights for 
these couples. Initially the UK legislation for NRTs prevented access to non- 
homosexual partners, but as with other regions and countries, was forced by 
human rights challenges in the courts to open access to single women and same-
sex partners. In 2009, the HFE Act 2008 comes into effect and allows same-sex 
and unmarried couples to be legal parents without having to adopt. In Canada, 
the Assisted Human Reproduction Act passed in 2004 allowed access to single 
women but also brought the grass-roots practices of lesbian and other women’s 
self-insemination under federal control. Meanwhile gay men sought access to 
surrogacy and also established grass-root practices with lesbian and other re-
producing allies who acted as egg donors and surrogates. Although today many 
assisted reproduction clinics do provide services to the LGB community, the 
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issue of its regulation remains mixed among these communities. Access to tech-
nologies, especially safe and reliable gamete collection, storage and transfer, is 
useful to same-sex couples and impossible to provide outside of medical and lab 
settings; however, concerns over the policing of sexuality remain. Provision of 
services to the trans communities is even more problematic.
Reproductive rights and legislated access to NRTs by trans people are tied 
up with the issue of legal identification of people who change their gender from 
that recorded at their birth. So-called gender re-designation or re-assignment is 
 experienced by many trans people as a sort of coming home; finally, they feel 
comfortable within their own skin. This is why the media activist group GLADD 
(originally the Gay and Lesbian Anti-Defamation League founded in 1985 New 
York City to address defamatory coverage of AIDS and the LGB community) 
proposes terms like designated male at birth and gender affirming surgery instead 
of gender re-assignment or sex-change surgery. It is not surprising then that trans 
groups have been lobbying governments to formally acknowledge chosen gender 
in documents including birth certificates, passports and national identity cards. 
Many countries and regions are willing to do this, but at a large price to trans 
people’s ability to reproduce.
Most of the countries of the Americas have laws concerning gender expression, 
as does Russia, China, India, South Africa and Australia. However, many re-
quire proof of gender-affirming surgery before birth certificates will be changed, 
which often means sterilization, and some countries including B elgium, the 
Czech Republic, Finland, the Netherlands, Turkey and Sweden require that the 
person be permanently sterilized. As the transgender scholar Blas Radi explains, 
people who wish to express their gender identity as something different than 
that designated at birth and have it publicly acknowledged run the risk of losing 
their reproductivity. This bio-sexual policing keeps heterosexual dimensions of 
gender and reproduction stable; the image of the heavily pregnant obvious man 
symbolizes the defamation of trans people as aberrations of “nature.” Trans re-
productive discrimination is also evident in the difficulty trans people have in 
accessing services required to preserve and support their reproductivity (such 
as egg and sperm freezing, gamete donations and surrogacy). However, before 
securing their right to reproduce, many trans people struggle for personal safety 
(their rates of suicide and sexual assault including by police are far higher than 
the norm) and for access to safe, effective and respectful medical care. Arkansas 
voted in 2021 to ban gender-affirming surgery and treatments to transgender 
youth; many trans people shy away from healthcare out of substantiated fears of 
rejection and abuse.
Reproductive justice and the NRTs
At the same time as critiques of NRTs developed, a substantial backlash  began 
against abortion rights, chiefly in the US. The decriminalization of abortion 
shortly following the 1960s sexual revolution with its new grasp on widely 
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available, highly effective contraception remains a significant mile marker in 
women’s reproductive rights in most developed contexts. The road since has not 
been without significant bumps; for decades, women have had to plead before 
panels of physicians to access abortion even if legally available. Many women 
within developed and parts of developed countries remain isolated from access to 
abortion by particularly racialized poverty and the racialized effects of geopoli-
tics. Women in places where religious authority continues to hold influence over 
the state have gained the right to abortion only recently such as in Ireland (2018) 
and Argentina (2020). In the US, for at least the past decade, there has been a 
steady attack on the 1973 Roe v Wade landmark decision of the US Supreme 
Court that ruled that access to abortion without excessive government impedi-
ments was a woman’s constitutional right to liberty of the person.
In April 2021, the policy research Guttmacher Institute, committed to 
 advancing women’s reproductive health and rights in the US, describes 2021 as 
“a defining one in abortion rights history.” An increasing evangelical influence 
in American politics with a strong anti-abortion platform, along with an increase 
in conservative judges in the Supreme Court (most notably due to the 2020 
death of the Supreme Court proabortion Justice Ruth Ginsberg followed by the 
 Republican-backed replacement with the prolife justice Amy Coney Barrett), 
has placed Roe v Wade at risk. In September 2021 The Court refused to object to 
the new Texas law banning all abortion as soon as a “heartbeat” can be detected 
(heart muscle forms and begins to emit an electronic signal at about six weeks).
Perhaps greater than the threat of overturning this constitutional protection 
for access to abortion at the federal level is the impact of over a decade of laws 
impeding access to abortion, state by state. States such as Texas, Oklahoma, 
Montana, Indiana, Arizona, South Carolina and Kentucky have passed numer-
ous restrictions on abortion access by reducing funding to abortion clinics and 
abortion providers or making it easier for state agencies to close clinics, forcing 
doctors to provide misinformation about risks to women seeking abortion (in-
cluding untrue statements that abortions cause cancer and depression) and forc-
ing women to undergo days of state-sanctioned counselling before accessing an 
abortion. These are known as TRAP laws: the Targeted Regulation of Abortion 
Providers. The 2021 report for the Guttmacher Institute tallies 549 state-based 
restrictions, including 165 abortion bans, introduced in 47 states over the first 
five months of 2021. In May 2021, Texas signed into legislation a ban on abor-
tions over six weeks in the pregnancy when few women know they are pregnant 
by this time. The law also allows anyone opposed to abortion, no matter where 
they live or their connection to a patient, to sue an abortion provider or anyone 
who helps with an abortion including those providing financial support or trans-
portation. Many of these bills are challenged and fail on appeal and in federal 
courts. But this doesn’t matter; their intention is to chill the reproductive rights 
environment and to ward off people seeking, assisting or providing abortions. 
This is also described as a chipping away at Roe v Wade without even having 
to take the matter to the Supreme Court. And that possibility remains due to 
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state-based TRAP laws and bans both of which increase attention not only to 
foetal personhood but to foetal rights. There is now a majority in the Court who 
are supporting challenges to Roe v Wade on the basis of such.
Although this attack on abortion rights seems to be freestanding and unre-
lated to NRTs, there is a link. The externalization of conception and the transfer 
of human gametes and embryos along with the genetic promise of embryo ge-
netic research provide a unique spotlight on the embryo and contribute to the 
development of foetal personhood as an in utero voyageur, as well as the genetic 
potential for human being. From the start of NRTs, attention flew to protect the 
interests of the embryo: they could not be bought or sold, and embryo research 
was tightly controlled and reserved only to those embryos deemed in excess to or 
incapable of becoming a person. A whole new area of family law was created to 
consider the plight of stored embryos when divorce or death of biological parents 
occurred and to manage kinship with gamete and embryo donation and surro-
gacy contracts. Initially NRTs were restricted to the reproduction of accepted, 
heterosexual kinship norms. Many places still ban access to members of the 
LGBTQ2+ communities. And ironically, abortion (known as selected reduction 
in IVF practices) is permitted in NRTs to provide a better chance of in utero 
survival in cases of multiple pregnancies. And so a double standard is set: those 
who can afford (in terms of economic and social capital) access to reproductive 
rights typically have reproductive choices and relatively easy access to the entire 
range of reproductive services (conceptive, contraceptive and abortion); those 
who cannot afford them, do not. This raises the matter of reproductive justice 
and the interconnecting globalized social structures of inequity that give rise to 
the difference in reproductive choice.
Since the first world population programmes were launched in India in the 
1950s following on the heels of Malthusian arguments of the planet’s finite carry-
ing capacity, there was a trend to tie development assistance to demonstrated lower 
birth rates in the name of global sustainability. Michelle Murphy, the professor of 
history and women and gender studies, provides an in-depth and critical over-
view of how national economies became prime indicators of national well-being. 
Then, Murphy indicates how those in globally dominating positions of economic 
power carved the world into developed, developing and undeveloped nations, 
with a formula for development having reproduction at the core. Population con-
trol was based on “averted birth” or the investment in preventing “the better-not 
born.” Contraceptive education and technologies fought for by early birth control 
advocates Sanger and Stopes as part of family planning rights quickly parlayed 
into cost-benefit analyses of controlled populations. It was estimated that an initial 
investment in the prevention of a single averted birth was 100 times more effective 
in raising the per capita gross domestic product (GDP) than investments focused 
on production. More recently, these principles have been applied to environmen-
tal sustainability: decreased birth rates in developing and undeveloped countries 
will increase economic sustainability for the people who avert birth as well as 
improve the environmental sustainability for the planet as a whole.
Reproductive rights and justice 125
Mass sterilizations in India have continued beyond the 1970s programmes 
funded by the World Bank, the Swedish International Development Agency and 
the UN Population Fund. In 2014, the BBC reported how India has now inter-
nalized control of reducing birth rates among their poor and ethnically margin-
alized populations: nearly 4 million women were sterilized between 2013 and 
2014. Earlier, during the 1975 State of Emergency in India, 6.2 million poor men 
were sterilized, 2,000 of whom died from botched surgeries. Sterilization camps 
continue in India today (mostly tubal ligation in women, as after 1975, men 
have veered sharply away from forced vasectomies) amidst widespread calls to 
Prime Minister Modi for strict crackdowns on what Modi himself described in 
2019 as a “reckless population explosion,” leading to his Population R egulation 
Bill. And because India has bought the population bomb argument, as the New 
 Zealand-based academic Nayantara Sheoran Appleton argues, many middle-class, 
educated, urban Indians agree that more population control is needed, not only 
to address matters of sustainability and standards of living but to address the des-
perate and deadly humanitarian crisis during the third wave of the COVID-19 
pandemic. Sheoran Appleton states that this perception that India’s problem is 
one of overpopulation, which is accepted internally and externally, has everyone 
“looking away” from the 2021 crisis. “We need to remember that population is 
not the problem so much as inequality, and looking away, is.”
Today population control has morphed into a much more socially acceptable 
characterization from averted births to what Murphy calls the “phantasma of 
the Girl.” This is a creature of the human rights movement applied both within 
and abroad and focuses on the spectre of the young girl living in ignorance and 
without the means and agency to make her own wise decisions about her repro-
ductive path (keep her family size within her means to support them). This is 
why contemporary development superpowers (the UN for example) turn to the 
education of girls as the way out of the desperation of poverty and substandards 
of living, including environmental degradation. It is an effective mechanism to 
attract funding dollars to the control of not just reproduction but also production 
in so-called developing and undeveloped countries. The Girl and her reproduc-
tive agency are the focus of global financial speculation, or as Murphy puts it, 
“the human capital approach to liberal feminism.” This is not only a matter of 
gender as the approach effectively replaces the word race with population: “pop-
ulations” tend to be coloured and controlled, whereas “people” tend to be white 
and have well-protected, so-called individual rights.
In 1970, the US Congress passed the Family Planning Services and Population 
Research Act providing $383 million for contraceptive programmes and hospital 
grants for voluntary sterilization. Five years later, LA-based medical residents 
were sued for performing tubal ligations (sterilization) on Mexican American 
women without their reasonable consent. Two decades later with the reform of 
the welfare act, Bill Clinton’s government linked benefits to a limited family size; 
if you exceeded the limit, you could forfeit your welfare. The rationalization by 
the government was that people should only have children if they could afford 
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them. President Trump called for the institutionalization of teen mothers so that 
they could not reproduce further and argued that cutbacks to social assistance 
would get rid of poverty. Audrey Farley of the Washington Post responded just 
prior to the pandemic, “What [poor] people need instead of cuts [to welfare] 
and intrusions into their reproductive decisions is access to employment, hous-
ing, food, and health care.” Other populations in developed countries whose 
reproductivity has been rendered problematic and in need of restriction (often 
sterilization) include Indigenous women in Canada, New Zealand and Australia, 
women addicted to drugs, homeless women, and women engaged in sex work. 
A new area of concern involves trans people who, in some countries, have to be 
sterilized to receive official documentation that reflects their gender affirmation.
Access to NRTs is controlled by a range of factors, not all financial and not 
all as one might expect in terms of racial difference. As an almost throwaway 
comment in her highly popular 2018 autobiography, Becoming, former First Lady 
of the United States, Michelle Obama, notes that she and her husband, Barack, 
resorted to IVF when Michelle could not conceive. She says how she was grateful 
that the costs were covered by her employer at the time. A couple of months into 
the pandemic, the Guardian Weekly published the story of Laura Barton, a young 
white writer and broadcaster, who found herself travelling to Greece as the pan-
demic hit for IVF treatment with frozen sperm from a Bermudian mechanical 
engineering student. She manoeuvred herself and the tank carrying the frozen 
sperm through lockdown conditions to access the Greek IVF clinic because it 
was more difficult to get access to IVF as a single woman in her hometown, 
whereas in Greece, if you have the cash, no questions are asked. Here she waited 
for the news of implantation following her hyperovulation and the fertilization 
of her eggs with the sperm from Bermuda. “On the day I get a negative preg-
nancy test, 717 people die of corona virus in the UK. For a long while, I sit on 
the edge of my bed and try to balance rationality and sorrow.”
Anita Allen, a freelance writer and author of It was all a Dream – A New Gen-
eration Confronts the Broken Promise to Black America, which was published just as 
the pandemic hit North America, also considers her reproductivity following a 
breakup, while family friends prod her about her vanishing years of reproduc-
tivity. In a Sunday New York Times article she explores freezing her eggs and her 
race: “Is egg freezing only for white women?” Although a growing trend among 
young professional women and a work benefit offered by companies including 
Apple and Facebook, Allen discovers that between 2005 and 2001, a New York 
City-based study found only 6% of those who choose to freeze their eggs are 
black; 80% are white. She finds the trappings surrounding the service “white-
washed” and the cost high, starting at around $10,000, which could effectively 
prohibit access to those who have suffered long-term economic discrimination 
due their race. She also points to her fear of resonating with racial stereotypes 
if she chooses single motherhood and discusses the stigma associated with Black 
women choosing an abortion, choosing to be a single mother, choosing to have 
multiple children and choosing IVF. Black women’s reproductivity is loaded in 
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ways that white women’s is not. And Black women are not considered much in 
the distribution of NRTs, despite the easy time of it that the Obamas’ seem to 
have enjoyed.
These three women, two Black and one white and all with the financial 
means to access expensive fertility services, have different experiences of them. 
One woman so desperate to reproduce travels during a global pandemic seeking 
assistance and feels strange as reports of deaths come in as she tries to conceive – 
it is a personal story of loss in difficult times. Another woman cannot help but 
notice that people who look like her are not in the fertility service brochures and 
when she checks, very few like her can afford or are encouraged to bank their 
reproductive potential in contrast to white women. While another woman, also 
Black, casually accesses IVF seemingly without any hindrance, systemic or per-
sonal. It is political when reproduction is a matter of rights or a matter of justice. 
But the distinction is not black and white.
Meanwhile the mundane world of reproductive health, which is typically 
measured in terms of adequate access to basic medical care during pregnancy, 
birth and afterwards, as well as access to reproduction information and effective 
contraception, suffers from widening disparities across the world. A Lancet series 
on maternal health reported by Wendy Graham and others in 2016 finds that, 
“the gap between the group of countries with the lowest and highest maternal 
mortality increased from around 100 times to 200 times difference between 1990 
and 2013.” Suellen Miller and others in the same series characterize this disparity 
by too much, too soon (such as unnecessary C-sections and episiotomies) at one 
end of the spectrum, and too little, too late (little or no basic healthcare, lack of 
proper nutrition, lack of contraceptives and botched abortion) at the other. They 
note how the disparity is found within developed populations such as in 2010 
when Black women in New York City were found to be more likely to die in 
childbirth than women in Vietnam or North Korea. Willem Ombelet, a gynae-
cologist and coordinator of ESHRE’s Special task Force on Developing Countries 
and Infertility, points to how infertility care is almost completely unaddressed in 
developing countries (except for the very wealthy who travel to private clinics 
in large urban centres in developed countries). And among the 180 million who 
suffer from infertility worldwide, according to WHO, those exposed to disease 
and receive little or no treatment, especially sexually transmitted disease, account 
for the majority of the infertile – in sub-Saharan Africa, this amounts to 85% of 
known infertility in women compared to 33% worldwide. Rarely is fertility a 
part of reproductive healthcare support in developing countries.
So, it is no surprise to find a social penthouse of NRTs with access determined 
by intersecting dimensions especially of race, socio-economic background, im-
mediate means and geopolitical location. In addition to the contrasting images 
cast above is reproductive tourism. And nowhere are social justice issues with 
reproductive tourism more apparent than in the international surrogacy industry. 
At the start of the new millennium, India sought to add commercial surrogacy 
to a growing slate of medical tourism services; by 2011, about 2,000 babies were 
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born through gestational surrogacy arrangements, with at least half of those chil-
dren thought to be returning to the UK. The total number of foreign surrogacy 
babies to leave India are estimated in the tens of thousands. Because commercial 
surrogacy is prohibited in the UK and elsewhere, people are less likely to report. 
In 2012, the number of Indian clinics offering surrogacy services was estimated 
to be at least 600, with the Indian Council for Medical Research predicting that 
fertility services in India offered to foreigners would be worth $6 billion. The 
comparative costs explain India’s popularity as a medical tourism destination 
for commercial surrogacy. The average charge for fertilization, gestation and 
birth in India in 2015 was $20,000–45,000 compared to $60,000–100,000 in the 
US. Foreign surrogacy arrangements were banned in India in 2015, although a 
year later an investigative journalist from The Guardian, Julie Bindel, discovered 
that commercial surrogacy in India for foreigners could still be had, including 
for same-sex families and single people (also banned by the Indian parliament). 
Commercial surrogacy remains a legal option to heterosexual Indian couples.
Kalinda Vora and Malathi Iyengar examine the complexities of international 
commercial surrogacy in India, citing similarities with the US slave trade as 
both commodified and trafficked bodies globally. The obvious draw for fertility- 
seeking tourists to India for surrogacy is the markedly lower cost but a high 
standard of medical care. There are enormous socio-economic disparities within 
India that create both healthcare services on a par with developed countries and 
a labour pool of low-paid egg and sperm donors and gestational surrogates. Their 
low wages represent comparably high incomes for them, and their financial des-
peration makes for a strong motivator to enter the industry. Vora and Iyengar 
also identify a reproductive flow of citizenship value from poor Indian surrogates 
with low social citizenship and protections in their own country to the North 
Westerners whose citizenship is reinforced and literally increased by the contrac-
tual arrangement. They argue that banning commercial surrogacy to foreigners 
in India does not improve the socio-economic and relatively low-valued social 
citizenship of the women who served as surrogates. And although the ban may 
seem to stop the exploitation of these people, we know the practices continue 
and pushing them underground is likely to increase the exploitation of this al-
ready very vulnerable group. And nothing is done to address the privilege behind 
the source of the exploitation, with many baffled by the prospect of international 
regulation of medical tourism.
Laura Mamo, who initially celebrated how lesbians hijack NRTs, particularly 
IVF and sperm donation to reproduce queered family forms, updated her analy-
sis in 2015 in the Journal of Family Issues with Eli Alston-Stepnitz to include gay 
men, gender queer and transgender people, and reproductive justice. Here they 
argue that by participating in the new world of NRTs, marginalized people from 
these communities reproduce not only people but also exploitative marketplaces 
as they realize their reproductive rights. On the one hand surrogacy arrange-
ments for gay men allow for alternative family forms. On the other hand, they 
perpetuate inequalities, especially through surrogacy. It is this complex interplay 
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of rights between marginalized people that comes to light in developed countries 
where surrogacy costs are either high or commercial surrogacy is forbidden, only 
to push the exploitation offshore where labour costs are drastically lower or to 
where gay men can afford up to five surrogates at a time while the surrogates are 
reimbursed for expenses only, such as in the UK and Canada.
Reproductive justice and biomedicalization
Initial feminist critique based on the medicalization and commercialization of 
conception was a nascent analysis of the intersecting interests of state, markets 
and patriarchy. It has now developed into a biomedical analysis that includes 
medicine, science and business alongside critiques of global capital flows, repro-
ductive tourism and competing claims for human rights. And nowhere is this 
more apparent than in the work emanating from the University of Cambridge’s 
ReproSoc (Reproductive Sociology Research Group) founded in 2012 and di-
rected by Sarah Franklin who took part in early meetings of FINRRAGE. The 
range of studies coming out of the group includes NRT use among Middle 
East Muslims, the anthropology of global IVF, the medicalization of menopause, 
studies of moral frameworks within commercial surrogacy in the US, India and 
Russia, the rise of non-traditional pregnancies using NRTs, human germline 
editing and transnational care, egg donation and cross-border NRTs and the 
datafication of reproduction. Here we see intersectionality in terms of globaliza-
tion, socio-religious contexts, sexual identities and capital all bent to the complex 
analysis of reproduction, kinship and replication.
The COVID-19 pandemic revealed inequalities internationally as well as intra- 
nationally. Vaccines were first injected into people in developed countries, 
 especially those with their own capacity for vaccine production, despite prom-
ises from pharmaceuticals and the countries controlling them to supply Covax, 
the international vaccine bank for worldwide, affordable and timely distribution. 
Arguments by infectious disease experts that in order to beat the pandemic all 
people throughout the World need to be vaccinated simultaneously, were muted 
as in the mediocre relief response mounted in the face of India’s desperate calls 
for help as their hospitals were overwhelmed during a third wave in the spring of 
2021: oxygen supplies crashed and infection and death rates skyrocketed. While 
many within developed countries also suffered and lost jobs, livelihoods, their 
homes, and access to medical care. Migrant workers and others supporting the 
supply trains in well-stocked countries, such as those in the surrounding areas 
of Toronto, suffered exponentially higher rates of Covid infection and death 
due to living and working in crowded and cramped conditions, with politicians 
dragging their feet on targeting these essential workers for vaccination. It is this 
systemic fracturing of society by geopolitical location, by citizenship, by job 
security, by class and by race and ethnicity that underlays reproductive  justice. 
In contrast to nationally protected individualized rights and liberal promises 
that all should have rights, reproductive justice focuses on interconnected and 
130 Reproductive rights and justice
population-based discriminations that bleed across state borders worldwide. 
Think about the unexpected drop in birthrates in developed countries during 
the pandemic. Many thought the lockdowns would increase the birthrate, but 
job risks, housing and food insecurity, families devastated by sudden deaths due 
to Covid and the strain of at-home schooling (predominantly affecting women 
of all socio-economic backgrounds) had people opting for family planning.
What happens if the logic of neo-population control goes genetic? How will 
what Murphy calls “the infrastructural distribution of life chances” shift as ge-
netic medicine goes mainline and publicly offered on stock exchanges, genetic 
research requires more basic material and we accept pre-implanted genetic engi-
neering (PGE) which has already been tried by a rogue Chinese scientist and is 
the next logical step from PGD and PGS. The bioethics professor at Dalhousie 
University and a key participant in the 2015 International Summit on Human 
Gene Editing, Francoise Baylis, examines the new kid on the genetic engineer-
ing block, CRISPR-Cas9, which may have a lot to do with our next steps in the 
biomedicalization of human being.
Jennier Doudna and Samuel Sternberg provide a clear description of CRISPR 
Cas9 and how it was fashioned into a highly effective genetic engineering tool. 
Streptococcus thermophilus (S.T.) is a powerful lactic-acid bacteria often found in 
the colon and also used worldwide to culture cheese and yogurt – a significant 
component of the planet’s food chain. When S.T. was found to be vulnerable to 
attack from bacteriophages (or phages which are actually viruses), there was great 
motivation to find a solution. By exposing the “workhorse” bacteria to some of 
the phage itself, scientists at Danisco, a large yogurt producer, found that it effec-
tively vaccinated the bacteria against infection. This not only protected a large 
food source but also revealed that bacteria have clever immune systems, capable 
of genetic engineering. When the scientists sequenced the bacteria’s genes, they 
kept coming across odd, repeated fragments of DNA. At first, they treated these 
sequences as annoying but then realized these fragments were the bacteria’s way 
of keeping a genetic record of viruses that had infected them – a crude immune 
system involving a form of genetic profiling. If the virus attacked, it would be 
recognized by the bacteria, and a powerful enzyme would be summoned which 
would cut out the virus from the bacteria’s DNA. The repeated segments that 
identified the dangerous virus were named in 2000 as “clustered regularly inter-
spaced short palindromic repeats” or CRISPR.
Cas9, the enzyme in the bacteria that acts like a pair of scissors and identified 
in 2005 and worked on by various scientists over the next nine years, was sim-
plified as an effective and easy-to-use genetic engineering cut-and-paste tool in 
2012 by the collaborating scientists, Jennifer Doudna (University of California, 
Berkeley) and Emanuelle Charpentier (Max Planck Institute). CRISPR-Cas9 
could now be programmed to target specified segments of DNA by loading the 
enzyme with the corresponding RNA. Once it locates its match, the enzyme 
would cut out the matched sequence and replace it with the desired genetic se-
quence which the enzyme also carried. The implications were staggering. Since 
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the externalization of an entire human genome with the advent of human IVF 
in the late 1970s, geneticists have been eager to engineer human genes but were 
prevented by the lack of engineering tools that could work on microscopic yet 
complex entities. And the risk of getting things wrong gave rise to the 40-year 
moratorium on implanting any genetically engineered human embryo or gam-
etes (sex cells that when altered affect all progeny), until recently when a Chinese 
scientist announced late in 2018 that he had used CRISPR Cas9 to genetically 
alter a selection of pre-implanted embryos to resist the HIV virus, and then 
implanted them. Twin girls were born as a result. Carl Zimmer of The New 
York Times announced the news with the headline: “Genetically modified people 
walk among us.”
Both the Chinese government and the scientific world reacted in horror and 
denounced the research. Baylis points to several ethical concerns raised by the 
Chinese story. First, she points to how voraciously fellow scientists criticized 
and condemned the scientist for taking this extraordinary step and grilled him 
on ethical matters such as consent. Baylis’ account leaves us wondering whether 
this reaction masked professional rivalry and that perhaps there were others using 
CRISPR Cas9 on human embryos and gametes, but less publicly. Implantation 
of genetically engineered embryos remains largely untried because of the cascad-
ing effects which cannot be predetermined or controlled; it is a step too far. On 
the other hand, somatic gene editing is widely embraced as more and more cures 
for those with genetic-related disease and illness emerge; genetically engineered 
chemotherapy is already in practice. Baylis warns that things are moving fast in 
the realm of pre-implantation embryo genetic engineering and there needs to be 
an inclusive, broad-based and carefully reasoned plan for a way forward: repli-
cation justice? Doudna warns of the same in A Crack in Creation – Gene Editing 
and the Unthinkable Power to Control Evolution. This level of control in a world so 
divided by various and dominant interests is more than daunting. How would 
averted births become averted replication? How would geneticists harness repro-
duction and those who reproduce to their ideals of who and what is replicated? 
And, as the pandemic has taught us well, these little animals (viruses and genes) 
don’t pay attention to our borders, national or corporeal.
Conclusions
As soon as the NRTs emerged as something medical practice could take up, 
critical voices spoke of continued issues with the medicalization of reproduction, 
especially for women. These included the level of experimentation and interven-
tion in female reproductivity that could cause individual harm. Matters of rights 
to access the technologies and in what role also arose. Reproductivity, especially 
female reproductivity, was partitioned and placed in a hierarchy reflecting exist-
ing structural inequities including class, race and globalization. Critiques moved 
from liberalized notions of rights to reproductive justice and a much bigger pic-
ture came into clear view far beyond the IVF clinic. Contradictions abounded: 
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some people were worth the effort and resources to reproduce no matter what, 
while populations of Others remained a source of concern in terms of their birth 
rates (or right to reproduce at all). Members of communities long denied access 
to family formation have to participate in the exploitation of maternity. And 
through it all runs commerce or, as Farida Akhter, one of the founding members 
of FINRRAGE, argued, relations of reproduction cannot be severed from the 
relations of production. There are large profits riding on the use of reproductive 
hormones; on surrogacy contracts here and abroad; and on the gathering, storing 
and transporting of human gametes and embryos. And there are unimagined 
profits in harnessing the power of genetics, which is now at hand.
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Breaking it down and winding it up: women and NRTs
We started this examination of gender, reproduction and technological devel-
opment by examining what reproduction has meant as far back as we can trace. 
We moved from elaborate prehistoric symbols and carvings through the first 
 recorded thoughts about reproduction, through the ups and downs of making 
sense of this essential and mysterious activity. Body parts were increasingly 
atomized,  mechanized and engineered. And through it all there was woman. 
Woman whose body swelled and who pushed out babies, and who then nursed 
those babies’ development. Woman portrayed as a divine creator for these live- 
giving qualities. Woman is different than man in both external and increasingly 
 visualized internal body parts. Woman as inferior to man in the meaning made 
of reproduction despite the greater obvious involvement; quality trumped quan-
tity as a reflection of growing beliefs in masculine creators in the abstract.
Women: As modern civil societies settled and science soared, reproduction was 
funnelled into expected, heteronormative family forms with still potent bless-
ings from religious authorities and a new voice added to the chorus: medicine. 
At times sneaking it and at times grabbing it, the emerging medical authority 
over reproductive matters took control away from traditional birth attendants, 
chiefly female midwives, and claimed it as their territory. Pregnancy and birth 
were treated as illness and in need of medical attention, and so women were 
 hospitalized and medicalized at exponentially higher rates than men. Mean-
while the steady drum of social control of reproduction by moral authorities 
 continued, trying to keep from women what doctors were learning that could 
control  reproduction chiefly in woman’s bodies. And women continued to bear 
the brunt for reproducing outside of expected norms as gametes (eggs and sperm 
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cells) pay no attention to religious, moral and legal sanctions and as pregnancy 
ends up in the lap of women.
And as women, people organized the clandestine exchange of contraceptive 
information, the development of effective contraceptives and access to safe abor-
tion, because if not them, then who? As early proponents of family planning 
argued, if women were to enjoy the benefits of modern society and improved 
qualities of life, they had to be able to manage and limit the number of their 
children. This was also the germ of the key principle behind global policies of 
population control where once again pregnant bodies often, not always, were the 
target of attention. Those most influential in the flow of global capital worried 
about the relatively substandard quality of life in these places, but most of all they 
worried about the effect of these growing populations on the entire planet, as-
suming it had a finite carrying capacity. Their ideal future was Star Trek: diverse 
populations well controlled in number, civil, capable of incredible technological 
development, never hungry or without work and free to explore new worlds 
and spread their programme for success and well-being. In the popular TV and 
film series, women looked and behaved a lot like men (except when an exotic 
sexual other served), and there was rarely a pregnant body to be seen. This was 
a universe with no apparent struggle over finite resources and reproduction was 
taken for granted, like the 1960s as idealized through American popular culture 
of the time.
However, in the actual state of affairs in 1960s America, the connection be-
tween birth control and population control was not lost, especially on Black 
Americans, Indigenous people throughout North America and Australasia and 
Others globally. Besides massive programmes designed by developed countries 
to reduce birthrates in developing countries, the control of subpopulations of 
women in developed nations occurred and continues today through various 
means, mostly involving financial incentives or disincentives; manifest and l atent. 
The struggle for individual woman’s right to choose when to reproduce and how, 
became a different kind of struggle for women brutally targeted as bearers of the 
“better-not born.” It involved and continues to involve struggles over structured 
inequities and injustices, often racialized, including access to decent standards 
of living, to healthcare and employment and to personal and community safety.
And now the word “woman” is under question. Its reproductive determina-
tion has become unhinged as those identifying as and appearing to be not women 
become pregnant and give birth, and because of the demand for a growing work-
force of gestational carriers and egg donors (also neither women, nor mothers). In 
keeping “woman” here, the purpose is not to blindly accept historical parameters 
of what constitutes a woman, but to acknowledge a pretty long history of the 
careful patrolling of those parameters.
And: Why such a fuss about such a little word like “and,” and one that only con-
nects normally bigger and more important words? Because the nature of that con-
nection matters. The phrase, women in reproductive technologies is far different 
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than, women and reproductive technologies. The former speak to gender and 
the medicalization of infertility perhaps or to the ongoing matter of women’s 
access to a long male-dominated medical profession. Both are important issues 
and part of the phrase with the and. But this phrase is more open, and the enti-
ties on either side of the little word stand close but independent of each other. It 
allows more discussion including the struggle for women’s independence from 
the material injustices, inequities and constraints arising from various ideologies 
of reproduction. It provides space between the two, perhaps too much for some 
who see gender itself as a technology or others who see NRTs as an opportunity 
for women’s employment or as an answer to infertility. But those discussions 
are not prohibited by the use of the little word, and. Finally, the use of or and as 
paints a bleak and dehumanized picture. The important point here is that and is 
a carefully chosen word.
New: By now there should be at least some appreciation for how the so-called 
new reproductive technologies drag along with them old assumptions about who 
has the right to reproduce and that medical and scientific authorities always act in 
the best interests of those they administer to. It is true that the externalization of 
conception from the human body is a significant threshold to profound disruptions 
of kinship and the genetic engineering of human beings and represents something 
new. Also, the medicalization thesis concerned with growing commercial inter-
ests in healthcare and pharmaceuticals morphs into heightened financial specu-
lation in fertility clinics, in a growing trade in human gametes and reproductive 
capacities, as well as in many highly promising medical applications of embryo 
research and stem cell lines. Various businesses have been poking around repro-
duction for new markets throughout the 20th century: harnessing the powers 
of reproductive hormones as anti-ageing treatments, increased medicalization of 
pregnancy and childbirth through the routinization of urine and blood tests and 
visual scans, genetic screening of in utero embryos to help eliminate children born 
with Down’s syndrome and spina bifida, and rising caesarian rates at birth includ-
ing the possibility of elective C-sections. New meant value-added options to the 
host of reproductive services available to those who can afford them including 
scanning and diagnosing embryos pre-implantation to avoid the difficult decision 
to abort if a genetic anomaly is discovered. Now, male infertility can be addressed 
during IVF by injecting a single sperm into the harvested egg, and gamete and 
embryo donation and surrogacy open a host of new possibilities for not only 
the medically infertile but those called socially infertile (non-heterosexuals and 
singletons). Again, even this disruption of genetic lineage and non-heterosexual 
family formation is not new. Women can choose to reproduce with people outside 
of condoned relationships and have done so for a long time. With more difficulty 
and considerable assistance from women, men can and have done so as well. It is 
the case that the access to genetic-based family formation is very new to trans and 
non-gender binary folks and is not available to non-heterosexuals everywhere. 
Also new is a markedly increased emphasis on genetic links to children, again in 
places where and among people who can afford it.
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The social control of reproduction also remains. Access to NRTs is far from 
universal, and places where infertility rates are rampant due to subsistence li ving 
and high rates of sexually transmitted disease are the least likely to be offered 
fertility services. There are very few places on the planet where high-end f ertility 
services (the NRTs with genetic screening) are offered with no cost to the pa tient. 
Meanwhile undesirable populations or ones considered problematic because of 
their poverty, their dependencies, their race and their sexual identity are targets 
of plans designed to reduce their birthrates, openly, underhandedly or through 
neglect of root and systemic socio-economic disparities. With the hand-in-hand 
development of NRTs and genetic engineering, the technologies of birth control 
may go viral, or eugenic: old ideas of the social control of reproduction meet new 
means of doing so.
Reproductive: Our understanding of reproductivity has developed substantially 
from nonsexual pregnancy and birth to theories based on what could be seen 
outside the body, and then to breaking down reproductive parts and increas-
ing our knowledge of the natural engineering of reproduction with advances in 
anatomy, neurology, circulation, hormones and finally genetics. But reproduc-
tion is not just science, it is also kinship, heavy with meaning and culture, and we 
work hard to control it morally, defensively, desperately and socially. The story of 
reproductive technologies includes these systems as well – who has been allowed 
to reproduce, who is allowed to keep their children, who is allowed to hold on to 
their meaning of pregnancy and birth and children and who is allowed to choose 
when they reproduce and under what conditions. It is a complex socio-cultural 
machinery that has developed over ages and still varies from place to place.
But we also need to acknowledge the difference made in that complexity of 
reproduction by the externalization of conception and the exposure of a fully 
formed cluster of human cells to manipulation, and the speed with which the 
changes have happened. In one generation we have created the ability to trans-
fer human gametes and embryos from one body to the other so that biological 
 parents are not necessarily legal parents who are not necessarily genetic parents. 
We can freeze and store human gametes and embryos and play around with time, 
having one twin born twenty years after the other. We are getting good at exam-
ining early embryonic clusters of cells and can now operate on the chromosome 
itself by moving DNA more and more precisely in and out of the chain. Much 
of these techniques are thanks to previous applications in breeding nonhuman 
mammals for the food industry and to a lesser degree trying to save animals 
 facing extinction.
This leads us to the question of when does reproduction become replica-
tion. During the pandemic, birthrates in developed countries dropped adding 
to an  already downward trend and causing considerable concern (many were 
 expecting an increased birthrate). The global birthrate is often evoked in terms 
of environmental sustainability, whereas national ones tend to be discussed in 
terms of financial sustainability. And in the complex algorithms of national econ-
omies, lowering birth rates can reach a tipping point (2.1 children per woman) 
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that spells economic decline: There are not enough people to replace the ones 
already here, or “who is going to look after me in my old age?” In response 
and during the pandemic, China recently increased its one-child policy to three 
children per woman, but young urban people in China hesitate to move beyond 
one child due to the cost of rearing children. There will likely be more national 
strategies to address dropping birthrates around the globe as an issue of flows and 
replication of capital. Breeding doesn’t seem like such a strange possibility.
Technologies: The word technology is probably the most loaded one in this 
phrase. It is so easy to reduce it to the mechanism, the specific surgical procedure, 
the thing. But never is technology only the thing. Systems of knowledge swirl 
around and through the thing; it does not spring fully formed from the earth, the 
lab or the factory. How seeds of curiosity are planted and allowed to grow follow 
power lines such that ideologies (heteronormativity, population control equals 
 development, the medical-genetic industrial complex) are more a reproductive 
technology and the engineering of genes than IVF and CRISPR-Cas9. Focus 
only on the later and you see little and understand even less.
What’s next? Kinship and biomedicalization in the 21st century
There are several reasons for reviewing the long history of reproductive thought. 
For one, this demonstrates how ideas have changed over time. For another, it also 
demonstrates the fallibility of science, even contemporary science. And finally, it 
demonstrates how political interests not only guide scientific and technological 
developments, it can blind them, sociologically speaking. Below is a selection 
of recent socio-technical developments hinging on reproduction as illustration.
In Chapter 1 we saw how even in modern medical science, the human egg is 
characterized as massive and passive in contrast with the mobile and c ourageous 
sperm. This gender discrimination follows a two millennial-long trajectory  starting 
with Aristotle’s theory that women provide the dumb matter and men provide 
the intelligent matrix in human reproduction. Today, the difficult-to-freeze hu-
man egg is revealing more mysteries and opening new pathways. In 2021, Nidhl 
Subbaraman announced in Nature that multiple labs are able to generate human 
blastocysts (about four-day-old embryos) from stem cells. Besides the serious eth-
ical concerns with such research, the achievement relies on developments in early 
embryology and the technical mastery of manipulating that relatively giant egg 
as it starts to divide into pluripotent cells immediately following fertilization. 
Artificial blastocyst generation involves turning stem cells into eggs that are then 
fertilized by sperm, and this research leads to the comment in another 2021 article 
from ScienceDaily: “Oocytes [eggs] are extremely unique because of their ability 
to bring forth the over two hundred kinds of highly differentiated cells needed 
to create an individual person.” Eggs are active agents and genetically versatile.
Eggs are a source of incredible hope, reports Sam Anderson, as two northern 
white rhinos, Najin and Fatu (mother and daughter), face extinction. They are 
the last two on Earth. Their eggs were carefully collected in 2019 in the hope 
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of fertilizing them with the frozen sperm of one of the last males of the species 
and implanting the embryos into a southern white rhino surrogate. IVF and the 
manipulation of gametes, including cloning, have circled back from their origins 
in animal husbandry to play a significant role in species preservation. This is 
a good thing, as the UN declared in May 2019 that we face a mass extinction 
event of 1 million plant and animal species. But it isn’t infertility that wiped out 
these species. It is profound disruptions to natural habitats, over-farming and 
over-hunting and poaching or simply, human development. Just as prehistoric 
cultures mixed the fertility of humans with the abundance of the world around 
them, we are starting to understand the worldwide web of reproductivity, not 
only among humans but well beyond to other animals, trees, fungi and to en-
tire ecosystems including weather and other atmospheric events, terrestrial and 
spatial. But we do remain fascinated with the gene as a nexus of control or “life 
itself,” as Sarah Franklin describes it. We hang on to the hope of genetically pre-
serving what we are losing.
We also continue to describe and explain genetically what we can, includ-
ing recently mothering. Abigail Tucker in her book, Mom Genes – Inside the 
New Science of our Ancient Maternal Instinct, explains how some mammals, humans 
and a few long-lived whale species stay around to help their daughters mother. 
Tucker provides ample examples of positive outcomes, physical and mental, for 
children and their mothers with grandmothers present and helpful, no matter 
what their socioeconomic backgrounds. In whales where the females continue 
to live after their reproductivity ends (a rarity among animals, including almost 
all mammals), they provide maternal direction to the young mothers and food 
source information to the entire pod that increases the chances of the species’ 
survival, another form of reproduction and another way of understanding sur-
vival of the fittest or evolution that relies on mothering. They believe that the 
primal mother–daughter relationship is etched in our brains. And in 2021 Jen-
nifer Pinkowski reported on recently unearthed evidence that women governed 
during the prehistoric Bronze Age (3300–1200 BCE).
Another part of the degradation of female reproductivity is the association 
of menses with failed reproduction and the discarding of unused material, with 
a similar sense of lack associated with menopause. This attitude has led to the 
marketing of hormone contraceptive pills so that women experience their period 
only four times a year as liberating. And as pregnancy and birth were medicalized 
during the 20th century, menopause stood out for the lack of medical and health 
attention it garnered. According to the gynaecologist Jen Gunter who published 
in 2021 The Menopause Manifesto on the 200th anniversary of the naming of the 
term, we are very ill-informed about what menopause is medically and we need 
to address the stigma associated with it. Gunter describes a “medical silo” where 
menopause resides today, leaving women in the dark, unable to talk about what is 
going on in any positive terms and often afraid to approach physicians with their 
questions or concerns. Post-menopausal women’s sexual lives are often consid-
ered worthless, and many internalize this.
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Gunter’s approach differs significantly from previous pharmaceutical ones 
that aimed to return women to premenopausal hormone levels with hormone 
 replacement therapy (until they found links to hormone sensitive cancers). In the 
June 6, 2021 issue of The New York Times, the reproductive hormone pharmaceu-
tical, Organon, placed a full-page ad proclaiming, “The next big advancement 
in women’s health” over a picture of a giant microphone. Organon is setting 
itself up as a “new global women’s healthcare company” and wants to hear from 
women everywhere. The hormonal contraceptive market is estimated to reach 
$20.55 billion by 2026, while as many as 20 million American men at any one 
time (most of whom are over 50) are reported by David Cox to medicate with 
Viagra chiefly to reverse impacts of ageing on their sexuality. Pfizer has earned 
$1.8 billion from Viagra since the early 2000s.
Medical interventions in pregnancy and birth have settled into the politi-
cal economic and racialized lines that divide populations throughout the world 
where wealthy, chiefly white women hold the most options to customize their 
maternity care with very low risks to themselves and their children. Those on the 
other side of these lines are at much higher risk for prenatal and perinatal issues 
with spotty to no access to basic healthcare, nutrition and domestic safety and 
soundness. But all is not over on the medicalization of old reproductive technol-
ogy: take for example infant formula and breastfeeding. Jenny Kleeman inves-
tigates two companies that emerged in 2019 that create artificial human breast 
milk, one of which, Biomilq, has gained significant investment ($3.5 million) 
for upscaling operations from the Bill and Melinda Gates Foundation. Biomilq 
developed a technique to culture mammary cells in vitro from cell lines purchased 
through commercial suppliers for breast cancer research. These cells line the 
mammary glands and once cultured in the lab start to produce milk, which can 
be collected. The targeted market includes women who have trouble breastfeed-
ing (physically, psychologically and socially) where the artificial milk is intended 
to augment the mother’s breast milk. They also hope to offer custom-produced 
milk from the mother’s own breast cells. The other company, Singapore’s Turtle 
Tree Labs, uses stem cells to produce and culture mammary cells and plans to 
license its technology to the world’s largest infant formula suppliers. However, 
no artificial milk can reproduce the capacity of a nursing mother’s body to ad-
just their milk according to ambient temperature (watering it down when more 
hydration is needed), to fight viral and bacterial infections and to provide the 
benefits of hormones and bacteria from the mother’s biome. What artificial milk 
addresses are problems associated with using nonhuman milk (intolerances and 
allergies) as the basis for infant nutrition among the world’s wealthy: Turtle Tree 
Labs estimates it costs them $30 litre to produce artificial human milk. Infant 
formula promoted in developing countries has long been criticized for masking 
global economic disparities, placing women and children at risk and providing 
profits for multinationals.
Meanwhile body-produced breast milk has been found to be an important 
source of COVID-19 antibodies for newborns, thanks to the quick-thinking 
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doctor and director of a Toronto human milk bank, Sharon Unger. While a wave 
of Covid patients filled intensive care units, including pregnant women and those 
who had recently given birth, Unger collected, pasteurized, and stored the breast 
milk to help these women feed their babies once they recovered. This led to 
studies of the transmission of the virus through breast milk and to findings that 
agents in the milk were found to block transmission of the virus through nursing, 
pasteurization kills the virus and mothers pass on COVID-19 viral antibodies to 
their nursing infants. Scientists in New York and Israel as well as Toronto are 
now exploring viral antibody production in breast milk for much broader appli-
cations (a new form of wet nursing). Women, especially those vulnerable to the 
heavy marketing of baby formula in developing countries in the face of restricted 
water sanitation and nutrition, forgo passing on these protective measures to 
their infant children as they simultaneously face greater risk of being affected by 
the virus due to global disparities in basic healthcare provision, including access 
to vaccines.
Reproducing bodies become a nexus for so much more than reproduction. An 
important side effect of the medicalization and routinized monitoring of preg-
nancy has led to the development of a tracking tool for the COVID-19 virus and 
its variants. Pregnant women’s leftover blood samples from public health units 
across Canada are being examined with the support of the federal COVID-19 
Immunity Task Force. They are hoping for a national picture of how the vi-
rus and its variants spread across the country. As with Toronto’s milk banking 
story above, this started as an initiative to explore the virus’ effect on pregnant 
women and potential transmission to their infants. Contemporary midwives led 
by  Hannah Dahlen, argued in 2014 that how women give birth (vaginally or 
by C-section) will eventually change our biomes and genetic makeup due to 
“wicked” interruptions in what has long been exchanged between mother and 
newborn. In 2021, the genetic scientist Milissia Maamar and colleagues reviewed 
the current state of epigenetic inheritance of environmental factors including 
exposure to DDT on genetic expression over generations of people. Grand-
daughters of women exposed to DDT run higher genetic propensities to obesity, 
cardiovascular disease and breast cancer.
An extreme extension of medicalization of reproduction is found in the de-
velopment of the artificial womb, or ectogenesis, which was used successfully in 
2017 to bring a very premature lamb embryo to term by the foetal surgeon, Alan 
Flake. The transhumanist Zoltan Istvan asks if this can solve the abortion debate. 
By this he means that any women not wishing to continue with a pregnancy 
could relinquish the embryo to be brought to term in an artificial womb for 
prenatal adoption. There is a snag, however: the success with the lamb relied on 
the embryo being well developed, at the equivalent of about five to six months’ 
human gestation when placed in the artificial womb. Again, technological fixes 
to social problems appear with little regard for reproductive rights (in this case, 
the right to early abortion rather than the much more complicated and involved 
transfer of a five-month embryo), the potential health risks to the developing 
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embryo without the benefit of a pregnant woman and the risks to reproductive 
justice as decisions are made about which foetuses warrant ectogenesis in the case 
of extreme premature births. Keep in mind that as late as 2018 Linda Villarosa of 
The New York Times reported that twice as many Black infants in America died 
as white ones: 4,000 Black infant deaths in a single year. The US remains one of 
the 13 countries worldwide where the maternal mortality rate is rising, and its 
Centre for Disease Control reported that the number of preventable near-death 
events for birthing women between 1993 and 2014 rose 200%, to 50,000 in 2014.
And there are issues within the practice of assisted conception as well. Despite 
a push for young professional women to rely on NRTs to delay their reproduc-
tivity, Sarah Richards of The New York Times reported that in 2019 only about 
10–14% of women who had frozen and banked their eggs in a NYC area egg 
bank had come to claim them for reproductive purposes. Many of these women 
are now beyond reproductive age, and it is presumed they will never return for 
the eggs. While in 2021 a Rhode Island couple were shocked to find that there 
were embryos left over from an IVF procedure they underwent over 20 years 
prior that were still being stored at a fertility centre. They blame a lack of legis-
lation and oversight for stored gametes and embryos slipping through the cracks 
and not being used as they were intended. They are suing the fertility centre for 
breach of contract, negligence and intentional infliction of emotional distress.
Genetic engineering is gaining more public exposure and acceptance. A new 
sort of live genetic engineering museum and lab called Labiomista (meaning 
the mix of life) opened in Genk in Belgium in July 2019. Oliver Wainwright 
reports that here are artistic renderings, including taxidermy, of mixed breeds (a 
pheasant with an iguana’s head) along with live animals that the artist Koen Van-
mechelen has been breeding for over two decades. He is trying to create the most 
multicultural and genetically varied chicken in the name of genetic diversity 
to improve fertility, immunity and resilience. But Vanmechelen has chosen the 
slow path to genetic engineering; it would be far quicker to genetically engineer 
the chicken embryos with a tool that is capable of identifying specified genetic 
strands, cutting them out and replacing them with others with CRISPR-Cas9. Is 
this critique or preparation for the world to come?
We know CRISPR was used in China to engineer two humans currently 
alive who have been altered so that they never contact AIDs. We know that the 
scientific world reacted strongly, claiming this was too much human interference 
in sex lines too soon. And then the pandemic hit, and we all learned more about 
viruses with coronas, mRNA vaccines and viral evolution (variants). Jon Gertner 
of The New York Times Sunday Magazine signals this moment as a paradigmatic 
shift to an acceptance of genomics worldwide. Genomics is the sequencing or 
detailed description of a genetic code. It requires a large amount of computing 
power and initially was very expensive. Only one person’s entire genetic code 
was chosen for sequencing, starting October 1990 and completed April 2003. 
It took a multinational funding and scientific consortium to complete the task 
which cost over $3 billion. Developments in computing and genetic screening 
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have dropped the cost of genomics by 10 million times and increased the quality 
100,000-fold in the last few years. The pandemic offered the perfect opportunity 
for widespread and constant screening of the virus as it spread and mutated, 
which sent commercial genomics into high gear. The new genomic sequencing 
machine, Illumina NovaSeq6000 or Nova-seeks, was developed from the chiefly 
publicly funded human gene sequencing project and each machine costs about $1 
million (there are 1,000 of them in the world). They can sequence the genes of 
an entire virus in about two days, and because of a willing Chinese scientist who 
mounted on the Internet the genetic sequence of a novel virus just identified in 
Wuhan in January 2020, they have been sequencing COVID-19 from the start. 
This helped accelerate the development of vaccines and will help with handling 
the variants. There are also promises for other applications.
By doing widespread genomic sequencing of populations for specific diseases, 
say Alzheimer’s, you can learn a lot about the prevalence of the disease, its uptake, 
genetic profiles inclined to become diseased and the efficacy (another pandemic 
term) of treatment. Environmental factors in genetic disease can be uncovered. 
And PGS could come to mean pre-implantation genomic sequencing – the rou-
tine scanning of the entire genomic profile of an individual to map out things 
like propensities for certain kinds of disease. The social and moral concerns for 
this are considerable. If you are interested in seeing what they could be, see the 
film Gattaca; it is not as dated as it may seem.
Gertner states how some describe these galloping developments in genetic 
sequencing and socio-economics as platform technologies. CRISPR-Cas9, used 
on top of the genomic platform technology, spells out a world of commercial and 
industrial potential. The researcher Neville Sanjana of the New York Genome 
Centre uses CRISPR-Cas9, a cheap, quick and easy gene editing tool, to study 
human disease by modifying and repairing strings of affected DNA. He speaks of 
the need to continually check his work, which can now be done through cheap, 
quick and easy genomic technology. Now they are talking in the same breath 
about “prenatal health,” not just screening.
Another potential platform technology in this area is in vitro gametogenesis 
(IVG) or the creation of embryos from egg and sperm cells cultured from stem 
cells. They have managed this in mice, but the genetic stability in human cells is 
not certain. As sex cells combine there is always the risk of a genetic slip. Using 
sex cells that are induced from pluripotent stem cells may increase this risk for a 
variety of reasons not fully understood in the lab. The implications of clinically 
applying a technology like this has researchers holding back. For now. The po-
tential for commercial developments from a platform technology like this one, 
where human genes can be sourced and altered cheaply, quickly and easily, is 
almost unimaginable.
And then there are the reproductive disruptors. Zoe Beery follows Laurie 
Bertram Roberts who runs the Mississippi Reproductive Fund helping Black 
women negotiate the shame-bound and financially prohibitive circuit to abor-
tion in states where TRAP laws reign supreme. She treats her clients with respect 
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and helps to pay bills at home. Same-sex marriage laws have blossomed across 
the globe over the past decade or so, and there has been increased support for 
trans people, especially youth, as well as for increasing reproductive rights for 
LGBTQ2+ communities. These are promising signs of a significant disruption 
in the reproduction of sexuality (which has implications for our arrangement 
of sexual reproduction). And there has been serious backlash including the gay 
club shooting in Orlando, Florida, in 2016, leaving 49 dead and 53 wounded 
(the US’s second largest mass murder) and the brutal and deadly oppression of 
LGBTQ2+ people in Senegal, Brunei and Russia. It was somewhat hopeful to 
see that when Andrew Higgins reported on the small Polish town of Krasnik 
that attempted to keep itself LGBT-free, it drew unwanted global attention as 
Europe’s laughingstock and risked losing EU funding; Krasnik’s mayor moved to 
drop the resolution. And the pandemic left an unexpected drop in already falling 
birthrates worldwide as well as marked improvements to our natural world. We 
need to address what reproduction means to us, all of us, to the northern white 
rhino, to the rain forests of Brazil and to reach far beyond speculations on what’s 
in the test-tube to life as fully lived.
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reproductive technologies (and invitro 
fertilization and infertility/fertility 
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contraception; legislation of new 
reproductive technologies; LGBTQ2+, 
maternal rights, paternal rights; 
reproductive justice; sexuality; surrogacy
reproductive tourism 104, 107–108, 114, 
127–129; see also embryos; gametes; in 
vitro fertilization; surrogacy
Roe v Wade see abortion
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